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Abstract 
 
Glucocorticoids have been implicated in many processes including 
successful embryo implantation, placentation, and the growth and 
development of the fetus. Glucocorticoid treatment has been advocated as a 
treatment to improve reproductive outcome for a number of reasons. 
Prednisolone treatment has been associated with improvement in clinical 
outcome in women with recurrent miscarriage and improvement in outcome 
of In Vitro Fertilisation. Steroids have been found to reduce the high levels of 
uterine natural killer cells which have been associated with recurrent 
miscarriage and recurrent implantation failure. Glucocorticoids stimulate peri-
implantation human chorionic gonadotrophin secretion from trophoblast of 
early human embryo and accelerate trophoblast growth and invasion. 
Elevated uterine NK cell levels during the implantation window are 
associated with reproductive failure and can be repressed by oral 
glucocorticoids.  
We have shown that decidualizing human endometrial stromal cells 
profoundly up regulate the expression and activity of 11beta-hydroxysteroid 
dehydrogenase type 1, the enzyme that converts inert cortisone to active 
cortisol; thus establishing a local cortisol gradient and activation of 
glucocorticoid and mineralocorticoid receptors.   We also found that elevated 
levels of uterine natural killer cells in the stroma underlying the surface 
epithelium of endometrium are associated with defective decidualization of 
resident stromal cells, inadequate cortisol biosynthesis and suboptimal 
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induction of corticosteroid-dependent enzymes involved in lipid droplet 
accumulation and retinoid transport pathway. 
Thus, impaired decidualization limits the induction of a local cortisol gradient 
in the stroma underlying the surface epithelium. This in turn accounts for 
possible inappropriate recruitment of uterine natural killer cells and 
suboptimal expression of metabolic genes involved in lipid biosynthesis and 
retinoid storage pathway.  
Based on the findings, we postulate that patients suffering recurrent miscarriage 
associated with high uterine NK cell density may benefit from corticosteroid 
treatment in early pregnancy; although this assumption will need to be tested in a 
larger clinical trial. 
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1.0 INTRODUCTION 
1.1 The Human Endometrium 
 
The endometrium is the innermost glandular layer and functions as a lining 
for the uterus. The endometrium is a dynamic tissue which, in response to 
the cyclical changes in levels of oestrogen and progesterone, undergoes 
recurrent proliferation, differentiation and tissue breakdown (Jabbour et al., 
2006; Salamonsen, 2003).  The key role of the human endometrium is to 
orchestrate the events that lead to fertilization, implantation and pregnancy. 
The endometrium is composed of the basal and functional layers (Fig 1.1). 
The basal layer is the deep layer adjacent to the myometrium, while the 
functional layer is the superficial two-thirds of the endometrium. The 
functional layer is again divided into stratum compactum and stratum 
spongiosum. Stratum compactum is the superficial thin layer with gland 
necks and dense stromal cells while the deeper stratum spongiosum is 
composed of glands and loosely arranged stroma. The functional layer of 
endometrium is shed each menstrual cycle (Nair & Taylor, 2010). The basal 
layer remains after menstruation and undergoes only limited changes during 
the menstrual cycle (Aplin & Singh, 2008). Cyclical ovarian function is 
essential for the regeneration of endometrium ensuring endometrial 
receptivity in the next cycle. On an average, a woman undergoes around 400 
cycles leading to menstruation and about 2 pregnancies in her reproductive 
life (Teklenburg et al., 2010). Failure to acquire a receptive phenotype can 
lead to subfertility and an impaired decidual response can lead to pregnancy 
complications such as pregnancy loss. 
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Figure 1.1:    An Illustration of Human Endometrium. The inset shows cells of the single 
layered prismatic epithelium, the basal lamina and the blood vessels are shown enlarged. 
Also seen are few glands which reach the myometrium. Figure adapted from Human 
Embryology Online course in embryology for medicine students developed by the 
universities of Fribourg, Lausanne and Bern (Switzerland) with the support of the Swiss 
Virtual Campus  
 
 
1.1.1  Structure of the endometrium 
 
 The uterus is a pear-shaped, muscular, hollow organ with a triple-layered 
wall with an outer serosal surface, the fibromuscular myometrium and an 
inner complex mucosal endometrium (Cooper, 2000). The endometrium 
consists of a single-layered simple columnar epithelium with or without cilia 
(depending on how far along the menstruation cycle is) and its basal lamina, 
uterine glands, and a specialised cell-rich connective tissue (stroma) 
1. Single-layered epithelium 
2. Basal lamina 
3. Uterine glands 
4. Connective tissue 
5. Blood vessels 
A. Superficial functional layer 
B. Basal layer 
C. Myometrium 
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containing a rich supply of blood vessels (Gilbert, 2000). Invaginating from 
the mucosal surface deep into the stroma are the tubular uterine glands lined 
with columnar epithelium. The uterus derives its blood supply from the 
uterine arteries, which pass through the myometrium and splits into two 
types of endometrial vessels (Rogers, 1996). The arteries that cross the 
uterine walls and are responsible both for the myometrial and the 
endometrial blood supply are named radial arteries. As their minor branches 
arrive close to the myometrial-endometrial junction, they give rise to the 
spiral and straight arteries, which penetrate into the endometrium through its 
basal layer. The straight arteries are very short and small and they provide 
the blood supply exclusively to the endometrial basal layer. Their division into 
smaller arterioles, capillary and venous networks; follows the same pattern of 
almost all other tissues in the body. 
On the other hand, the spiral arteries, which are highly sensitive to oestrogen 
and progesterone, penetrate the endometrial functional layer, grow and send 
branches within it and exhibit very different and unique patterns. They grow 
in length much faster than the whole endometrium grows in thickness. These 
arteries have to "accommodate" this growth by continuously accentuating 
their coiling. The spiral arteries give rise to two types of smaller arterial 
branches: 1) the common ones (similar to all others in the body), which gives 
rise to the arteriovenous capillary plexuses and networks that nourish the 
functional endometrial layer; 2) arteriovenous anastomosis, through which 
branches of the spiral arteries merge directly into the endometrial veins, 
constituting a kind of vascular "shunt", without any previous division into 
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capillaries. As to the endometrial veins, they exhibit dilations named "venous 
lakes."  
 
 
Figure 1.2:    The Uterine blood supply (source: 
http://emedicine.medscape.com/article/1949215-overview) 
 
 
1.1.2  Cyclical changes of the human endometrium 
 
The human endometrium is a unique dynamic tissue which undergoes cycles 
of tissue remodelling which includes proliferation, differentiation, recruitment 
of inflammatory cells, apoptosis, tissue breakdown and repair under the 
influence of sex steroid hormones, oestrogen and progesterone (Chiazze et 
al., 1968; Al-Sabbagh et al., 2012; Aitken et al., 2008). After menstruation 
(days 1-5), the endometrium is a thin layer made up of the stratum basalis, 
containing the lower portions of the glands and spiral arteries. The circulating 
ovarian steroid hormones, both oestrogen and progesterone are low during 
menstruation which abolishes the negative feedback; hence the anterior 
   
20 
 
pituitary resumes gonadotrophin secretion. Follicular recruitment in the ovary 
occurs under the influence of these peptide hormones (Mihm et al., 2011) 
secreted by the anterior pituitary (Mihm et al., 2011). The developing follicles 
secrete oestrogen from granulosa cells, which in turn stimulates the remnant 
basal layer of the endometrium resulting in the proliferative phase. This 
phase lasts between 5-13 days. Epithelial cells rapidly proliferate to 
reconstitute and migrate to the surface to cover the denuded endometrial 
surface (Mihm et al., 2011). During this phase, the stromal cells undergo 
proliferation as seen by the mitotic divisions and the vascular endothelial 
cells proliferate causing the spiral arteries to lengthen and grow into the 
replenishing endometrium (Gellersen et al., 2007) and remain relatively 
straight. At the start of the proliferative phase, the glands extend only slightly 
into the stratum functionalis from the basal layer, however, by the late 
proliferative phase they would have extended onto the endometrial surface. 
As this phase progresses, these tubular glands become larger and more 
convoluted and mitotic figures appear. The endometrium grows from 1-2mm 
thick in the early proliferative phase to 5-6mm by the time of ovulation 
(Rogers, 1996). The surface and glandular cells acquire cilia and microvilli, 
which increase the cell surface area in order to improve the secretory and 
absorptive functions of the tissue. 
The increasing circulating oestrogen levels trigger the luteinising (LH) surge 
by day 14 which stimulates ovulation (Mihm et al., 2011). Ovulation marks 
the start of the progesterone driven secretory phase. Progesterone is 
secreted by the resultant corpus luteum following ovulation. The pre-
receptive endometrium in the days following ovulation (days 15-19), 
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becomes receptive during the mid-secretory phase (days 20-23). The post-
ovulatory rise in progesterone stops endometrial proliferation and induces 
differentiation or decidualization lasting for about 4 days (days 24-28) 
(Gellersen et al., 2007; Gellersen & Brosens, 2003; Brosens & Gellersen, 
2006). There is a dramatic remodelling of the endometrium along with 
characteristic cytoarchitectural changes in this phase. The glands become 
tortuous and sacculated with accumulation of glycogen, spiral arteries 
become increasingly coiled and there is influx of uterine natural killer (uNK) 
cells (Gellersen et al., 2007). The stromal cells undergo transformation to 
decidual cells, with associated oedema along with changes in the 
extracellular matrix (ECM). The endometrium is now 7-18mm thick. The 
decidualizing endometrial stromal cells form a cuff around the changing 
spiral arteries (Craven et al., 1998). The end of secretory phase is 
characterised by a thick stroma, which is highly vascularised with 
endometrial arterioles forming vascular clusters in the functional layer and 
absence of mitotic figures. This environment is favourable for blastocyst 
implantation. However, in the absence of a conceptus, the corpus luteum 
degenerates and the associated fall in progesterone levels induces 
spasmodic contraction of the spiral arterioles leading to ischemia of the 
functional layer. This layer is subsequently shed by menstruation (days 1-5). 
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Figure 1.3: Endometrial cycle under the influence of oestrogen and progesterone in 
proliferative and secretory phase respectively. Three different cell populations undergo 
changes from proliferative to secretory endometrium. The stromal cell population change 
from spindle shaped to more rounded decidual cells. The stromal cells become more 
confluent. There is increase in the number of uterine Natural Killer (uNK) cells in relation to 
the other leucocytes. The glandular cells undergo proliferation. 
 
1.2   Menstruation 
 
Menstruation is unique to a few species - the humans, old world primates, 
and wild fruit bats and elephant shrews (Zhang et al., 2007). It is also 
interesting that decidualization of the endometrial stromal tissue in the 
absence of pregnancy occurs only in the menstruating species, thus implying 
a functional link between these two phenomena. Menstruation is defined as 
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the shedding of the superficial functional layer of the endometrium in 
response to the reduction in circulating progesterone leading to overt 
bleeding (Tabibzadeh, 1996). Earlier studies indicated that hypoxia and 
tissue destruction causes menstrual bleeding (Zhang & Salamonsen, 2002; 
Salamonsen, 2003). Recent studies have shown evidence that breakdown of 
endometrium is characterised by apoptosis, loss of decidual features, 
infiltration of inflammatory cells (neutrophils and mast cells) (Lathbury & 
Salamonsen, 2000) and activation of metalloproteinase (MMP) (Salamonsen 
& Woolley, 1999). Also, local production of prostaglandins causes 
vasospasm of the spiral arterioles and subsequent ischemia and sloughing of 
the endometrium (Henriet et al., 2012). 
 
1.2.1  Purpose of menstruation 
 
Menstruation is thought to have a more defined purpose rather than just an 
evolutionary accident.  It is thought that cyclic endometrial decidualization 
and menstrual shedding is an example of physiological preconditioning that 
prepares uterine tissue for the dramatic vascular remodelling, reactive 
oxygen species production and hyperinflammation associated with deep 
hemochorial placentation (Brosens et al., 2009). Menstruation and 
pregnancy are both inflammatory events albeit of very different magnitudes. 
Both events are associated with variable degrees of uterine free radical 
production, oxidative stress, ischemia-reperfusion injury, vascular 
remodelling, and angiogenesis (Jennings et al., 1990; Otani, 2008). 
Therefore, it seems not only plausible but likely that cyclic endometrial 
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remodelling and menstruation preconditions the human uterus for pregnancy 
(Brosens et al., 2009).  
1.3   Decidualization 
 
In humans and in a small handful of species, decidualization takes place 
independent of conception. This is a progressive process occurring in the 
late mid secretory phase in a temporal and spatial fashion comprising of 
morphologic, biochemical, and vascular modifications initiated by the 
presence of progesterone after oestrogen priming (Ramathal et al., 2010).   
The implanting blastocyst initially apposes and attaches to the luminal 
epithelium of the endometrial lining about 6–7 days after conception. Soon 
after the epithelium is breached, the interface lies between trophoblast and 
decidual cells. The trophoblast invasion extends beyond the endometrium 
into the uterine junctional zone, which is the inner third of the myometrium 
(Brosens et al., 2010; Brosens et al., 1995). The decidua–trophoblast 
dialogue orchestrates the remarkably dynamic process by which the 
blastocyst becomes completely embedded in the uterine wall within a few 
days, as early as 10 days after LH surge (Norwitz et al., 2001; de Ziegler et 
al., 1998).  A defect predisposes to related pregnancy complications, 
including miscarriage, preeclampsia, fetal growth restriction, and preterm 
labour. Inadequate uterine receptivity is thought to be responsible for two-
thirds of implantation failures(Simón et al., 1998). 
 
Decidualization is characterized by transient local oedema, influx of 
macrophages and specialized uterine natural killer cells, angiogenesis and 
the extraordinary transformation of resident endometrial stromal fibroblasts 
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into secretory, epitheloid-like decidual cells (Gellersen et al., 2007; Brosens 
et al., 2009; Cloke et al., 2008), first apparent in the vicinity of terminal spiral 
arteries and then spreads throughout the endometrial compartment.   
Morphologically, the undifferentiated, elongated fibroblast-like endometrial 
stromal cells transform into enlarged round cells with specific ultrastructural 
modifications comprising of enlargement and rounding of nucleus, expansion 
of Golgi complex and rough endoplasmic reticulum along with cytoplasmic 
accumulation of lipid and glycogen droplets. The size increases by five times 
with an open vesicular nucleus and pale cystoplasm easily identified 
morphologically on standard haematoxylin and eosin (H&E) staining. 
Decidual cells develop multiple projections on the cell surface which extends 
into the ECM or indent adjacent cells and expresses desmin, α-smooth 
muscle actin and vimentin signifying a myo-fibroblastic phenotype (Oliver et 
al., 1999). There is emerging evidence that HESCs show an interesting 
mesenchymal-epithelial transition during decidualization (Li et al., 2010); 
where mesenchymal cells show invasive and mobile properties and epithelial 
cells show cell-to-cell cohesion and integrity of multicellular organs forming 
barriers separating internal and external environments (Micalizzi et al., 2010; 
Shook & Keller, 2003). Upon decidualization, HESCs expresses a myriad of 
genes characteristic of epithelial cells (Gellersen et al., 2007). 
 
Two of these genes, IGF-binding protein-1 (IGFBP-1) and prolactin (PRL), 
are preferentially induced in HESCs during decidualization and are therefore 
recognized as specific markers of decidualization (Gellersen & Brosens, 
2003; Giudice et al., 1993).There is concomitant laying of a peri-cellular rim 
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of extracellular matrices such as laminin, type IV collagen, fibronectin and 
heparin sulfate proteoglycan as part of their differentiation program (Dunn et 
al., 2003; Tabanelli et al., 1992). It is unusual for basement like extracellular 
proteins to surround mesenchymal cells in this manner (Loke et al., 1995). 
This rim of matrix along with IGFBP-1 is thought to provide the scaffold for 
trophoblast cells to move over in their passage towards the arteries and 
myometrium.  
 
1.3.1  Functions of the decidua 
 
Under the influence of progesterone, endometrial stromal cells become 
specialized epithelioid cells thus acquiring a secretory phenotype, which 
regulates numerous biological functions including trophoblast invasion, 
immunomodulation, hemostasis, angiogenesis and oxidative stress defence 
mechanisms, all of which are essential in ensuring a successful pregnancy. 
However, in the absence of pregnancy, the progesterone levels decline 
which in turn activates a sequence of events leading to tissue breakdown of 
the superficial endometrial layer and menstrual bleeding (Brosens & 
Gellersen, 2006). Both implantation and menstruation are considered as 
inflammatory events characterized by leukocyte infiltration and increased 
inflammatory mediator expression in endometrium. 
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1.3.2  Progesterone and cAMP signalling Pathways 
 
Progesterone 
Progesterone, estrogen and cyclic adenosine monophosphate (cAMP) 
together regulate the decidualization of human endometrial stromal cells in a 
time-dependent manner. Decidualization in vitro can be achieved by 
separating primary HESC’s and by culturing them with a combination of 
synthetic progesterone (medroxy progesterone acetate; MPA) and cAMP 
analogue (8-Bromo-cAMP; 8-Br-cAMP). The ovarian hormones progesterone 
and estrogen are essential for decidualization and mainly act through their 
respective receptors, i.e. progesterone receptors (PRs) PR-A and PR-B and 
estrogen receptors (ERs) ERa and ERb. The androgen receptor (AR) is also 
involved in decidualization (Cloke et al., 2008). Knock-out studies in mice 
have shown the absence of decidualization and implantation when they lack 
PR-A and PR-B (Lydon et al., 1995). PR-A is required to inhibit the 
oestrogen induced hyperplasia and limit the proliferative effects of PR-B 
(Mulac-Jericevic et al., 2000). Upon decidualization, HESC’s show down 
regulation of PR-B, rendering the PR-A as the dominant isoform (Mote et al., 
1999; Wang et al., 1998). 
 
Progesterone treatment alone induces a slow and minimal differentiation 
response in HESC’s taking up to 10days. Treatment with 8-Br-cAMP, the cell 
permeable analogue gives an immediate effect, although not sustained in 
long term cultures (Brosens et al., 1999). 
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Cyclic AMP signalling 
The in vivo activity of adenylate cyclase and cyclic adenosine 
monophosphate (cAMP) levels are higher in the endometrium than the 
myometrium and during the secretory phase (Tanaka et al., 1993). The 
cAMP signalling cascade is activated by the progesterone dependant 
decidualization of the stromal cells (Brar et al., 1997). Cyclic AMP was 
thought to be the initial activator of decidualization and to be crucial for the 
slow-acting progesterone pathway (Tang & Gurpide, 1993).  There seems to 
be more than one mechanism by which cAMP signalling sensitises HESC’s 
to progesterone. Cyclic AMP initiates decidualization with a sustained 
activation of the protein kinase A (PKA) pathway that sensitizes the stromal 
cells to the activity of progesterone (Gellersen & Brosens, 2003). The 
Luteinising hormone (LH)  surge and the follicle stimulating hormone (FSH) 
peak stimulate cAMP at first (Tang & Gurpide, 1993) and then relaxin, 
corticotropin-releasing hormone, prostaglandin E2 or human chorionic 
gonadotropin from trophoblasts take over the stimulation of cAMP until term 
if pregnancy occurs (Houserman et al., 1989; Tang et al., 1994; Telgmann & 
Gellersen, 1998; Makrigiannakis et al., 1999). 
 
1.4   Endometrial receptivity and window of 
implantation 
 
In placental mammals, the uterus differentiates into an altered state when 
implantation-competent blastocysts are ready to initiate implantation. 
Successful implantation is a subtle dialogue between the maternal 
endometrium and the embryo. A receptive endometrium is a prerequisite 
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from the maternal side (Giudice, 1999a) which lasts for a limited period of 
time.  The luminal epithelium undergoes precisely defined morphological 
changes until a receptive endometrium is developed. These changes were 
described as early as 1950 by Noyes, Hertig and Rock, and occur under the 
control of sex steroid hormones, oestrogen and progesterone. Uterine 
sensitivity to implantation is classified into prereceptive, receptive and 
nonreceptive (refractory) phases. During the prereceptive phase, the uterus 
is unable to initiate implantation; however the uterine environment is less 
hostile to blastocyst survival. In contrast, during the refractory phase, the 
uterine environment is unfavourable to blastocyst survival. The average 
length of the human menstrual cycle is 28-30 days.  During the secretory 
phase, the uterus is considered prereceptive for the first ~7 days following 
ovulation (day 0). Following this, days 7-10, the uterus becomes receptive, 
also known as ‘Window of Implantation’. The nonreceptive (refractory) phase 
comprises the rest of the secretory phase. The ‘implantation window’ is 
described as the period in the mid-luteal phase from day 19 to day 24, when 
implantation can take place (Navot et al., 1991; Dominguez et al., 2003) and 
is time limited (Wilcox et al., 1999). This corresponds to the time when the 
embryo hatches, 6 days after LH surge, and consequently ready for 
implantation within the following 24 hours (Aplin & Singh, 2008).  This 
synchronisation is also thought to serve as the mechanism to select against 
the developmentally compromised embryos (Teklenburg et al., 2010b). Also, 
Wilcox et al in 1999, demonstrated that implantation beyond the period of 
endometrial receptivity is strongly associated with early pregnancy loss 
(Wilcox et al., 1999). Reduced endometrial receptivity has been found in an 
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increasing number of unexplained infertilities (Lessey et al., 1995). Adequate 
development of endometrium in the proliferative phase under the influence of 
rising oestrogen is crucial for synchronisation of the maturation process in 
the progesterone mediated secretory phase which is necessary for 
implantation (Hoozemans et al., 2004). Opening of the implantation window 
is characterised by remarkable ultra-structural changes in the endometrial 
epithelial cell morphology which includes cytoplasmic protrusions of the 
endometrial surface arising from the apical surface of epithelial cells 
extending into the uterine cavity, known as pinopodes (Nikas, 1999). The 
pinopode formation and maintenance is dependent on progesterone 
(Stavreus-Evers et al., 2001). The timed correlation of pinopode expression, 
period of blastocyst hatching, along with the preference of the blastocyst to 
attach to pinopodes suggests that pinopodes are structural markers of the 
receptive endometrium (Aghajanova et al., 2008; Achache & Revel, 2006).  
 
Like every phase of the menstrual cycle, this phase of receptivity is no doubt 
orchestrated by many known and unknown genes regulated by autocrine, 
paracrine and juxtacrine factors. A number of molecules have been identified 
to be involved in this process, such as integrins and their ligands (e.g. 
osteopontin), mucins, growth factors (HB-EGF), cytokines (LIF, leptin, IL-1, 
IL-11, IL-15), homeobox transcription factors (HOXA gene products), lipids 
and other molecules (Aghajanova et al., 2008; Giudice, 1999b; Wang & Dey, 
2006). 
Since the development of microarray technology (Schena et al., 1995), many 
researchers have attempted to profile the endometrium in different phases of 
   
31 
 
the cycle. Each study has provided a list of candidate genes (Carson et al., 
2002; Kao et al., 2002; Borthwick et al., 2003; Mirkin et al., 2005; Riesewijk 
et al., 2003), but the number of common genes for ‘endometrial receptivity’ is 
small (Horcajadas et al., 2007). This poor consistency was possibly due to 
differences in the experimental design, data analysis, timing of the 
endometrial sample in the menstrual cycle, differences in the geographical 
location of the subjects and different statistical methods employed. Despite 
all these differences, molecular and genetic evidence indicate locally 
produced signalling molecules, including cytokines, growth factors, 
homeobox transcription factors, lipid mediators and morphogens, together 
with ovarian hormones specify the uterine receptivity and impaired 
expression of these receptivity genes is increasingly linked to common 
reproductive disorders. Although the luminal endometrial epithelium is the 
primary barrier in the implantation process, the progesterone responses in 
this cellular compartment that underpin the receptive phenotype are 
mediated by signals derived from the underlying stromal cells (Simon et al., 
2009) i.e. from decidualization of the stromal compartment. 
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Figure 1.4:    Endometrium in menstrual cycle showing the ‘window of implantation ‘or 
receptive period 
 
 
1.5   Implantation 
 
Implantation is a dynamic process involving embryo apposition, adhesion to 
the endometrial epithelium and encapsulation into the stroma (Loke et al., 
1995). This period spans from the time of blastocyst hatching to the 
formation of a primitive placental circulation system. The process is initiated 
upon contact between the blastocyst and endometrium. 
 
1.5.1  Pre-implantation embryo development 
 
Within 24 hours of fertilization, the zygote undergoes a regulated series of 
mitotic cell divisions. It is transported actively through the fallopian tube by 
the cilia and muscular contractions into the endometrial cavity, which lasts for 
four days. (Croxatto, 2002) At 4 cell stage, the genomic activation starts to 
switch from maternal to embryonic transcription (Duranthon et al., 2008).  
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The embryo then follows the 8 cell stage, the blastomere stage, the morula 
stage (16cells) and then the blastocyst before implantation.  The trophoblast 
cells (outer cell layer) undergo compaction, connected by tight junctions and 
microvilli with synchronous formation of a blastocyst cavity. The blastocyst 
will then hatch from the zona pellicuda, which is a glycoprotein membrane 
surrounding the oocyte. The blastomere cells are totipotent with the ability to 
differentiate into any cell type in the developing embryo. The first cells to 
attach and invade the endometrium are trophectoderm cells (Meseguer et 
al., 2001). The trophoblasts produce a number of cytokines, growth factors 
like human chorionic gonadotrophin (hCG), tumour necrosis factor-α (TNF-α) 
and interleukins, which signal the maternal tract to promote implantation 
(Chen et al., 2005; Merviel et al., 2001). The receptive endometrium 
responds to these signals leading to the cross-talk between the trophoblast 
cells and the endometrium mediated in an autocrine and paracrine manner. 
This cross-talk requires many molecules including integrins, matrix-
degrading enzymes, their inhibitors, growth factors, cytokines and their 
receptors, and modulator proteins (Giudice, 1999b; Nardo et al., 2003b; 
Nardo et al., 2003a).  
About 60% of all pregnancies in the pre-implantation period are unsuccessful 
due to various factors like poor quality embryo, chromosomal abnormalities 
and mosaicism (Brosens & Gellersen, 2010). Mosaicism however decreases 
drastically in the cleavage stage embryo (Santos et al., 2010).  
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1.5.2  Implantation process 
 
Implantation occurs 6-7 days post fertilization (Croxatto, 2002). On 
apposition of the embryo to the endometrial surface, there is binding of the L-
selectin expressed on the trophoblast with the oligosaccharide ligands on the 
luminal epithelial cells and a loose connection is established (Fazleabas & 
Kim, 2003). There is active communication between the trophoblast and 
endometrium conveyed by receptor-ligand-interactions (Aplin & Kimber, 
2004). After adhesion, trophoblast cells differentiate into syncytiotrophoblast 
on the outside and cytotrophoblast on the inside and invasion starts with the 
lytic activity of the syncytiotrophoblast weakening the endometrial structures 
enabling penetration. The blastocyst then penetrates the endometrial luminal 
epithelium into the endometrial stroma up to the inner third of the 
myometrium. The endovascular extravillous trophoblast cells invade the 
terminal spiral arteries, plugging them for several weeks before destroying 
the musculoelastic wall thus establishing high-flow, low resistance 
uteroplacental circulation (Grewal et al., 2010). By day 9, the embryo is 
completely embedded in the endometrium. Now the balance between the 
trophoblast invasion and the maternal restraint on invasion is essential to 
prevent detrimental effects on the mother (Emera et al., 2012). By day 10, 
the cytotrophoblast invades the entire endometrium and the inner third of the 
myometrium. The endometrium also has a selective role by being able to 
dispose the developmentally compromised embryos by triggering a 
menstrual like event   (Teklenburg et al., 2010b). Increased vascular 
permeability and neoangiogenesis mediated by vasoactive substances like 
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vascular endothelial growth factor (VEGF) and angiopoietin are critical for 
early placentation. 
For a successful implantation, there needs to be a co-ordinated development 
of a good quality embryo, a receptive and a selective endometrium 
specifically during the implantation window.  
1.6  Immunomodulation 
 
The father of reproductive immunology, Peter Brian Medawar in 1953, for the 
first time described the “paradox of pregnancy”, (Medawar, 1953). 
Intriguingly, the fetus escapes maternal immune rejection even though it is a 
semi-allograft comprising of both paternal and maternal genetic components. 
This pivotal question led to the birth of many studies looking at the immune 
cells in reproduction. 
 
1.6.1  Immune cells in the endometrium 
 
Leukocytes comprise approximately 30–40% of decidual stromal cells in 
early human pregnancy. During decidualization, there is an influx of innate 
immune cells. The population of immune cells in the endometrium and 
decidua are distinctly different to that of peripheral blood (Bulmer et al., 1991; 
Johnson et al., 1999). In particular, there are virtually no B cells and very few 
neutrophils (Salamonsen & Lathbury, 2000).  Three main cell types are seen: 
T cells, macrophages and uNK cells (also called large granular lymphocytes) 
(Bulmer et al., 1988) The numbers and proportions of each cell type vary 
through the menstrual cycle and in early pregnancy. Approximately 45% of 
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leukocytes are made of T cell leukocytes in the proliferative endometrium. 
Their absolute numbers remain constant throughout the cycle and in early 
pregnancy, however, their relative numbers decrease as the proportion of 
uNK cells increase (Bulmer et al., 1991). Macrophages make up 
approximately 15-20% of endometrial leukocytes; their numbers increase 
slightly during the secretory phase of the cycle and early pregnancy so that 
they comprise 20% of leukocytes in the placental bed in early pregnancy 
(Bulmer et al., 1988). The uNK cells however show cycle dependant 
changes. 
 
1.6.2  Peripheral Natural Killer (NK) cells 
 
Mature NK cells constitute 5-20% of the total lymphocyte population in the 
peripheral blood. There are two subsets of NK cells, based on their 
expression of receptors CD56 and CD16 (Moffett-King, 2002). The subset in 
the peripheral blood expresses CD56dim CD16+ and has cytotoxic and lytic 
activities. NK cells populate different peripheral lymphoid and non-lymphoid 
organs including lymph nodes, thymus, tonsils, spleen and uterus. (Freud & 
Caligiuri, 2006; Vosshenrich et al., 2006). 
 
1.6.3  Human uterine Natural Killer (uNK) cells 
 
The presence of granulated cells in the human endometrium was first noted 
in 1920. The cells were characterised by the presence of phloxinophilic 
cytoplasmic granules in the phloxine tartrazine stain (HAMPERL & 
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HELLWEG, 1958; Dallenbach et al., 1987). The phenotype of the uNK cells 
differ from the usual peripheral blood NK cells by being CD56bright and CD16-. 
There is a small subgroup of peripheral blood NK cells with this phenotype. 
However, the CD56bright NK cells in the peripheral blood is different to the 
CD56bright uNK cells in that those in the peripheral blood are less granular 
and less cytotoxic than the CD56dim NK cells (Cooper et al., 2001) whereas 
the uNK cells have characteristically abundant cytoplasmic granules and at 
least in some studies are able to efficiently lyse NK targets (Jones et al., 
1997). The uNK cells also differently express NKp30, NKp44 and NKp46, 
whilst the peripheral blood NK cells express NKp30 and NKp46 (Ritson & 
Bulmer, 1987; El Costa et al., 2009). They differ from the majority of NK cells 
found in the peripheral blood; the majority express CD56 and CD38 but not 
the classical T-cell or NK-cell markers CD3, CD4, CD8, CD16 and CD57 
(Bulmer et al., 1991). The CD56 expression is tenfold higher than the 
peripheral cells.  uNK cells are referred to as CD56bright and CD16- cells.  
 
Terminology: 
Many terms have been used for the granulated cells identified in the 
endometrium of many species, which are confusing and remain inconsistent. 
In humans, different names include: ‘granular endometrial stromal cell’ 
(HAMPERL & HELLWEG, 1958), ‘endometrial granulocytes’, based on their 
lymphocyte-like morphology, ‘K¨ornchenzellen’ or ‘K’ cells (Dallenbach et al., 
1987) and, more recently ‘endometrial (or decidual) granulated (or granular) 
lymphocyte (or leucocyte)’ (Bulmer et al., 1991).  With recognition of the 
diversity of NK populations in general and expression of NK receptors, it 
seems reasonable to adopt the term ‘uterine NK cell’, which emphasises that 
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these represent a special NK cell subgroup. In humans, uNK cells are not 
really ‘uterine’ but ‘endometrial’, being absent in myometrium. 
 
Localisation and distribution of uNK cells  
Uterine NK cells are a phenotypically distinct subset of NK cells and to date, 
similar cells have not been described in substantial numbers in other organs. 
Uterine NK cells have been identified in both non-pregnant endometrium and 
pregnant decidua. uNK cell numbers show the most dramatic menstrual 
cycle dependent changes. uNK cells are detected in the stratum functionalis 
in the late secretory phase and early pregnancy decidua, forming aggregates 
around spiral arteries and glands (Bulmer et al., 1991). Their differentiation is 
triggered by decidualization. Their numbers are almost equal to the T cells in 
the proliferative phase with an increase in numbers during the mid-secretory 
phase of up to 70% of the endometrial leukocyte population and continue to 
increase further in early pregnancy (King et al., 1989). Their numbers begin 
to decline by 14-16 weeks of pregnancy (Bulmer & Lash, 2005).There is little 
information about their distribution in the second trimester of pregnancy. 
However, there seems to be a decline in the uNK cell population to virtually 
nil at term (HAMPERL & HELLWEG, 1958; DALLENBACH-HELLWEG & 
NETTE, 1964).  
  
Origin of uNK cells: Trafficking from blood or in situ differentiation 
of uterine NK cells? 
It has been a matter of debate whether human CD56bright uNK cells arise 
from uterine progenitors or from other CD34+ hematopoietic progenitor cells 
in the implantation site. There is evidence supporting both trafficking of 
differentiated cells from the peripheral circulation and in situ differentiation 
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and proliferation (Bulmer & Lash, 2005; Manaster & Mandelboim, 2010; 
Manaster & Mandelboim, 2008). Reports suggest strongly that at least a 
significant proportion, if not all, mature human uNK cells arise from extra-
uterine progenitors in secondary lymphoid tissues and in the thymus 
(Manaster & Mandelboim, 2010).  
In the late secretory endometrium and early pregnancy decidua, uNK cells 
are seen in the functional layer forming aggregates around the spiral arteries 
and glands (Bulmer et al., 1991). This typical perivascular distribution was 
thought to be due to the diffusion of progesterone from the blood into this 
area. However, more recently, this is thought to reflect trafficking of uNK cells 
or their precursors from the circulation (Trundley & Moffett, 2004). The 
perivascular distribution could reflect a role in the remodelling of spiral 
arteries which is an essential feature of early pregnancy. There are however 
several arguments against the trophoblast induced trafficking of these cells. 
The uNK cells are seen prominently in the premenstrual endometrium in the 
absence of trophoblast and in the intrauterine decidua of ectopic pregnancy 
(von Rango et al., 2001). Exogenous progesterone also shows a similar 
effect. 
  
Human uNK cells are terminally differentiated cells found in the transient 
decidua. This striking association of the uNK cells with decidua is 
independent of the trophoblast. Even, areas of ectopic decidualization as 
seen on the ovarian surface or in the cervix in pregnancy invariably contain 
uNK cells. Comparably, these cells are seen in the intrauterine decidua of 
ectopic pregnancy (von Rango et al., 2001; Vassiliadou & Bulmer, 1998).  It 
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has been reported that peripheral blood NK cells from pregnant women had 
a greater migratory capacity through decidual endothelial cells and stromal 
cells than peripheral blood NK cells from males or non-pregnant women 
(Carlino et al., 2008). Also, upon treatment of decidual stromal cells with 
progesterone, there is increased migration of NK. The peripheral blood NK 
cells acquire a chemokine receptor pattern similar to that of decidual uNK 
cells (Carlino et al., 2008).   
 
On the other hand, there is evidence that the uNK cells originate from in situ 
differentiation of immature progenitor cells from the circulation. There are no 
reports of substantial numbers of ‘usual’ NK cells in endometrium at any 
stage of the menstrual cycle or in early pregnancy. There is however a report 
of local differentiation of uNK cells in the mouse and CD34- positive (Bilinski 
et al., 2008) as well as CD56- positive leukocyte stem cells in the secretory 
phase endometrium (Lynch et al., 2007). Incubation of peripheral blood NK 
cells in TGBβ1 has been shown to lead to conversion into a uterine NK cell 
phenotype (Keskin et al., 2007). Forty percent of CD56+ uNK cells isolated 
from the late secretory phase endometrium express Ki67, a marker of mitotic 
activity (Jones et al., 1998). Stromal mitoses are a recognised factor in 
premenstrual endometrium. This again suggests the possibility of local 
proliferation of uNK cells.  
 
Uterine NK cells and decidual cells  
The co-localization of uNK cells with the stromal cells is entirely independent 
of trophoblasts. Uterine NK cells have been detected in the intrauterine 
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decidua of ectopic pregnancies (Vassiliadou & Bulmer, 1998; King et al., 
1999)  and in foci of endometriosis which have undergone decidual change 
(King et al., 1999). The close association with decidualization suggests a 
possible role of progesterone in their regulation, however, uNK cells do not 
express progesterone receptors and are not functionally altered by 
progesterone (King et al., 1996; Stewart, 1998). The cells have been shown 
to express oestrogen beta receptors, prolactin receptors and glucocorticoid 
receptors (Gubbay et al., 2002; Henderson et al., 2003). The influence of 
progesterone is therefore likely to be via the stromal cells. The perivascular 
distribution of uNK cells suggests a close association with HESC 
decidualization as this is the first area to undergo predecidual change in the 
late secretory phase (Dallenbach et al., 1987). Also, the presence of uNK 
cells in the foci of endometriosis and in ectopic sites undergoing 
decidualization without prominent vascular supply leads to the possibility that 
the HESC’s could have a role in the differentiation of uNK cell, similar to the 
role of bone marow stromal cells in the NK cell differentiation (Rosmaraki et 
al., 2001). Interleukin-15 (IL-15) is necessary for the generation of normal NK 
cell numbers in vivo and HESC’s upon decidualization produce IL-15, at least 
in part apparently under progesterone control (Okada et al., 2000; Kitaya et 
al., 2000). It is therefore possible that uNK cell population is unique to the 
uterus and they differentiate from the precursor cells under the influence of 
HESC’s under the influence of progesterone (Bulmer & Lash, 2005). 
 
 
Function of uNK cells  
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The exact role of the transient uNK cell population has been of great interest 
to researchers. They were initially thought to be a potential threat to the fetus 
since early studies in mice showed increased numbers in abortion-prone 
animals (de Fougerolles & Baines, 1987). However, more recent studies 
suggest a positive role for uNK cells in the maintenance of pregnancy.  Mice 
knockout studies have shown that the placentae of uNK cell deficient mice 
are hypertrophic and result in fetal death (Guimond et al., 1997), thus 
showing that although they are equipped with cytotoxic killing machinery, 
they have limited killing activity. The suggested functional roles of uNK cells 
include: regulation of trophoblast invasion (uNK cells and macrophages), 
spiral artery remodelling (uNK cells) and immune tolerance (T cells, 
regulatory T cells and dendritic cells) (Bulmer et al., 2010).  
 
The uNK cells produce plenty of immunoregulatory cytokines like TNF α, 
TGF β1 and IFN γ (Interferon gamma) but the importance of these cytokines 
are not established (Bulmer & Lash, 2005). The tightly controlled invasion of 
uterine tissues and spiral arteries is an essential feature of pregnancy 
(Pijnenborg et al., 1983). The uNK cells have been found to undergo 
apoptosis a few days prior to menstruation, but are maintained if pregnancy 
occurs and when rescued by hCG (King et al., 1989; Koh et al., 1995).  This 
temporal and spatial distribution has led to speculation that they play a role in 
the control of trophoblast invasion. The role of cytokines and growth factors 
produced by uNK cells in the regulation of trophoblast invasion continues to 
be the interest of many studies.  
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In view of the spatial aggregation of uNK cells around the spiral arteries in 
early pregnancy and the fact the uNK cells are a major source of angiogenic 
factors (Lash et al., 2006; Hanna et al., 2006), recently, a new role has been 
proposed for these cells in the remodelling or transformation of the uterine 
spiral arteries in conjunction with the trophoblasts (Pijnenborg et al., 2006; 
Kam et al., 1999). Further evidence is provided from mouse studies that uNK 
cells are important for vascular remodelling in pregnancy although changes 
comparable with those in human pregnancy are not seen in mice (Croy et al., 
1997). This reflects a role for uNK cells in the mediation of uterine vascular 
changes rather than in control of trophoblast invasion. 
 
Where do uNK cells go? 
The uNK cells decrease by the end of the menstrual cycle and in late 
pregnancy. It has been reported that the uNK cells undergo death by 
apoptosis (Kusakabe et al., 1999; Hammer & Dohr, 1999). However, there is 
no evidence of apoptosis on Terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL) studies (Jones et al., 1998). The other possibility 
raised is that uNK cells degranulate in late pregnancy (Spornitz, 1992). 
There is no definite evidence regarding the fate of uNK cells. 
 
uNK cell population in Recurrent Miscarriage (RM)  
Recurrent miscarriage is defined as the loss of three or more consecutive 
pregnancies in the first trimester of pregnancy affecting approximately 1% of 
the population (Regan & Rai, 2000). The cause of repeated pregnancy loss 
is multifactorial. This could be embryological like abnormal embryonic 
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karyotype or maternal like causes which affect the endometrium and/or 
placental development (Aplin, 2000; Li et al., 2002). Maternal factors thought 
to contribute to recurrent miscarriage include coagulation disorders, 
autoimmune defects, endocrine disorders and endometrial defects (Regan & 
Rai, 2000; Li et al., 2002; Li, 1998). However, in half of the RM patients, no 
contributory factors are identified. It has been postulated that a proportion of 
these losses may be due to immune causes. 
 
Several studies have shown increased numbers of CD56+, CD16+ NK cells 
in the peripheral blood of women with RM either prior to or during pregnancy 
compared with healthy fertile non-pregnant or pregnant controls (Aoki et al., 
1995; Kwak et al., 1995). The peripheral CD56+ NK cell activity decreases in 
normal fertile women during the first trimester of pregnancy in contrast to the 
high activity of CD56+ NK cell activity in women with RM (Kwak et al., 1995; 
Higuchi et al., 1995). On the contrary, there was a decrease in the decidual 
CD56+ cells in placental tissues from spontaneous miscarriages in RM 
compared with tissue from spontaneous miscarriages in women without RM 
and women requesting termination (Yamamoto et al., 1999; Quack et al., 
2001). However, three separate immunohistochemical studies have shown 
increased numbers of CD56+ cells in the non-pregnant endometrium of 
women with RM (Clifford et al., 1999; Quenby et al., 1999; Tuckerman et al., 
2007) and lower numbers were seen in women with RM who subsequently 
had a live birth compared to those who miscarried (Quenby et al., 1999).  An 
explanation for these differences could be that the increased number in the 
endometrium could be due to CD56+, CD16+ cells as suggested previously 
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by  Lachapelle et al., 1996 (Lachapelle et al., 1996), while the decreased 
number reported in decidua could be the CD56+, CD16+ population. This was 
supported by a study in 2002 which showed increased numbers of CD16+ 
cells in early pregnancy decidua of women with RM (Emmer et al., 2000).  
 
1.6.4  HLA compatibility 
 
A conception must be recognized as non-self in order to trigger an 
immunologic process that prevents the maternal immune system from 
rejecting it. Inadequate response of the maternal immune system to 
stimulation by paternal antigens, due to HLA sharing, has been implicated in 
recurrent pregnancy loss (Carp et al., 1994) or recurrent implantation failure 
(RIF) (Elram et al., 2005). Such inadequate response may involve the 
imbalance of T helper 1:T helper 2 (TH1:TH2) response, causing the 
maternal system to be more cytotoxic. 
 
1.6.5  CD3+ T cells 
 
CD3+ T cells are the second most abundant population of leukocytes within 
the endometrium and decidua. No differences in the numbers of CD3+ T 
cells in endometrium were found between RM and control women 
(Lachapelle et al., 1996; Quenby et al., 1999). There was no difference in 
their numbers between early pregnancy decidua from normal fertile women 
and women with RM (Yamamoto et al., 1999; Quack et al., 2001) and in 
decidua from normal pregnancies and after spontaneous abortion 
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(Vassiliadou & Bulmer, 1998). The studies have shown a shift towards a 
higher CD4+/CD8+ ratio in endometrial biopsies from women with RM 
(Quenby et al., 1999; Lachapelle et al., 1996).  
 
1.6.6  Macrophages 
 
There was no significant difference in macrophage number in the first 
trimester decidua and in the decidua of spontaneous abortions between RM 
and control population (Quack et al., 2001; Vassiliadou & Bulmer, 1996). 
However, in the non-pregnant endometrium of RM patients, there was an 
increase in macrophages compared to the endometrium of RM population 
who had a live birth (Quenby et al., 1999). 
 
1.6.7  Cytokines 
 
Many cytokines and chemokines have been suggested to have a role in 
human implantation {van Mourik, 2009, Embryonic implantation: cytokines`, 
adhesion molecules`, and immune cells in establishing an implantation 
environment}. Amongst those studied include Interleukin 6 (IL-6), Leukaemia 
inhibitory factor (LIF), Interleukin 11(IL-11) and Interleukin 15(IL-15).  
 
Interleukin 11(IL-11) 
IL-11 and LIF are members of the IL-6 family. IL11 is identified as a growth 
factor acting on multiple stages during hematopoiesis, synergizing with other 
factors (Du, 1994; Paul, 1990). Their biological roles include proliferation, 
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differentiation and cell survival, all of which are essential for blastocyst 
development and implantation (Du, 1994). 
 
Both LIFR and IL11Ra are expressed by human endometrial epithelium and 
the ligands are upregulated during the receptive phase and secreted into the 
uterine lumen. Hence, they may act on the luminal epithelium to facilitate 
blastocyst attachment during implantation. They are found to increase 
adhesion of primary endometrial epithelial cells to fibronectin and collagen IV 
(Marwood, 2009) which are present on the blastocyst surface (Shimomura, 
2006) as well as in the first trimester trophoblast (Kurosawa, 1985), 
respectively. Mice studies have shown that IL-11 is required for maturation of 
uNK cells. 
 
Interleukin 15(IL-15) 
 
Interleukin-15 (IL-15) is necessary for the generation of normal NK cell 
numbers in vivo and HESC’s upon decidualization produce IL-15, at least in 
part apparently under progesterone control (Okada, 2000; Kitaya, 2000). It is 
expressed in the human endometrium, decidua and placenta (Kitaya, 2000; 
Verma, 2000). It is expressed in both the stromal and epithelial components 
of the endometrium. Before decidualization, it is expressed higher in the 
epithelial cells than stromal cells during most of the cycle and following 
decidualization the expression is higher in the stromal cells (Kitaya, 2000; 
Chegini, 2002). 
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1.6.8  Th1/Th2 balance in pregnancy 
 
Cytokines can be functionally divided into two groups: those that are pro-
inflammatory and those that are essentially anti-inflammatory but that 
promote allergic responses. Th1-type cytokines tend to produce pro-
inflammatory responses; interferon gamma being the main Th1 cytokine. In 
order to counteract excessive pro-inflammatory response, Th2-type 
cytokines are produced which includes interleukins 4,5,13 and interleukin10. 
In humans, Th1 cells predominate the non-pregnant endometrium especially 
in the proliferative phase (Gargett, 2007). It appears that pregnancy rejection 
is mediated by Th1 cytokines whereas Th2 response confers protection. 
Progesterone is found to drive the Th2 response, possibly acting as the 
switch from Th1 to Th2 activity at the maternal-fetal response (Piccinni, 
1995). 
 
1.7  Steroid hormone regulation of 
endometrium 
 
The human endometrium is a steroid responsive tissue undergoing cycles of 
sequential proliferation, differentiation, breakdown and repair. During this 
course, it prepares and allows implantation of a blastocyst and supports any 
resultant pregnancy. Implantation and menstruation are under the control of 
steroid hormones. During each menstrual cycle the endometrium is exposed 
to three distinct hormonal environments: the oestrogen dominated 
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proliferative phase; the progesterone dominated secretory phase; and the 
progesterone withdrawal immediately prior to and during menstruation.  
 
1.7.1  Steroid receptor expression in the 
endometrium 
 
The endometrial tissue expresses receptors for oestrogen, progestin, 
androgen and glucocorticoids and this has been well documented by 
immunohistochemical studies. There are two isoforms of oestrogen receptors 
– ERα and ERβ. During the secretory phase, both ERα and ERβ are present 
in the glandular epithelium and endometrial stroma. The expression of ERα 
decreases in the glandular epithelium and stroma of endometrium in the 
secretory phase. ERβ1 localisation is unaltered across the menstrual cycle, 
while ERβcx/β2 decreases in the glandular epithelium of the functional layer 
in the mid secretory phase (Critchley, 2001; Critchley, 2002; Taylor, 2000). 
ERβ1 is expressed by the uNK cells (Henderson, 2003) and both ERβ1 and 
ERβcx/β2 are present in the endometrial endothelium (Critchley, 2002). 
 
Progesterone has two isoforms – PR-A and PR-B.  PR-A is expressed in the 
secretory endometrial stroma and in first trimester decidua (Mote, 1999; 
Wang, 1998; Brosens, 1999). Both isoforms are reduced in the glandular 
epithelium in the secretory phase. The endometrial endothelium or uNK cells 
do not express PR; however both isoforms are expressed in the perivascular 
cells (Wang, 1998; Henderson, 2003; Perrot-Applanat, 1994). 
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Glucocorticoid receptor (GR) is expressed in the endometrial stroma, 
endothelium of endometrial blood vessels and uNK cells peaking at the time 
of menstruation (Henderson, 2003, McDonald, 2006, Bamberger, 2001).  
Androgen receptor (AR) is expressed only in the endometrial stroma and 
detectable throughout the menstrual cycle and first trimester decidua with 
maximal expression in the proliferative phase (Burton, 2003, Horie, 1992, 
Milne, 2005). 
 
1.7.2 Glucocorticoids 
 
Glucocorticoids have been implicated in many processes that underpin 
successful embryo implantation, placentation, and the growth and 
development of the fetus (Michael, 2008). 
Metabolism 
Glucocorticoids play a vital role in the control of metabolism in all tissues and 
at a cellular level influences the amino acid, fatty acid and carbohydrate 
metabolism. Cortisol is the principal active glucocorticoid. Cortisol acts by 
binding to the mineralocorticoid receptor (MR) and glucocorticoid receptor 
(GR). A balance between synthesis and metabolism controls the circulating 
cortisol concentrations available to bind to these receptors. In the past, 
cortisol metabolism was thought to occur mainly in the liver, but we now 
know it occurs in many peripheral tissues including endometrium. The 
metabolism of cortisol plays a critical role in determining the activity of the 
hypothalamo-pituitary-adrenal (HPA) axis. 
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Medroxy progesterone acetate, a progestin used in many in vitro studies acts 
through the GR (Bamberger, 1999), and the antiprogestin RU486 acts as an 
antiglucocorticoid (Schatz, 1997). 
 
The key enzyme in the metabolism of cortisol is 11β-hydroxysteroid 
dehydrogenase (11βHSD). By catalysing the interconversion of active 
glucocorticoid, cortisol and inactive cortisone, it is able to control the 
concentration of active glucocorticoid available to bind to GR. Furthermore, it 
is able to protect the MR from illicit occupation by cortisol (Tomlinson, 
2001).Tissue levels of active endogenous glucocorticoids depend on the 
expression of 11βHSD enzymes. Although the 11βHSD1 isoform is a 
bidirectional enzyme, it predominantly catalyzes the conversion of inert 
cortisone (E) to active cortisol (F), thus increasing tissue levels of active 
glucocorticoids (Courtney, 2008). The reduced nicotinamide adenine 
dinucleotide [NAD(H)]-dependent type 2 isoform (11βHSD2) acts as a 
dehydrogenase, converting F to E (Ferrari, 1996). The main cellular targets 
for F are glucocorticoid receptor (GR) and mineralocorticoid receptor (MR). 
However, GR normally co-localizes with 11βHSD1 in vivo, whereas 
11βHSD2 is commonly found in MR-expressing tissues. Nevertheless, 
hypercortisolism can result in apparent mineralocorticoid excess as in 
Cushing syndrome . Further, some cell types like adipocytes do not 
significantly express 11βHSD2, thus enabling F to act through MR (Yang, 
1997, Engeli, 2004). 
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Figure 1.5:   The 11βHSD isoenzymes: 11βHSD1 is a NADPH-dependent reductase which 
converts inactive cortisone to active cortisol and 11βHSD2 is a NAD-dependent 
dehydrogenase enzyme reverses the conversion from active cortisol to inactive cortisone 
 
Glucocorticoids and endometrium 
 
Both the isoforms of 11βHSD as well as GR and MR are expressed in 
human endometrium (McDonald, 2006).  Interestingly, GR expression is 
confined to stromal cells, whereas MR is reportedly present in both stromal 
and glandular compartments. Further, 11βHSD1, but not 11βHSD2, is highly 
up-regulated upon differentiation of primary human endometrial stromal cells 
(HESCs) into specialist decidual cells in vitro (Takano, 2007). This 
progesterone (P4)-driven differentiation process bestows unique functions on 
the endometrium that are essential for pregnancy, including the ability to 
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regulate trophoblast invasion, to modulate local angiogenesis, to recruit 
specialized uNK cells and macrophages, and to resist environmental and 
oxidative stress (Leitao, 2010, Gellersen, 2007). The speculation based on 
these observations, is that induction of 11βHSD1 would lead to increased F 
bioavailability, which in turn regulates the expression of distinct GR- and MR-
dependent gene networks in decidualizing HESCs. Consequently, 
modulation of glucocorticoid action represents a potential strategy for the 
treatment or prevention of a variety of pregnancy-related disorders. 
1.8   Clinical Perspective 
 
Human reproduction is remarkably inefficient compared to other mammalian 
species (Robillard, 2003, Preeclampsia and human reproduction. An essay 
of a long term reflection}. The probability of conception is 25-30% per cycle 
and only 50% of these conceptions continue beyond 20 weeks of gestation. 
Clinical miscarriage only accounts for 15% and, about 85% of total 
pregnancy losses are implantation failure and pre-clinical losses (Macklon, 
2002) and are therefore not clinically recognized as pregnancies (Norwitz, 
2001). Approximately 70% of spontaneous conceptions are lost prior to the 
completion of the first trimester of pregnancy. The pregnancy rate per cycle 
is even lower when in vitro fertilization (IVF) is employed in a natural cycle 
(Vlaisavljevic, 2007). 
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1.8.1  Reproductive failure 
 
Reproductive failure is a broad term which includes the inability to conceive 
and the inability to maintain a pregnancy. This includes: Infertility, repeated 
implantation failure (RIF) in women undergoing In vitro fertilization (IVF) and 
recurrent miscarriage. Infertility is failure to conceive after regular 
unprotected intercourse after one year in the absence of reproductive 
pathology. Recurrent implantation failure is frequently defined as failure to 
achieve a pregnancy following 2-6 cycles of IVF with three fresh IVF 
attempts (Tan, 2005). Recurrent miscarriage is defined as the loss of three or 
more consecutive pregnancies prior to 20–22 weeks of pregnancy {Stirrat, 
1990, Recurrent miscarriage}. 
 
 
Figure 1.6:   Overview of outcome of 100 conceptions 
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30 
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1.8.2  Infertility 
 
The prevalence of subfertility is high in humans affecting 10% of couples in 
the reproductive age. One in five to six couples in the UK suffer with this 
problem.  Over 72 million women worldwide, aged 20-44, are currently sub 
fertile and every second couple seek medical care for subfertility (Boivin, 
2007). Female fertility is regulated by a complex co-ordination and 
synchronization of interactions in the hypothalamic-pituitary-ovarian (HPO) 
axis; influenced by different diseases/ dysfunctions of the reproductive tract, 
neuroendocrine system, immune system or general disease (Evers, 2002). 
The known causes of female infertility include: ovulatory dysfunction, tubal 
disease, uterine factors and cervical factor. In 15-20% of cases, no cause is 
found and hence termed unexplained infertility. In 25-30% of couples, 
primary male factor infertility is diagnosed. 
 
1.8.3  Recurrent Implantation Failure (RIF) 
 
Repeated implantation failure (RIF) is determined when embryos of good 
quality fail to implant following several in vitro fertilization (IVF) treatment 
cycles. Different fertility centres use different definitions; hence, the exact 
prevalence of RIF is difficult to determine (Laufer, 2012). RIF is frequently 
defined as failure to achieve a pregnancy following 2-6 cycles of IVF with 
three fresh IVF attempts (Tan, 2005) or more recently as failure to implant 
after at least three consecutive IVF attempts, in which 1–2 embryos of high 
grade quality are transferred in each cycle (Simon, 2012). 
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There are many variables that influence implantation of a potential embryo 
transferred in an IVF cycle including a hormonally primed “receptive” 
endometrium, hence any abnormality attributed to the embryo, the 
endometrium or the immune system will result in implantation failure. 
Increased numbers of CD56+ cells have been found in the endometrium of 
women with RIF after IVF (Lédée-Bataille, 2004; Lédée-Bataille, 2005). 
 
1.8.4  Recurrent miscarriage 
 
Three or more consecutive spontaneous miscarriages with or without 
previous live births are defined as recurrent miscarriage and this condition 
affects about 1–3% of women during their reproductive years (Carrington, 
2005). The couple not only experience emotional and physical trauma, but 
live in anxiety of a further miscarriage when they conceive. 
 
Primary RM refers to patients with consecutive losses and no prior 
successful pregnancy; secondary RM refers to losses following a live birth. 
Known risk factors for RM are genetic disorders, uterine pathologies, 
endocrine dysfunctions, autoimmune diseases, acquired and inherited 
thrombophilia as well as environmental factors (Rai, 2006). The cause for 
RM in 50% of patients is unknown (Li, 2002). The unexplained RM are 
clinically challenging and frustrating for the clinician. The prognosis is 
however good with a live birth rate of 75% following referral to a specialized 
clinic without any treatment (Clifford, 1997). Treatment of proven efficacy is 
available for only 15%. Recurrent or sporadic miscarriage is attributed to 
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either a chromosomal/ developmental abnormality in the embryo or due to 
uterine/endometrial factors. 
1.8.5  Endometrium in RM 
 
The endometrium in RM appears to be ‘super-receptive’ allowing embryos of 
low viability to implant, presenting as a clinical pregnancy before miscarrying 
(Salker, 2010; Aplin, 1996; Quenby, 2002). 
Higher numbers of uNK cells were found in the preimplantation endometrium 
of women with idiopathic RM compared to controls (Clifford, 1999; Quenby, 
1999). Higher levels of uNK cells have been also been found in the decidua 
miscarried from women with RM compared with controls (Quack, 2001), and 
the decidua of RM patients were more active (Chao, 1995), and 
phenotypically different to those from healthy pregnancies (Emmer, 2002; 
Yamamoto, 1999). Higher CD56+ NK cells were found in the decidua from 
chromosomally abnormal miscarriages than in chromosomally normal 
miscarriages (Yamamoto, 1999). The decidual leucocytes from the 
miscarried tissue of women with unexplained RM and a normal fetal 
karyotype compared to women with RM and abnormal fetal karyotype 
(Quack, 2001). 
 
Furthermore, high preconceptional peripheral NK activity was found to be 
predictive of further miscarriages in women with RM (Aoki, 1995; Ntrivalas, 
2001) and women who had higher numbers of uNK cells were more likely to 
miscarry in a subsequent pregnancy (Quenby, 1999). 
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Henderson et al. (Henderson, 2003) found that uNK cells express the 
glucocorticoid receptor and the ERβ1 receptor, thereby raising the possibility 
of immunomodulation of this cell population with pharmacological treatment. 
uNK cells express the glucocorticoid receptor (GR) but lack the progesterone 
receptor (PR), rendering them directly responsive to cortisol but not 
progesterone. Immunomodulation with IVIg, third-party donor cell 
immunization, paternal cell immunization, trophoblast membrane infusion 
and steroids were suggested. A Cochrane review in 2003 showed no 
beneficial effect from IVIg, third-party donor cell immunization, paternal cell 
immunization and trophoblast membrane infusions, after evaluating 19 trials 
(Scott, 2003). Quenby et al. (Quenby, 2005) showed that glucocorticoid 
(prednisolone) treatment can reduce the high numbers of uNK cells during 
the peri-implantation window. 
 
1.8.6  Glucocorticoids in RM 
 
Glucocorticoids treatment has been advocated for the prevention of early 
pregnancy loss based on its ability to reduce the abundance of uNK cells 
during the peri-implantation window (Quenby, 2005), to stimulate human 
chorionic gonadotropin secretion by cultured human cytotrophoblasts 
(Ringler, 1989) and to accelerate trophoblast growth and invasion (Mandl, 
2006).  
However, implantation is an inflammatory process that depends on local 
release of pro-inflammatory cytokines and prostaglandins (Bazer, 2010; 
Chard, 1995; Kelly, 2001; Sharkey, 1998). By disabling the cytokine-
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prostaglandin signalling cascade, glucocorticoids potentially could impact 
adversely on early pregnancy events. Furthermore, compelling evidence 
suggests that prolonged exposure to high levels of glucocorticoids in 
pregnancy is detrimental for both placental and fetal development 
(Aufdenblatten, 2009; Gennari-Moser, 2011; Seckl, 2004). 
 
 
 
 
 
  
 
 
 
Figure 1.7:    Schematic representation showing glucocorticoids acting on the uNK cells via 
the GC receptors 
In summary, a receptive endometrium plays a pivotal role in implantation. A 
defect in the receptivity of endometrium is attributed to implantation failure 
and recurrent pregnancy loss. The expression of glucocorticoid receptors in 
the stroma of the endometrium and its role in decidualization is indeed 
intriguing. Interestingly, the finding of elevated number of uterine NK cells in 
the endometrium of recurrent implantation failure and recurrent miscarriage 
uNK cells 
GC 
GC receptor 
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and their expression of glucocorticoid receptor raises the possibility of 
immunomodulation of the endometrium in early reproductive failure.  
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1.9   Hypothesis and Aims 
 
I postulate that the decidualization is closely associated with local 
corticosteroid metabolism regulated by the key enzyme 11βHSD and this is 
reflected by the uterine natural killer cell population in the sub-epithelial 
endometrium. 
Specific Aims:  
• To study the expression and activity of 11βHSD1 in decidualizing 
human endometrial stromal cells and local cortisol biosynthesis. 
• To study the glucocorticoid and mineralocorticoid pathways in the 
human endometrial stromal cells involved in local corticosteroid 
metabolism. 
• To characterise the decidualization in patients with elevated uterine 
NK cell population in the sub-epithelial endometrial stromal cells by 
studying the decidual markers in timed endometrial biopsies. 
• To establish that excessive uNK cell levels in mid-luteal endometrial 
samples reflects relative local corticosteroid deficiency possibly 
secondary to inadequate induction of decidual 11βHSD1 and thus 
resulting in impaired local metabolic function. 
• To translate these findings to potential pharmacological 
immunomodulation of the impaired endometrium in women with early 
reproductive failure.  
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2.0 Materials and Methods 
 
2.1  Materials 
 
2.1.1  Antibodies 
 
Primary 
Antibody Dilution Manufacturer 
CD56(NCL-CD56-1B6)  
Lyophilized mouse monoclonal 
1:200 Novocastra 
Anti-HSD 11 B1(ab83522)  
Rabbit polyclonal 
1:2000 Abcam 
MCR (H-300): sc-11412 
Rabbit polyclonal 
1:1000 Santa Cruz 
GR (E-20):sc-1003 
Rabbit polyclonal 
1:1000 Santa Cruz 
RETSAT HPA007961 
Rabbit polyclonal 
1:1000 Sigma Life Science 
DHRS3 15393-1-AP 
Rabbit polyclonal 
1:1000 Protein Tech 
RBP4 11774-1-AP 
Rabbit polyclonal 
1:1000 Protein Tech 
 
Secondary 
Horseradish peroxidase(HRP) – 
conjugated goat anti-rabbit IgG 
Dako 
 
Normal serum 
Goat Dako 
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2.1.2  Cells 
 
Endometrial cells Tissue biopsy 
HESC Human endometrial stromal cells 
(primary) 
 
2.1.3  Small interfering RNA (SiRNA) 
ProFection mammalian transfection kit purchased from Promega was used. 
The RefSeq gene accession numbers are as follows: 
SiCONTROL nontargeting(NT) SiRNA pool 
GR SiGENOME SMART pool SiRNA 
MR SiGENOME SMART SiRNA 
 
2.1.4 Culture media and materials 
 
Dulbecco’s modified eagles medium 
(DMEM)/F-12(1:1) 1x nutrient mixture, with 
L-Glutamine, 15mM HEPES± Phenol red 
Invitrogen 
Charcoal Sigma 
Collagenase type IA Sigma 
Dextran Sigma 
Deoxyribonuclease I (DNase I) Roche 
Foetal bovine serum (FBS) heat inactivated Invitrogen 
L-Glutamine, 200mM (x100) Invitrogen 
Penicillin (10,000U/ml)-streptomycin (10,000 
micrograms/ml) solution (x100) 
Invitrogen 
Trypsin-EDTA solution (x1) Invitrogen 
Tissue culture plastic ware Orange scientific 
Falcon Nunc 
Corning   
Starlab 
VWR 
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2.1.5  Reagents 
 
Absolute Ethanol VWR 
Acetone BDH 
30% acrylamide/Bis solution (37.5:1) Bio-Rad 
Agarose powder Appleton woods 
Ammonium Persulphate (APS) Sigma 
Bovine Serum albumin (BSA) fraction V Sigma 
8-Bromoadenosine-3,5’ – cyclic 
monophosphate sodium salt (8-Br-cAMP) 
Sigma 
Bromophenol blue Sigma 
 
2.1.6  Buffers and solutions 
All buffers and solutions were made with deionised and distilled water. Solutions 
were stored at room temperature (RT), unless otherwise stated. 
Phosphate buffered Saline 
140mmM Nacl 
2.5mM KCL 
1.5mM KH2PO4 
10mM Na2HPO4 
Tris Buffered Saline (TBS) 
130mM NaCl 
20mM Tris, pH 7.6 
 
TBS-Tween 20 (TBS-T) 
0.1% Tween 20 in TBS 
 
Tris-Borate EDTA (TBE) Buffer (10x) 
0.9 M Tris-Borate 
2mM EDTA, pH 8.0 
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Hanks Balanced Salt Solution (HBSS) 
120mM mM NaCl 
5.4mM KCL 
0.8mM MgSO4 
10mM HEPES 
10mM Glucose 
Adjust pH to 7.4 with NaOH 
 
HBSS with CaCl2 
1.8mM CaCl2 in HBSS buffer 
Adjust pH to 7.4 with NaOH 
 
Dextran Coated Charcoal (DCC) suspension 
1% (w/v) activated charcoal 
0.1% (w/v) Dextran 
 
DNA Loading Buffer (10x) (Store at -200C) 
0.2% (w/v) Bromophenol blue 
40% (v/v) Glycerol 
0.25 M EDTA, pH 8.0 
 
Basic Lysis Buffer (Store at -200C) 
10mM Tris-HCl, pH 7.5 
5mM EDTA 
150mM NaCl 
50mM NaF 
30mM Sodium Pyrophosphate 
10% (v/v) Glycerol 
0.5% (v/v) TritonX-100 
1 Complete Protease Inhibitor cocktail Tablet per 50ml of buffer 
 
Radio Immuno Precipitation Assay (RIPA) buffer (Store at -200C) 
1% NP-40 (v/v) 
1% Triton X-100 
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150mM NaCl 
2mM NaF 
1% Sodium Deoxycholate (w/v) 
0.1% SDS (w/v) 
10mM Tris, pH 8.8 
1 Complete Protease Inhibitor cocktail Tablet per 50ml of buffer 
 
High Salt Buffer 
0.4m KCl 
20mm HEPES (pH 7.4) 
20% glycerol 
0.5mM PMSF 
1 Complete Protease Inhibitor cocktail Tablet per 50ml of buffer 
 
Protein loading buffer (Laemmli Buffer) (Store at -200C) 
50mM Tris-HCl, pH 6.8 
50mM Imidazole, pH 6.8 
1% (w/v) SDS 
10% Glycerol 
2% (v/v) beta- mercaptoethanol 
0.002% (w/v) Bromophenol blue 
 
Acid Alcohol Solution 
1% HCl (v/v) in Ethanol 
4% PFA Solution 
4% PFA (w/v) in PBS 
Adjust to pH 7.4 with NaOH 
 
Western SDS Running Buffer (10x) 
250mM Tris Base 
1.9M Glycine 
1% (w/v) SDS 
Western Transfer Buffer 
250mM Tris Base 
192 mM Glycine, pH 8.3 
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20% (v/v) ethanol 
 
Western Blocking Buffer and Secondary Antibody Incubation 
Solution 
5% (w/v) non-fat milk in TBS-T 
Western Primary Antibody Incubation Solution 
3% (w/v) BSA in TBS-T 
 
Western stripping Buffer 
100mM beta-mercaptoethanol 
2% (w/v) SDS 
62.5mM Tris-HCl, pH 6.7 
 
SDS Polyacrylamide Gels 
Resolving Gels 
375mM Tris-HCl, pH 8.9 
1% (w/v) SDS 
10% (v/v) Acrylamide Bis Solution (37.5:1) 
0.03% (w/v) APS 
TEMED added at 1:1500 
 
Stacking Gel 
80mM Tris-HCl, pH 6.8 
80mM Imidazole 
0.06% (w/v) SDS 
5% (v/v) Acrylamide Bis solution (37.5:1) 
0.06% (w/v) APS 
TEMED added at 1:1500 
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2.1.7  Immunohistochemistry  
 
Immunofluorescence blocking solution 
3% BSA (w/v)/ 10% normal serum (v/v) in PBS 
 
Immunofluorescence Antibody dilution solution  
3% BSA (w/v)/ 0.5-10% normal serum (v/v) in PBS 
Immunohistochemistry Primary Antibody dilution solution  
0.3% BSA (w/v)/ 10% normal serum (v/v) in PBS 
Immunohistochemistry Secondary Antibody dilution solution  
0.3% BSA (w/v)/ 1% normal serum 
2.1.8  Enzyme Linked Immunoassay (ELISA) 
 
Quantikine kits used: 
Human IL-15 Immunoassay (Catalogue Number D1500) consisting of the following: 
 IL-15 Microplate - 96 well polystyrene microplate (12 strips of 8 wells) coated 
with a mouse monoclonal antibody against IL-15 
 IL-15 Conjugate - 21 mL/vial of a mouse monoclonal antibody against IL-15 
conjugated to horseradish peroxidase with preservatives 
 IL-15 Standard - 2.5 ng/vial of recombinant human IL-15 in a buffered 
protein base with preservatives; lyophilized 
 Assay Diluent RD1-19 - 11 mL/vial of a buffered protein base with 
preservatives 
 Calibrator Diluent RD5-5 - 21 mL/vial of a buffered protein base with 
preservatives. For cell culture supernate samples 
 Calibrator Diluent RD6-10 - 21 mL/vial of a buffered protein base with 
preservatives. For serum/plasma samples 
 Wash Buffer Concentrate - 21 mL/vial of a 25-fold concentrated solution of 
buffered surfactant with preservatives 
 Color Reagent A - 12.5 mL/vial of stabilized hydrogen peroxide 
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 Color Reagent B - 12.5 mL/vial of stabilized chromogen 
(tetramethylbenzidine 
 Stop Solution - 6 mL/vial of 2 N sulphuric acid 
 Plate Covers - Adhesive strips 
Human IL-11 Immunoassay (Catalogue Number D1100) consisting of the following: 
 IL-11 Microplate - 96 well polystyrene microplate (12 strips of 8 wells) coated 
with a mouse monoclonal antibody against IL-11 
 IL-11 Conjugate - polyclonal antibody against IL-11 conjugated to 
horseradish peroxidase with preservatives 
 IL-11 Standard - recombinant human IL-11 in a buffered protein base with 
preservatives; lyophilized 
 Assay Diluent RD1S - buffered protein base with preservatives 
 Calibrator Diluent RD5K - buffered protein base with preservatives 
 
For cell culture supernate samples:  
 Calibrator Diluent RD6N - animal serum with preservatives 
 
For serum/plasma samples: 
 Wash Buffer Concentrate - 25-fold concentrated solution of buffered 
surfactant with preservatives 
 Color Reagent A - stabilized hydrogen peroxide 
 Color Reagent B - stabilized chromogen (tetramethylbenzidine) 
 Stop Solution - 2 N sulphuric acid 
 Plate Covers - adhesive strips 
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2.2  Methods 
2.2.1 Ethics Approval and Patient Recruitment 
 
The study was approved by the University Hospitals of Coventry and 
Warwickshire Research ethics Committee (1997/5065). All women who 
participated in this study were fully informed through patient information 
leaflet and by the researcher. Written consent was obtained from all patients 
before endometrial sampling (Appendix 1).  
2.2.2  Timed Endometrial samples 
 
Timed samples were collected from control group and the study group. The 
study group comprised of patients with idiopathic recurrent pregnancy loss 
(RPL). Idiopathic recurrent pregnancy loss (RPL) patients; where RPL is 
defined as three or more consecutive pregnancy losses before 24 weeks 
gestation and the cause is not known. The control group comprised of 
women with unexplained infertility; where unexplained infertility is defined as 
delay in conception after 12 months of unprotected intercourse after 
excluding anovulation, tubal disease, endometriosis and impaired semen 
quantity and quality.  
All participants monitored daily luteinizing hormone (LH) levels using 
ovulation prediction kits (Assure Ovulation Predictor, USA). Endometrial 
biopsies were timed between 7 and 11 days after the pre-ovulatory LH surge 
(LH+7 to LH+11). Sample was obtained using a Wallach EndocellTM sampler 
(Wallach, USA) under ultrasound guidance, starting from the uterine fundus 
and moving downwards to the internal cervical os.  
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The samples were split into two. One part for the purposes of 
immunohistochemistry, the endometrial tissues were formalin-fixed for 12-24 
hours, paraffin-embedded and serially sectioned (5micronmeters) onto 
polysine glass slides.  
All patient samples were analysed for the uterine NK cell count and then 
further divided into high and low uNK groups to do further experiments. Only 
women with previous recurrent miscarriages were used in the experiments. 
Sixty three patients were recruited and all of them had the uNK cell testing. 
Table1 below shows the patient characteristics for all the patients. There was 
higher number of high uNK cell population.  
   Control group (n=18) Study group (n=37) 
Age   
Range 29-41 31-40 
Median 35 38 
Number of miscarriages   
Range 3-5 5-12 
Median 4 6 
Previous live births (%) 20 0 
CD56+ (%)   
Range 1.1-4.5 5.3-27.8 
Median 2.3 11.75 
 
Table 1:   Comparison of Clinical and endometrial characteristics of women in the study- 
controls, RMC with low uNK cell population and RMC with high uNK cell population 
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Two-thirds of the biopsy specimens show high uNK cell count whereas 
literature reports 30% of recurrent miscarriage population show high uNK cell 
count. This discrepancy is because of inclusion of both recurrent miscarriage 
and recurrent implantation failure patients. However, the experiments used 
biopsy specimens only from recurrent miscarriage population. 
During the cell culture process, there was significant attrition in the number of 
samples(n) due to different reasons including insufficient sample size, 
infection of the cells, insufficient amount of extracted samples for mRNA or 
for protein analyses. Table 2 shows the patient characteristics recruited for 
cell culture studies. 
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uNK cell count Low <5% High ≥5% 
  (n=12) (n=10) 
uNK cell density (%, mean±SE) 3.2±0.3 10.2±1.3 
      
Age (yrs, mean±SE) 34.3±1.6 36.8±1.7 
      
Past history of previous pregnancy   
   Gravida 3 (3-6) 5 (3-9) 
      
   Parity 0 (0-1) 0 (0-1) 
      
Miscarriage     
      
   First trimester 3 (0-6) 5 (0-8) 
      
   Second trimester 0 (0) 0 (0-3) 
 
Table 2: Patient characteristics of women in the cell culture experiments- controls, RMC 
with low uNK cell population and RMC with high uNK cell population 
 
2.2.3 Endometrial samples for primary cell culture 
 
The other part of the biopsy sample was collected in 10% DCC/FCS 
DMEM/F12 supplemented with antibiotic/antimycotic. 
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2.3  Cell Culture 
 
2.3.1  General maintenance of cell cultures 
 
All HESCs were managed in a standard cell culture incubation conditions 
using a NU-5500 Direct Heat Autoflow CO2 Incubator (NuAire, Inc), which 
provided a humid atmosphere with 5%v/v CO2 maintained at 37
0C. Class ‖ 
labguard Microbiological Safety Cabinet (NuAire, Inc) was used for cell 
culture. The working surface of the cabinet was swabbed with 70% alcohol 
and the cabinet was left running for 5minutes before commencing work. 
Sterile plastic tissue flasks (Corning), plugged disposable serological pipettes 
(Corning) and plastic universal tubes (Sterilin) were used for routine 
culturing.  
 
2.3.2 Preparation of Dextran coated charcoal (DCC) 
stripped fetal calf serum (FBS) 
 
FBS contains endogenous steroid hormones that may mask the effect of 
exogenously added ligands. Serum used for cell culture was therefore 
stripped of small molecules by DCC treatment. A 500ml of FBS had 1.25g of 
charcoal and 125mg of dextran added and the solution incubated in a water 
bath at 560C for 2hours, inverting at regular intervals. Following 
centrifugation at 4000g for 30 min, the supernatant was filter sterilized using 
a 0.2µm bottle neck filter into a sterile bottle, aliquoted and stored at -200C. 
For cell culture DMEM/F12 was supplemented with 10, 5, 2 and 0.5%v/v 
DCC/FCS. 
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2.3.3 Primary human endometrial stromal cell culture 
 
Samples were collected in Earle’s buffered saline containing 100U/ml 
penicillin and 100 µg/ml streptomycin. The fresh endometrial biopsy was 
washed twice with 1:1 mixture of serum free DMEM and Ham’s F12 
(DMEM/F12) to remove mucous and blood. The sample was then finely 
minced in a Petri dish using scalpels. Following this, the tissue was 
transferred into a T-25cm2 flask containing 10ml of digest media which 
enzymatically dispersed the HESC’s. The digestion media consisted of 
additive free DMEM containing 0.5mg/ml collagenase type IA (Sigma) which 
disintegrated the extracellular matrix and 0.1mg/ml DNAse I (Roche) which 
eliminated the viscous DNA released during the breakdown process as some 
cells die. The biopsy sample was left to digest at 370C by vigorous shaking 
every 20 minutes for the first hour. Following this, 10ml of 10% DCC/DMEM 
was added to stop the collagenase activity. After centrifugation at 400g for 
4min, the pellet containing epithelial, glandular, stromal and red blood cells 
was resuspended in a maintenance medium of DMEM/F12 containing 10% 
dextran-coated charcoal-treated fetal bovine serum (DCC-FBS), 1% L-
glutamine, and 1% antibiotic-antimycotic solution.  
 
The cells were then transferred to a T-75cm2 flask and left undisturbed for an 
hour at 370C. The stromal cells differentially adhere earlier compared to the 
epithelial cells thus allowing their separation. Morphologically the stromal 
cells were examined for their development and confluence every 24 hours. 
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After 1hr, the media contained epithelial cells and red blood cells which were 
transferred to a second T-75cm2 flask. The flask with stromal cells was 
replenished with fresh 10% DCC/DMEM. This method of separation and the 
purity has been assessed in our laboratory and is well established {Brosens, 
1999, Progesterone receptor regulates decidual prolactin expression in 
differentiating human endometrial stromal cells}. The proliferating stromal 
monolayer cells were maintained in 10% DCC/DMEM. Once they reached 
confluence, they were passaged. The medium was briefly removed, the cells 
washed with 10ml of pre-warmed PBS and then aspirated. Also 5ml of pre-
warmed trypsin-EDTA was added for 5 min at 370C, followed by gentle 
tapping of the flask. Trypsin activity was then terminated by adding 10ml of 
10% DCC/DMEM. The cells were resuspended by centrifuging at 1000rpm 
for 5min and then cultured at a suitable dilution, typically 1:3. Experiments 
were carried out in   well plates in 10  DCC/DMEM. All experiments were 
carried at or before the third passage when the cells reached  80  
confluence. 
 
2.3.4 Hormone treatment of cells 
 
All monolayers were cultured in 2% DCC/DMEM for 24h prior to treatment. 
All hormone treatments were carried out in 2%DCC/DMEM. In 
decidualization experiments, confluent monolayers were maintained in 
DMEM/F12 now containing 2% DCC-FBS and treated with 0.5mM 8-
bromoadenosine cAMP(8-bromo-cAMP) (Sigma,St.Louis,MO) alone or in 
combination with 1 µM medroxyprogesterone acetate (MPA) (Sigma), 1 µM 
P4 (Sigma), 0.1 µM dexamethasone (DEX) (Sigma), 0.1 µM E (Sigma), 1 µM 
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aldosterone (Sigma), 10 µM RU26752 (Sigma), 0.1 µM carbenoxolone 
disodium salt (CBX) (Sigma), or 0.1 µM PF 915275 (PF) (Tocris Bioscience, 
Abingdon, UK). 
 
2.3.5  Transient transfection 
 
Primary HESCs, cultured in 12-well plates until confluency, were then 
transfected using the ProFection mammalian transfection kit (Promega, 
Madison, WI) as per the manufacturer’s instructions. Prior to transfection, the 
media was changed to 1.5ml DMEM/F-12 without antibiotics and 
supplemented with 5% DCC-FBS until 80-90% confluency. Each well was 
treated with 100nM of the following small interfering RNA (siRNA) reagents 
(Dharmacon, Lafayette, CO): siCONTROL nontargeting (NT) siRNA pool, 
GR siGENOME SMARTpool siRNA, or MR siGENOME SMARTpool siRNA. 
The cells were incubated at 370C in a humid atmosphere maintained at 5% 
CO2. After 24h of incubation, the media was replaced and treated as 
indicated and the cells were harvested when appropriate. 
 
 
2.4  Tissue specimens 
 
Endometrial biopsies were obtained as detailed earlier in section 2.2.2. 
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2.4.1  Protein Analysis 
2.4.1.1 Protein extraction from cell for Western blot analysis 
 
Cells were grown in 6-well plates and treated or transfected as appropriate. 
The cells were washed with ice cold PBS and whole cell extracts were 
obtained by lysing the adherent cells directly in 100µl of protein lysis RIPA 
buffer containing protease inhibitors. Cells were scraped, transferred to 1.5ml 
tubes and stored at -200C. Protein concentration was determined and 
typically 30µg of protein combined with protein loading buffer were boiled at 
100 0C for 5 min and loaded in SDS-polyacrylamide gels. 
 
Alternatively, protein was extracted using 100µl protein loading Laemmli 
buffer previously heated to 900C. Cells were scraped, transferred to 1.5ml 
tubes, sonicated for a few seconds, boiled for 5 min at 1000C and centrifuged 
at 15,000g for 5min at 40C. Equal volumes of each sample were loaded into 
the gel. 
2.4.1.2   Loading buffer (Laemmli buffer) 
 
Loading buffer has a high detergent content and along with the heat of this 
extraction protocol, it ensured instant and complete protein denaturation thus 
preserving any post-translational modifications like sumoylation and 
phosphorylation. HESCs were cultured in 6-well plates. An equal volume of 
loading buffer preheated to 85 0C was added to each well, scraped and 
transferred into microcentrifuge tubes. The lysates were then heated for 5min 
at 1000C and were snap-frozen on dry ice and stored at -800C. 
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2.4.1.3  Determination of protein concentration 
 
Quantification of total cell protein concentrations were carried out for 
Western analysis. Bradford assay reagent containing Coommassie dye was 
used to determine protein concentration. On binding to arginine and 
hydrophobic amino acid residues in the protein, this dye exhibits an 
absorbance shift with the bound form of the dye which is blue showing an 
absorbance spectrum maximum at 595 nm. The unbound anionic forms are 
green and red. A set of standards were created using bovine serum albumin 
(BSA) diluted in distilled water at concentrations 0,1,2,4,8,12,16,20µg/µl with 
the final volume being 800µl of distilled water. The proteins samples were 
diluted 2:800 in 800µl and by adding 200 µl of Bradford reagent, a final 
volume of 1ml was produced for each standard and sample. This sample 
was mixed well and incubated at room temperature for 30mins. Following 
this, 200µl of sample and standard was loaded in duplicate into flat bottom 
optically clear 96-well plate and absorbance read at 595 nm using 
OPTImaxTM microplate reader (Molecular Devices) and analysed using 
SOFTmax® PRO software (Molecular Devices). The protein concentrations 
were then calculated by reference to the standards. 
 
2.4.1.4   SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Proteins were resolved on discontinuous polyacrylamide gels using 
Invitrogen Xcell SureLock Mini-cell apparatus. The resolving gels were made 
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using 10% acrylamide, 1% SDS and 375 mM Tris-HCL pH 8.9. The stacking 
gels were made using 5% acrylamide, 1% SDS and 125 mM Tris-HCL pH 
6.8. Polymerizations of these gels were initiated adding TEMED and APS. 
The resolving gel poured between the gel plated up to about 2cm from the 
top and overlaid with saturated butan-2-ol. The butan-2-ol was rinsed off 
after polymerization was complete and stacking gel was added on top of the 
resolving gel and appropriate comb inserted. The comb was removed once 
the stacking gel was set. The gel plate was fitted onto the electrophoresis 
tank and running buffer (1x) added. An equal amount of protein sample 
(typically 30 µg) was diluted 1:1 loading buffer and denatured at 1000C for 
5min. Samples were loaded alongside pre-stained molecular weight markers. 
Gels were run in 1x Western SDS running buffer at 80V for approximately 
30min allowing slow and even entry of the samples into the stacking gel. 
Subsequently, the gels were resolved at 125 V for 1 hour until the dye had 
migrated to the bottom of the gel. The gels were then removed from the 
cassettes for transfer.  
 
2.4.1.5   Western Blotting 
 
The Invitrogen Xcell IITM Blot Module was used to transfer resolved proteins 
from gel onto a polyvinylidene fluoride (PVDF). The PVDF transfer 
membrane was first activated in 100% methanol. The following sequence 
was created onto the cathode: one sheet of Whatman filter paper, the gel, a 
PVDF transfer membrane and another piece of Whatman filter paper. This 
sandwich was rolled to eliminate air bubbles and an anode plate was fitted 
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on top. A voltage gradient of 25V at 230mA was created perpendicular to the 
gel for 2h. This allowed migration of the negatively charged particles from the 
gel towards the anode and then deposited onto the PVDF membrane. The 
membrane was then air dried and reactivated in 100% methanol. Following 
this, the membrane was blocked in Western blocking buffer for 30mins at 
room temperature (RT) and then at 40C overnight on the roller. Following 
day, the membrane was washed with 1x TBS-T for 5 min. The membrane 
was then treated with primary antibody diluted in Western primary antibody 
incubation solution and then incubated for 2h at RT on the roller. After three 
15 min washes with 1X TBS-T, the membrane incubated for 1h at RT with 
HRP-conjugated antibody, raised against the primary antibody, diluted in 
western secondary antibody incubation solution. After three 15minute 
washes with 1x TBS-T;, the protein bands were visualised by enhanced 
chemiluminescence with ECL plus Western blot detection system as per 
manufacturer’s instructions. The membrane was then exposed to 
autoradiography films. 
 
2.4.1.6   Stripping of membranes for Western Blotting 
 
In order to re-probe the PVDF membrane with different primary antibodies, 
the antibodies were stripped off the membrane with Western stripping buffer 
at 60 0C for 30 min. The membrane then washed with 1X TBS-T three times 
10 min each, then blocked and incubated with the new antibody. 
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2.4.2  RNA isolation and extraction 
 
An allocated workbench for RNA decontaminated using RNAseZAP 
(Ambion) and only RNAse-free plastic ware were used for this procedure to 
minimise the risk of RNA degradation and RNAse contamination. All 
solutions were prepared with diethylpyrocarbonate (DEPC) treated water. 
Chloroform, isopropanol and 70% v/v ethanol and microcentrifuge tubes 
were pre-chilled at -20 0C prior to the extraction. 
Firstly, total RNA was extracted from the cells using STAT-60 reagent as per 
the instructions from the manufacturer. STAT-60 is a monophasic solution of 
phenol and guanidine isothiocyanate that maintains the RNA integrity whilst 
simultaneously disrupting cells and dissolving cellular components. Cells in 
6-well plates were directly lysed by adding 400 µl of the reagent and the cells 
scraped. The samples were allowed to incubate for 5min at RT to allow 
complete dissociation of nucleoprotein complexes and then transferred to 
1.5ml tubes. To each sample 20% volume of chloroform was added and the 
microcentrifuge tube vortexed for 15sec and samples stored at -800C for a 
minimum of 30min. The tubes were then centrifuged at 12,000g for 30min at 
40C to separate the solution into a lower red, phenol-chloroform phase, an 
interphase and a colourless aqueous phase. The RNA remained in the 
aqueous layer while the DNA and proteins extracted into the organic phase 
and the interphase. The aqueous top layer was then transferred to a new 
pre-chilled tube. The RNA was precipitated by adding 50% volume of ice 
cold isopropanol. Samples were then vortexed and incubated at RT for 10 
minand centrifuged at 12,000g for 15min to create a white RNA pellet. The 
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supernatant was then discarded. The RNA pellet was washed with 1:1 
volume of 70% v/v ethanol and centrifuged at 12,000g for 15min. The 
purified RNA was then air dried, dissolved in a suitable volume of DEPC 
treated water and stored at -80 0C. RNA concentration was determined using 
a spectrophotometer at A260 (ND-1000, NanoDrop). Pure RNA shows an 
A260/A280 ratio of 1.8-2.1 with lower ratios indicating presence of 
contaminants like proteins and phenol. 
 
2.4.3  Gene Expression Analysis using Real Time 
Quantitative PCR (qRT-PCR) 
2.4.3.1   The Principle 
 
The measurement of mRNA levels was used to indicate gene expression. 
This involves removal of genomic DNA from the samples followed by first 
strand complimentary DNA (cDNA) synthesis and then relative quantification 
of the target template using specific primer pairs and RTQ-PCR. RTQ-PCR 
is based on detection of a fluorescent signal produced proportionally to the 
PCR product during each cycle i.e. in real time, as opposed to the end point 
detection by conventional quantitative PCR methods. Although several 
detection chemistries can be used, the simplest and economical is SYBR 
green, a dye that binds all double stranded DNA molecules. Upon binding, it 
emits fluorescence in proportion to the double stranded amplicons. The laser 
light emitted via optical fibres leads to excitation of the fluorophores within 
the samples and the resulting fluorescence signal is directed to a 
spectrograph attached to a charged coupled device camera detector. The 
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SYBR green assay requires optimisation as it can detect non-specific PCR 
products like primer-dimers.  
The ABI StepONE sequence detection system (Applied Biosystems) 
software calculates the change in fluorescence intensity (ΔRn) due to 
amplification. This is calculated using the formula ΔRn = Rn+ - Rn-, where 
Rn+ is the fluorescence emission of the product at each time point and Rn-, is 
the fluorescence emission of baseline usually between 3-15 cycles. The 
software further constructs amplification plots of ΔRn vs cycle number. As 
the amplification proceeds, the change in fluorescence intensity reaches a 
threshold, which is defined as a statistically significant point above the 
baseline, usually determined as 10 times the standard deviation of the 
baseline (cycles 3-15). The threshold cycle (Ct) is calculated by determining 
the point at which the fluorescence crosses the chosen threshold limit that 
correlates to the initial amount of target quantity. Ct values decrease linearly 
with increasing input target quantity.  
 
2.4.3.2   Primer selection and Optimisation 
 
The length and location of PCR primers were chosen using the Primer 3 
Output Program (http://frodo.wi.mit.edu). Primers were selected on different 
exon or intron-exon boundaries to avoid contaminating genomic DNA. To 
reduce the possibility of amplifying genomic DNA not complimentary from the 
sample; the primer pairs were selected within a short sequence of DNA 
crossing an intron-exon boundary. All primer pairs were optimised with 
annealing temperatures around 600C. Lyophilized primers were diluted in 
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DEPC-treated water to storage concentration of 100pmol/µl and later diluted 
again to a working concentration of 20pmol/µl.  
Each primer pair was optimised using a combination of forward and reverse 
primer concentrations ranging from 50nM to 900nM using a fixed amount of 
cDNA template. Optimal primer concentration was chosen based on the 
lowest Ct and highest ΔRn. Primer details are as seen in Appendix II. 
  
2.4.4  Isolation of genomic DNA and cDNA synthesis 
 
In order to remove small quantities of genomic DNA contamination, DNase I, 
Amplification grade from Invitrogen was used.  One Unit of DNase I was 
added to 1µg of total RNA and incubated for 15min at RT in the presence of 
1 x DNase I reaction buffer in a total volume of 10µl made up with DEPC-
treated water. The reaction was stopped by adding 0.5µl 25mM EDTA 
incubating at 650C for 15min. 
SuperScriptTM First Strand Synthesis System for RT-PCR kit from Invitrogen 
was used to generate complimentary deoxyribonucleic acid (cDNA) from 
total RNA. Eight µl of DNase I treated RNA was mixed with 1µl 
deoxyribonucleotide triphosphate (dNTP) mix (10mM of each dATP, dTTP, 
dGTP, dCTP) and 1µl Oligo (dT) (0.5µg/µl) and the volume made up to 10 µl 
with DEPC-treated water. Samples were incubated at 650C for 5min and 
placed on ice for 1min. A master mix (for n+1samples) was prepared 
consisting of 2µl 10x RT buffer, 4µl 25mM MgCl2, 2µl 0.1 M DTT and 1µl 
RNase OUT (40U/µl). Nine µl of mastermix was added to each RNA/primer 
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mix and samples collected by centrifugation and incubation at 420C for 2min. 
One µl (50U) SuperScript II Reverse Transcriptase was then added to each 
reaction and samples were incubated for a further 50min at 420C. The 
reactions were then terminated by incubation at 700C for 15min. The residual 
RNA template from the newly synthesised cDNA-RNA hybrid molecule was 
digested using 1µl RNase H (2U) for 20min at 37 0C. cDNA samples were 
stored at -20 0C.  
 
2.4.5  Amplification of Target cDNA 
 
The mRNA detection was done using SYBR green. All reactions were set up 
in a 96-well plate as follows: 1µl cDNA template, 12.5µl SYBR green 
mastermix and an appropriate ratio of primers in a total volume of 25µl made 
up with DEPC-treated water. Negative controls without cDNA template were 
included. All measurements were done in triplicate in the ABI StepONE 
Sequence Detection System (Applied Biosystems). The plate was then 
heated at 950C for 10min to activate the AmpliTaq Gold DNA polymerase. 
The amplification process then took, 40 cycles of 950C for 15sec 
(denaturation), 600C for 1min (annealing and extension). Data analysis was 
carried out using the ΔΔ-Ct method. RNA input variances were normalized 
against the levels of the L19 housekeeping gene, which encodes a ribosomal 
protein. 
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2.5  Microarray analysis 
 
Genome-wide microarray analysis was performed on primary cultures 
established from four different patients. Each culture was first transfected 
either with NT-siRNA or siRNA oligos against MR or GR. The cells were then 
decidualized for 4 days with 8-bromo-cAMP, Progesterone, and E 
(Cortisone). Total RNA was extracted using STAT-60 reagent (AMS 
Biotechnology, Abingdon, UK). RTQ-PCR was performed after first-strand 
cDNA synthesis to determine the level of GR and MR knockdown. RNA 
quality was analyzed on an Agilent 2100 bioanalyzer (Agilent Technologies, 
Waldbronn, Germany). Microarray analysis on total 
RNA samples was performed by UCL Genomics using Bioconductor version 
2.0 and R version 2.9.0. The robust multi-array analysis algorithm was used 
to obtain normalized data and gene signals. This method performs within-
chip and between-chip normalizations in a single step. Gene summaries are 
generated using the Affymetrix Expression Console software. The criteria 
used to generate lists of differentially expressed genes are based on 
standard filtering by fold change (50%change) and include false discovery 
rate filter (p=0.05). Gene ontology annotation was performed using the 
Database for Annotation, Visualization, and Integrated Discovery 
Bioinformatics Resources 6.7 (SAIC-Frederick, Inc., Frederick, MD). 
Microarray data have been deposited in Gene expression omnibus (GEO) 
database, accession number GSE42538. 
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2.6  Enzyme-linked immunosorbent assay 
(ELISA) 
 
ELISA is a biochemical technique used to detect the presence of an antibody 
or an antigen in a sample. Quantikine Human IL-11 and IL-15 immunoassays 
(R&D Systems) were used and performed as per the manufacturer’s 
protocol.  
Principle: The assay employs the quantitative sandwich enzyme 
immunoassay technique. A monoclonal antibody specific for IL-11/ IL-15 was 
precoated onto the 96 well polystyrene microplate. Standards and samples 
were pipetted into the wells and any IL-11/IL-15 present was bound to the 
immobilised antibody. After washing away any unbound substances, an 
enzyme-linked monoclonal antibody specific for IL-11/IL-15 was added to the 
wells. Following a wash to remove any unbound antibody-enzyme reagent, a 
substrate solution was added to the wells. Subsequently, a colour develops 
in proportion to the IL-11/IL-15 bound in the initial step. The colour 
development is stopped and the intensity of the colour measured. 
Procedure: The supernatant from the cultured and treated HESCs were 
stored at -200C. One hundred µl of assay diluent was added to each well. 
Fifty µl of standard/sample/control was then added per well and covered with 
adhesive strip. This was incubated for 3 hours at RT. Each well aspirated 
and washed with 400µl wash buffer, repeating the process 3 times for a total 
of 4 washes. After the last wash, the plate is inverted and blotted. Two 
hundred µl of the conjugate (IL-15/IL-11) was added to each well and plate 
covered with a new adhesive strip and incubated for 45 min at RT. The 
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process of washing and aspirating repeated. Subsequently, 200µl of 
substrate solution were then added to each well and incubated at RT for 30 
min, protected from light. Finally, 50µl of stop solution added to each well 
which changes the colour of the solution from blue to yellow. The optical 
density of each well determined within 30min using a microplate reader set to 
450nm. The wavelength correction was set to 540 nm to 570 nm. 
 
2.7   Confocal immunofluorescence microscopy 
 
Primary HESCs cultured on glass slides were fixed with 4% 
paraformaldehyde (Sigma) and permeabilized by 0.1% Triton X-100 (BDH 
Chemicals, London, UK). BODIPY 493/503 (Invitrogen Ltd.) was applied at 1 
µg/ml in PBS. BODIPY-stained samples were washed with PBS thrice for 5 
min before imaging. 4,6-Diamidino-2-phenylindole (DAPI) was used to 
identify nuclei. We examined samples under epifluorescent optics, and digital 
image were obtained with a Zeiss 510 confocal laser scanning microscope 
(Zeiss, Oberkochen, Germany). 
 
2.8  Immunohistochemistry (IHC) 
 
The endometrial biopsy tissue was fixed in neutral buffered formalin 
overnight at RT. IHC was performed to stain for the CD56 bright uterine NK 
cells. IHC was used to categorise the samples into high and low uterine NK 
cell population. The subjective nature of assessment in IHC has been its 
major drawback as an analytical technique. This was overcame by using 
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ImageJ analysis which is a semi-automated digital image which produces 
highly reproducible results for stromal cell counting with the use of the point 
picker tool for uNK cell counting {Drury, 2011, Endometrial cell counts in 
recurrent miscarriage: a comparison of counting methods}. 
 
2.8.1  Principle 
 
 Immunohistochemistry staining technique allows the visualisation of the 
antigens through sequential application of a specific antibody to the antigen 
(primary antibody), a secondary antibody to the primary antibody and an 
enzyme complex with a chromogenic substrate with interposed washing 
steps. The enzymatic activation of the chromogen results in a visible reaction 
product at the antigen site. The specimen is then counterstained and cover 
slipped. The slide is then scanned and analysed. 
2.8.2  Procedure 
 
The procedure was performed with the help of research histopathologist 
Sean James. 
 
 Figure 2.1:    Schematic process from tissue sampling to analysis 
1 
• Tissue fixation 
• Tissue processing 
2 
• Embedding in paraffin 
• Sequential sectioning 
3 
• Antigen retrieval 
• Immunohistochemistry 
4 
• Photographing 
• Image Analysis 
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Adhesive coated slides were pre-labelled, one slide for each antibody, plus 
several spares for negative controls. Sections are cut at 4 µm and dried 
overnight in the 56 0C oven. 
Antigen retrieval using PickCell Antigen retrieval unit: For antigen retrieval 
the slides incubated for 30min at 500C in 1mM EDTA, pH 8.0. Seven ml of 
Tris-EDTA buffer concentrate at pH7.8 or buffer A (pH6), B (pH8), C (pH4.5) 
or U (pH6) and 63 ml distilled water was placed into a slide chamber in the 
antigen retrieval unit. To optimise the antibody, tissues were exposed to 
different pH buffers to find the best one. The slides are inserted into the 
diluted buffer. The lid was closed and left for 2h. During this time, the unit 
reaches the temperature/pressure required and then cools down to a safe 
level for handling. 
Optimisation: Sufficient numbers of known positive control sections of 3µm 
each were cut freshly (to avoid reduction in epitope activity). The slides are 
then exposed to a range of pH’s in the PickCell antigen retrieval unit – pH4.5, 
pH6.9, pH7.8, pH8.0. Subsequently, they were stained (as described below) 
at a range of serial dilutions based on the manufacturer’s recommended 
dilutions- 1/50, 1/100, 1/200, 1/400, 1/800, 1/1600. Following staining, the 
slides were checked microscopically and a judgement was made to choose 
the best dilution based on the level of background staining and the level of 
non-specific staining seen. 
Staining technique: Following antigen retrieval, the sections were washed 
with distilled water. The borders around the sections marked with a 
hydrophobic pen and the slide placed in a metal moist chamber. 
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Endogenous peroxidase activity was blocked with Leica peroxidase block 
ensuring the tissue on each slide is covered with the solution and left for 
5min. The moist chamber was covered after each step. This was followed by 
two washes with TBS for 5min each time. Then, the tissue was covered and 
incubated with 100µl Leica protein block, incubated for 5min and the solution 
drained off. Subsequently, the slide was incubated in 200µl of primary 
antibody (optimal dilution determined by serial dilutions of known positive 
controls at varying pH buffers) overnight at 4 0C. The following morning, the 
slides were washed with TBS for 10min, twice. The slides were then 
incubated with 100µl of Leica post primary block for 30min at RT. The slides 
were then washed with TBS twice, 5min each time. Subsequently, they were 
incubated with 100µl of Leica Novolink polymer solution for 30min at RT. 
Again, two washes 5min each with TBS performed. The slides now were 
incubated with 2-3 drops of Leica DAB working solution (50µl of DAB 
chromogen in 1ml of Novolink DAB substrate) and left for 5min. The slides 
washed twice, 5min each with TBS and drained off. The slides were then 
counterstained with haematoxylin for 1min, washed in distilled water followed 
by incubation in TBS for 2-3 min to blue haematoxylin. The slides were then 
placed into a metal slide rack, dehydrated and mounted.  
 
2.8.3  Construction of Tissue Micro Array (TMA) 
 
Areas of interest, i.e. subepithelial regions, were spotted and tissue 
microarrays comprising duplicate 0.6mm cores from 18 cases in each group 
were constructed using Alphelys TMA Designer R 2 version 1.0.0.8. Sections 
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(3µm) were cut from completed array blocks and transferred to silanized 
glass slides. Sections from these arrays were then stained for CD56, 1:200 
(NCL-CD56-1B ; Novocastra), 11βHSD1, 1:300 (AB83522; Abcam, 
Cambridge, UK), MR, 1:400 (H-300: SC-11412; Santa Cruz Biotechnology, 
CA) and GR, 1:200 (E-20: SC-1003; Santa Cruz). Semi-quantative analysis 
was performed using imageJ software and the color deconvolution plug-in 
described below. 
 
2.8.4  Image J Analysis 
 
‘Image J’ is a freely available java-based (hence platform-independent) 
public domain image processing and analysis program developed at the 
National Institutes of Health, Bethesda, Maryland, USA which is rapidly 
gaining popularity as an objective, reproducible, cost-effective and time-
saving method of automated image- based immunohistochemistry evaluation 
{Girish, 2004, Affordable image analysis using NIH Image/ImageJ}. It can 
display, edit, analyze, process, save and print 8–bit,16–bit and 32–bit 
images. It can read many image formats including TIFF, GIF, JPEG, 
BMP,DICOM, FITS and ‘raw’. It can calculate area and pixel value statistics 
of user-defined selections. 
 
Digital images of IHC-stained slides were obtained using Mirax Midi slide 
scanner. This instrument scans brightfield sections at a x20 objective, at a 
resolution of 0.23µm/pixel. This produces images that can be dynamically 
manipulated within the viewer software (Panoramic Viewer from 3D Histech) 
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this allows optical magnifications up to x20, and digital magnification to x200. 
Images were saved in bitmap format which was further analysed using the 
Image J software. Where the epithelial edge was not visualised, they were 
excluded from the study. 
The field of view under x400 under high power is 450 micrometers. The field 
size is inversely proportional to the magnification. This means is that the field 
size divided by the same amount as the magnification was multiplied by, 
gives the field of view. High power field at x40 magnification covers a field 
view of 4500 micrometers. Five HPF at x40 was taken to analyse the density 
of CD56+ cells. 
2.8.4.1   Point Picker plug-in 
 
The point picker plugin available in ImageJ freeware (National Institutes of 
Health, Bethesda, MS, USA); allows cells to be marked with a coloured cross 
by clicking with the mouse. Upon completion, the number of counted cells is 
displayed in a text box. This makes this method the gold standard for cell 
counting, as cells are marked in the display screen and several observers 
can comment ⁄discuss and come to an agreement {Drury, 2011, Endometrial 
cell counts in recurrent miscarriage: a comparison of counting methods}. A 
grid was applied to each image and the point picker plugin used to quantitate 
stromal cell number and uNK cell number. As uNK cell density varies with 
endometrial depth, counting of CD56+ cells was confined to the stroma 
underlying the luminal epithelium. Five randomly selected high-power fields 
were assessed per biopsy using imageJ analysis to minimize inter-observer 
variability {Drury, 2011, Endometrial cell counts in recurrent miscarriage: a 
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comparison of counting methods;Girish, 2004, Affordable image analysis 
using NIH Image/ImageJ;Mariee, 2012, The observer and cycle-to-cycle 
variability in the measurement of uterine natural killer cells by 
immunohistochemistry}.  The uNK cell count is calculated by: 
  
%uNK=   uNK cell count X 100 
                         Stromal cell count 
 
Normal uNK cell density was defined as 5% CD56 cells in the stroma 
underlying the luminal epithelium {Quenby, 2005, Prednisolone reduces 
preconceptual endometrial natural killer cells in women with recurrent 
miscarriage;Tang, 2009, Prednisolone Trial: Study protocol for a randomised 
controlled trial of prednisolone for women with idiopathic recurrent 
miscarriage and raised levels of uterine natural killer (uNK) cells in the 
endometrium}. 
 
2.8.4.2   Colour Deconvolution plug-in 
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The colour deconvolution plugin for ImageJ implements stain separation was 
performed using Ruifrok and Johnston's method {Ruifrok, 2001, 
Quantification of histochemical staining by color deconvolution}. The 
command Image>Color>RGB split, this plugin unmixes an RGB (Red Green 
Blue) image produced by subtractive mixing (inks, histological dyes) into 
separate channels corresponding to up to 3 determined colors. This is useful 
e.g. to do pigment separation. The plugin provides a number of "built in" stain 
vectors; the ones used in the study include Haematoxylin and Eosin (H&E) 
and Haematoxylin and DAB (H DAB). This tool was used in the analysis of 
immunostained intensity to evaluate antigen expression. The antigen 
expressions analysed are 11βHSD 1, GR and MR. Each core in the TMA 
was separately analysed and represented as percentage area of positively 
stained (H DAB) area compared to the stroma (H&E). 
 
2.9  Radio-thin layer chromatography 
 
The activity of 11βHSD1 in HESCs was analyzed essentially as described in 
literature {Su, 2004, Novel 18beta-glycyrrhetinic acid analogues as potent 
and selective inhibitors of 11beta-hydroxysteroid dehydrogenases}. Briefly, 
the microsome-containing fraction of undifferentiated and decidualized 
HESCs was incubated with reduced nicotinamide adenine dinucleotide 
phosphate (NADPH) (1mM) and [3H] E. [14C] F (3X103dpm) was added to 
monitor procedural losses together with 50µg of unlabeled F. The assay was 
performed under initial rate conditions, and less than 12% of the substrate 
was converted to product. Precursor and product steroids were separated by 
thin layer chromatography using chloroform:methanol (9:1, vol/vol). 
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Retention factor values for F and E were 0.5 and 0.8, respectively. The 
amount of radioactivity was measured by scintillation spectrometry. Enzyme 
activity was determined as the amount of product formed per milligram of 
protein per hour after correction for procedural losses.  
 
2.10 Statistical analysis 
 
Data was analysed using the statistical package Graphpad Prism version 6.0 
(Graphpad software Inc, San Diego, CA, USA). Student’s t-test and Mann-
Whitney U test were used when appropriate.  
Logarithmic transformations were used when data were not normally 
distributed. This was particularly used for gene expressions as gene 
expression levels are skewed in linear scale. This is because some of the 
data points (lower expressed genes) are between 0 and 1 where 1 means no 
change and other data points (higher expressed genes) are between 1 and 
positive infinity. Log transformation also made the data more symmetrical 
and the parametric statistical test becomes more accurate. 
Variables that were not normally distributed were analysed using Man-
Whitney U test for paired comparisons. This was used for analysing areas of 
staining were expressed in colour deconvolution. Results were expressed at 
standard deviations (SD) or means ± standard error of the mean (SEM). 
Statistical significance was assumed when p < 0.05. 
 
 
 
99 
 
 
 
 
 
 
 
Chapter 3: Induction of 11βHSD 1 
and Activation of Distinct 
Mineralocorticoid Receptor and 
Glucocorticoid Receptor 
Dependent Gene Networks in 
Decidualizing 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
100 
 
3.0 Human Endometrial Stromal Cells 
 
3.1  Introduction 
 
Glucocorticoid treatment has been advocated as a treatment to improve 
reproductive outcome for a number of reasons: 
1. High levels of uterine natural killer cells have been associated with 
recurrent miscarriage and recurrent implantation failure, reduction of 
these occurred with prednisolone.  
2. Prednisolone was associated with an improvement in clinical outcome 
in a pilot trial in women with recurrent miscarriage (Quenby et al., 
2005b).  
3. Steriods were associated with improvement in IVF outcome in a meta-
analysis treatment (Boomsma et al., 2007).  
4.  Glucocorticoid stimulated peri-implantation hCG secretion from 
trophoblast of early human embryo (Ringler et al., 1989),  
5. Glucocorticoids accelerated trophoblast growth and invasion (Mandl et 
al., 2006).  
 
However, successful implantation requires some inflammatory events with 
pro-inflammatory cytokines and prostaglandins (Chard, 1995; Sharkey, 1998; 
Kelly et al., 2001; Bazer et al., 2010). Glucocorticoid may act to disable the 
cytokine-prostaglandin signalling cascade for implantation and 
decidualization because of anti-inflammatory action. Hence is it unclear as to 
whether glucocorticoids are beneficial to implantation.  
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Glucocorticoids include active glucocorticoid, cortisol (Kendall’s compound, 
F) and inert glucocorticoid, cortisone (Kendall’s compound, E). In 
glucocorticoid metabolism, the enzymatic reversible inter-conversion of 
cortisol and cortisone is catalyzed by 11β-hydroxysteroid dehydrogenase 
(11βHSD) family. NADP(H)-dependent enzyme, 11β HSD type1 (11βHSD1) 
basically regenerates cortisol from cortisone and NAD(H)-dependent 11β 
HSD type2 (11βHSD2) acts as a dehydrogenase converting cortisol to 
cortisone (cortisol-cortisone inter-conversion) (Lakshmi & Monder, 1988). 
The main binding receptor for cortisol is glucocorticoid receptor (GR; 
NR3C1), but cortisol also has a high affinity for mineralocorticoid receptor 
(MR; NR3C2), since MR has structural and functional kinship with GR.  
Therefore excess cortisol binding MR can result in apparent 
mineralocorticoid excess, such as Cushing syndrome (Arriza et al., 1987). 
Further, 11βHSD1 is normally found co-localised with GR, while 11βHSD2 is 
commonly found in MR-expressing tissues. However in adipose tissue, 
cortisol inactivating enzyme, 11βHSD2 is not significantly expressed, thus 
cortisol also acts through MR (Yang et al., 1997; Engeli et al., 2004). And the 
balance between GR and MR assumes the important role for regulation of 
inflammatory adipocyte responses (Hoppmann et al., 2010).  
In this thesis the critical determinant of implantation is considered to be 
decidualization (chapter 1). Decidualization which is progesterone (P4) 
dependant process seems to bestow unique functions on the endometrium 
that are essential for pregnancy, including the ability to regulate trophoblast 
invasion, to modulate local angiogenesis, to recruit specialized uterine 
natural killer cells and macrophages, and to resist environmental and 
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oxidative stress (13, 185). Furthermore in this thesis decidual changes in 
human endometrial stromal cells (HESCs) are thought to be the most 
significant component of decidualization (chapter 1).  
HESCs express 11βHSD1 and GR predominantly in menses phase, and 
11βHSD2 and MR in secretory phase. Hence, both the isoforms of 11βHSD, 
as well as GR and MR are expressed in human endometrium (McDonald, 
2006). In decidualizing endometrium, 11βHSD1, GR and MR, but not 
11βHSD2, are expressed (McDonald et al., 2006), similar to adipose tissue.  
Interestingly, GR expression is confined to stromal cells, whereas MR is 
reportedly present in both stromal and glandular compartments. 
Furthermore, 11βHSD1, but not 11βHSD2, is highly up-regulated upon 
differentiation of primary human endometrial stromal cells (HESCs) into 
specialist decidual cells in vitro (Takano, 2007).  
However the role of glucocorticoids via 11βHSD1/GR/MR signalling in the 
decidual transformation of endometrial stromal cells remains poorly 
understood. Moreover, GR and MR knockout animals die after birth (Cole et 
al., 1995; Berger et al., 1998), therefore little is still known about the 
reproductive consequences of GR and MR absence.  
 
In this chapter we investigated the hypothesis that during decidualization of 
HESCs the induction of 11βHSD1 leads to increased F bioavailability, which 
in turn regulates the expression of distinct GR- and MR-dependent gene 
networks.  
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3.2   Results 
3.2.1  Expression patterns of 11βHSD1 and 2, GR, and 
MR in undifferentiated and decidualized HESCs 
& impact of progesterone and dexamethasone 
on this signalling pathway 
 
The first experiment was set up to examine the role of corticosteroid 
signalling in decidualization. Hence to explore the role of 11βHSD1, GR and 
MR upon decidual change, primary HESCs were prepared as untreated (0 
days) or treated with 8-bromo-cAMP and MPA for 2, 4, 6 and 8 days.  
Decidualization was determined based on the morphological appearance 
and changes in the stromal cells. This comprises of change in spindle 
shaped cells to more rounded cells and the cells become more confluent. 
Strikingly, the 11βHSD1 mRNA and protein levels were induced significantly 
upon decidualization as seen in figure 3.1.A. This significant increase in the 
induction of 11βHSD1 is seen in a time dependant manner, increasing with 
the days of decidualization. Upon studying the activity of 11βHSD1 
decidualizing HESCs using chromatography, the 11βHSD1 activity was 
upregulated as well as its expression levels as seen in figure 3.1.B. 
However, the induction of 11βHSD2 expression was low in HESCs, and in 
the absence of treatment with 8-bromo-cAMP and MPA, expression further 
declined in response to low-serum (2% DCC-FBS) culture conditions. 
On examining the regulation of 11βHSD1 mRNA in response to 
differentiation signals in 10 independent primary cultures, the 11βHSD1 
transcript levels invariably increased by several orders of magnitude in 
response to 8-bromo-cAMP and MPA treatment as shown in Fig. 3.1.C.  
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Undifferentiated HESCs also abundantly express GR. However, treatment 
with 8-bromo-cAMP and MPA down-regulated this nuclear receptor as seen 
in Fig. 3.1.A. MR followed a reversed pattern with expression gradually rising 
in differentiating HESCs. Notably, culturing HESCs in low-serum conditions 
for several days was sufficient to alter MR and GR expression in opposite 
directions, although the effect was much more pronounced upon 8-bromo-
cAMP and MPA treatment (Fig. 3.1.A). Furthermore, the down-regulation of 
GR and reciprocal induction of MR at protein level in decidualizing cells were 
reflected at transcript level (Fig. 3.1., D and E). 
The switch from GR dominance to MR dominance is even better appreciated 
in the bar graph shown in Fig 3.2. 
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Medroxy progesterone acetate which was used in the above experiment has 
both progestogenic and corticosteroid actions, hence the next experiment set 
up was to study the effect of Progesterone (P4) and dexamethasone (DEX) 
on their own upon 11βHSD1/GR/MR signalling pathway in decidualizing 
endometrial cells.  
 
 
 
 
 
 
 
FIG 3.2. This figure further reinforces the clear switch from GR (glucocorticoid) to MR (mineralocorticoid) 
dominance at mRNA transcript levels  
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3.2.2  P4 drives the expression of 11βHSD1 in 
decidualizing HESCs 
 
In order to investigate the effect of progesterone (P4) and dexamethasone 
(DEX) on the 11βHSD1/GR/MR signalling pathway in decidualizing 
endometrial cells, cultures were untreated or treated with 8-bromo-cAMP 
alone or in combination with P4 or DEX for 2,4 and 8 days. 
The induction of 11βHSD1mRNA level was undoubtedly dependent on the 
combination of cAMP and P4 (Fig. 3.3.A). This finding was also reflected in 
the protein analysis as seen in Fig.3.3.B).  
GR, MR, 11βHSD1 and progesterone receptor (PR:NR3C3) belong to a 
subgroup of nuclear receptors and the steroid receptor superfamily. Thus 
GR, MR, 11βHSD1 and PR protein levels were confirmed with the parallel 
treatment for 4 days. GR protein level was reduced by treatment with 8-
bromo-cAMP plus P4 or DEX. The 11βHSD1 level was undoubtedly 
increased by the treatment with 8-bromo-cAMP plus P4, on equality with 
RTQ-PCR data, but the ability of DEX was insufficient to regulate 11βHSD1. 
Time-course analysis demonstrated that, in contrast to P4, DEX had little or 
no effect on the induction of 11βHSD1 transcripts in 8-bromo-cAMP-treated 
cells (Fig. 3.3A). Compared with treatment with 8-bromo-cAMP alone, 
addition of DEX did up-regulate 11βHSD1 protein levels, although this 
response was much more pronounced with 8-bromo-cAMP and P4 
(Fig.3.3B). Western blot analysis also revealed that cAMP signalling drives 
the down-regulation of GR and reciprocal induction of MR in decidualizing 
cells (Fig. 3.3B). As previously reported {Brosens, 2009, A role for 
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menstruation in preconditioning the uterus for successful pregnancy}, 8-
bromo-cAMP reduces cellular levels of PR isoforms (PR-A and PR-B). 
Although co-treatment with P4 induces a mobility shift in PR migration on 
SDS-PAGE, reflecting ligand-dependent receptor phosphorylation, DEX had 
no effect (Fig.3.3B).  
Upon comparing the induction of two decidual markers, PRL and IGFBP1, in 
primary cultures with 8-bromo-cAMP and either P4 or DEX; unlike P4, DEX 
had no effect on cAMP-dependent induction of PRL transcripts in HESCs 
(Fig. 3.3C). However, DEX was more potent than P4 in enhancing IGFBP1 
expression in cultures stimulated with 8-bromo-cAMP, especially during the 
early stages of the decidual process (Fig.3.3D).  
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To test whether 11βHSD1-dependent F biosynthesis modulates the 
expression of decidual marker genes, primary HESCs were decidualized with 
8-bromo-cAMP and P4 in the presence or absence of E. The primary cell 
cultures were differentiated with 8-bromo-cAMP and P4 in the presence or 
absence of E. After 4 days, the mRNA transcript levels of PRL, IGFBP1 and 
11βHSD1 were determined. 
 Addition of E has no effect on the induction of PRL. However, it strongly 
enhanced the expression of IGFBP1 and, albeit less pronounced, 11βHSD1 
transcripts (Fig. 3.4). Conversely, treatment of primary cultures with an 
11βHSD1inhibitor (CBX or PF) attenuated the induction of IGFBP1 and 
HSD11B1 but not PRL (Fig. 3.5). These observations underscore that 
11βHSD1-dependent cortisol biosynthesis impacts selectively on the 
expression of decidual marker genes. 
 
 
 
 
 
Figure 3.4: Effect of cortisone (E) on the expression of decidual marker genes. Primary 
HESCs were differentiated with 8-bromo-cAMP and P4 in the presence or absence of E. 
PRL, IGFBP1 and 11βHSD1 transcript levels were determined after 4 days of treatment. The 
data, normalized to L19 mRNA, are expressed in arbitrary units; mean ± SEM. ** indicates P 
< 0.001 
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3.2.3  Identification of GR and MR dependent genes in 
decidualizing HESCs 
 
Next step was to identify GR and MR dependent genes responsive to 
endogenous F biosynthesis in differentiating HESCs. To do this, four 
individual primary cultures were first transfected with NT-, GR-, or MR- 
siRNA and then treated with 8-bromo-cAMP, P4, and E for 4d. Total mRNA 
and protein lysates were extracted from parallel cultures. Western blot 
analysis was used to confirm GR and MR knockdown (Fig. 3.6A). GR 
knockdown had no impact on MR, 11βHSD1, or PR levels. In contrast, MR 
silencing seemed to hinder the induction of 11βHSD1 and modestly up-
regulated GR levels. Total RNA extracted from decidualizing cultures 
transfected with NT-, GR-, or MR-siRNA was processed for whole genome 
microarray analysis. Using a cut-off of more than or equal to 1.5-fold change, 
179 and 107 Grand MR-selective genes, respectively, were identified 
(P<0.05) (Fig. 3.6B). Interestingly, GR knockdown resulted in significantly 
more up- than down-regulated genes (106 vs. 73, respectively; X2test, P < 
0.001), whereas MR knockdown had the opposite effect (up- and down- 
regulated genes: 35 vs. 72, respectively; X2test, P < 0.001). Appendix IV, 
Tables 1–4 list the genes induced or repressed by GR and MR. We also 
identified 60 genes under control of both nuclear receptors in decidualizing 
HESCs with only a single gene, GRIA1, regulated in an opposing manner 
(Appendix IV, Table 5). We chose GRIA1 as well as WNT4 and FBXO32 
(putative GR- and MR-dependent genes, respectively) for initial validation of 
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the array findings. Using independent cultures, we first monitored the 
expression of these genes in response to treatment with 8-bromo-cAMP, P4, 
and E for 4 or 8 d and then examined the impact of either GR or MR 
knockdown. GRIA1, which encodes for one of the four ionotropic 2-amino-3-
(3-hydroxyl-5-methyl-isoxazol-4-yl) propanoic acid receptor subunits 
{Sugimoto, 2010, Ionotropic glutamate receptor AMPA 1 is associated with 
ovulation rate}, is profoundly repressed in differentiating cells with transcript 
levels declining more than 90% after 4d of treatment (Fig. 3.7A). This 
repression was partially relieved upon GR knockdown but enhanced in 
response to MR silencing (Fig. 3.7B). WNT4 and FBXO32 are both induced 
upon decidualization predominantly in a Grand MR-dependent manner, 
respectively (Fig. 3.7). Interestingly, FBXO32, which encodes the E3 
ubiquitin ligases Atrogin-1, was recently shown to be an 11βHSD1-
dependent gene in skeletal muscle cells {Biedasek, 2011, Skeletal muscle 
11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of 
E3 ubiquitin ligases atrogin-1 and MuRF-1}. In agreement, treatment of 
primary cultures with either CBX or PF inhibited FBXO32 and GRIA1 
expression in decidualizing cells PRL (Fig. 3.5). In case of GRIA1, this 
suggests that MR-dependent induction may be dominant over GR-dependent 
inhibition. However, 11βHSD1 inhibition had no significant effect on the 
induction of WNT4 in decidualizing cells. Thus, like other steroid hormone 
receptors, GR and MR modify decidual gene expression in a ligand-
dependent and ligand-independent manner. 
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Figure 3.6: Identification of GR- and MR-regulated genes in decidualizing HESCs. A, Western blot analysis 
of GR, MR, 11βHSD1, and PR expression in protein lysates extracted from primary cultures first transfected 
with NT-, GR-, or MR-siRNA and then treated with 8-bromo-cAMP, P4, and E for 4 d. _-Actin served as a 
loading control. C, Venn diagram showing the number of differentially expressed genes in decidualizing 
cells treated with 8-bromo-cAMP, P4, and E for 4 d in response to GR or MR knockdown. 
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3.2.4  GR limits the expression Krüppel-associated 
box domain containing ZNF (KRAB-ZNF) 
transcriptional repressors 
 
After correction for multiple testing (Benjamini and Hochberg false discovery 
rate), gene ontology annotation revealed that the genes repressed by GR 
were strongly enriched for KRAB-ZNF proteins (P < 0.0001). In fact, 18 
members of this family of transcriptional repressors were upregulated upon 
GR knockdown: ZNF91, ZNF92, ZNF100, ZNF253, ZNF254, ZNF311, 
ZNF420, ZNF484, ZNF486, ZNF585A, ZNF586, ZNF613, ZNF624, ZNF625, 
ZNF626, ZNF669, ZNF738, and ZNF791. Notably, the expression of five 
(ZNF181, ZNF223, ZNF254, ZNF625, and ZNF669) also increased upon MR 
knockdown (Appendix IV Tables 4 and 5). Validation analyses demonstrated 
that the expression of ZNF486 transcripts declines modestly upon treatment 
of HESCs with 8-bromo-cAMP, P4 and E (Fig. 3.8A, left panel). In agreement 
with the array findings, GR knockdown selective up-regulated ZNF486 
mRNA levels in differentiating HESCs by approximately 2-fold (Fig. 3.8A, 
right panel). KRAB-ZNF proteins block transcriptional initiation by recruiting a 
variety of chromatin modifiers to promoters of target genes, resulting in an 
increase in H3K9me3 {Groner, 2010, KRAB-zinc finger proteins and KAP1 
can mediate long-range transcriptional repression through heterochromatin 
spreading;Frietze, 2010, ZNF274 recruits the histone methyltransferase 
SETDB1 to the 3' ends of ZNF genes}. To monitor this repressive chromatin 
mark to determine whether GR plays a role in chromatin remodelling that 
underpins the decidual phenotype {Grimaldi, 2011, Down-regulation of the 
histone methyltransferase EZH2 contributes to the epigenetic programming 
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of decidualizing human endometrial stromal cells}; western blot analysis 
revealed a gradual decline in global H3K9me3 levels in response to 
differentiation cues (Fig. 3.8B, left panel). Knockdown of GR, and perhaps to 
a lesser extent of MR, was sufficient to reverse this response (Fig. 3.8B, right 
panel). 
 
 
 
 
Figure 3.8:   GR signalling plays a role in chromatin remodelling in decidualizing HESCs. A, 
ZNF486 transcript levels were measured in four primary cultures treated 8-bromo-cAMP, 
P4, and E for the indicated time points (left panel) as well as in cultures decidualized for 4 d 
after GR or MR knockdown (right panel). The results show mean fold change (±SEM) 
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relative to levels in undifferentiated cells (dotted lines). * P<0.05. B, Western blot analysis 
of H3K9me3 expression in total protein lysates from primary cultures treated 8-bromo-
cAMP, P4, and E for the indicated time points (left panel) as well as from cultures 
decidualized for 4 d upon GR or MR knockdown (right panel). β-Actin served as a loading 
control. 
 
 
3.2.5 MR is essential for retinoid metabolism and lipid 
droplet biogenesis 
 
In contrast to GR, MR acts primarily as a transcriptional activator in 
decidualizing HESCs (Appendix IV Tables 1 and 5). Perhaps the most 
striking observation is that several MR-induced genes encode for key 
enzymes involved in retinoid metabolism and cholesterol homeostasis, 
including retinol saturase, members of the shortchain  DHRS (DHRS3, 
DHRS4, and DHRS4L2), the dehydrocholesterol reductase DHCR7, and the 
steroidogenic acute regulatory protein-related lipid transfer protein domain 
containing protein STARD5. To validate the array findings, we focused on 
DHRS3 (also known as retinal short-chain dehydrogenase/reductase 1). This 
enzyme was highly induced at both mRNA and protein level in a time 
dependent manner upon treatment of primary HESCs with 8-bromo-cAMP, 
P4, and E (Fig. 3.9A). MR knockdown attenuated the induction of DHRS3 
transcripts in decidualizing cells (Fig. 3.9B, right panel). To further explore 
MR dependency of DHRS3 expression in decidualizing cells, primary 
cultures were treated with 8-bromo-cAMP, P4, and either aldosterone or 
RU26752, a MR antagonist (Agarwal, 1999; Kelly, 2011). Although addition 
of aldosterone potentiated the induction DHRS3 in cells differentiated with 8-
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bromo-cAMP and P4, RU26752 completely abolished this response 
(Fig.3.9B, right panel). DHRS3 has recently been implicated in endoplasmic 
reticulum (ER)-derived lipid droplet formation (Deisenroth, 2011). Loading of 
primary HESCs with a cell-permeable lipophilic fluorescence dye, BODIPY 
493/503, followed by confocal microscopy demonstrated that Decidualization 
is associated with highly dynamic changes in the appearance of these 
cytoplasmic lipid droplets. Undifferentiated HESCs contain numerous small 
droplets. Unexpectedly, these lipid droplets were consistently less abundant 
after 4d of differentiation (Fig.3.9C). By day 8, the droplets had re-
accumulated especially near the periphery of the cells. Four days later, fewer 
but larger and more centrally localized lipid droplets were present in 
decidualizing HESCs (Fig. 3.9C). Next, we treated primary cultures with 8-
bromo-cAMP, P4, and either aldosterone or RU26752 for 8d.  Interestingly, 
although addition of aldosterone favoured the formation of larger droplets, 
RU26752 virtually abolished their presence all together (Fig. 3.9D). 
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Figure 3.9:  MR-dependent induction of DHRS3 in decidualizing HESCs is 
associated with dynamic changes in cytoplasmic lipid droplets. DHRS3 expression 
was examined in parallel primary cultures treated with 8-bromo-cAMP, P4, and E for 
the indicated time points as well as after GR or MR siRNA knockdown by RTQ-PCR 
(A) or Western blot analysis (B). DHRS3 expression was analyzed in four 
independent primary cultures. The left panel shows percentage change (±SEM) in 
mRNA expression relative to levels in undifferentiated cells (dotted lines). C, 
Confocal micrographs showing lipid droplets stained with BODIPY (green) and 
nuclei stained with 4,6-diamidino-2-phenylindole (DAPI) (blue) in HESCs treated 
with 8-bromo-cAMP, P4, and E for the indicated time points. D, Representative 
confocal images of HESCs decidualized with 8-bromo-cAMP and P4 in the 
presence or absence of aldosterone or RU26752 for 8 d. Scale bar, 10 µm. 
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3.3   DISCUSSION 
 
Elevated circulating P4 levels maintain the maternal decidual response in 
pregnancy and are therefore indispensable for survival of the fetus. However, 
circulating levels of androgens, aldosterone, and F also increase in early 
pregnancy (Gennari-Moser, 2011; Jensen, 2002; Castracane, 1998; Cloke, 
2012). Furthermore, the endometrium expresses the full complement of 
cognate receptors as well as a host of steroidogenic enzymes that will 
determine the local bioavailability of different ligands. For example, increased 
expression accounts for the higher conversion of testosterone to 
dihydrotestosterone in secretory compared with proliferative endometrium 
(Ito, 2002; Cloke, 2008). From the experiments, P4 drives 11βHSD1 
expression, which is further reinforced by F production and signalling. This 
positive feedback mechanism renders 11 βHSD1 one of the most highly 
induced genes upon HESC differentiation (Takano, 2007). Further, 
decidualization is also associated with a rebalancing of corticosteroid 
receptors in favour of MR. MR and GR show significant amino acid homology 
in their ligand- and DNA-binding domains with PR and androgen receptor 
(AR) (Funder, 1997). Together, these four receptors constitute the 3-
ketosteroid receptor subfamily of nuclear receptors. The structural homology 
between these receptors implies that a degree of promiscuity may exist in 
the binding of various natural or synthetic ligands. This is indeed the case. 
For example, P4 binds MR, although the physiological consequences of this 
interaction, if any, are still unknown (Myles, 1996). Similarly, MPA, which 
unlike P4 does not have the propensity to partition onto glass and plastic in 
culture, is widely used to study PR responses in vitro, yet it is also a potent 
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activator of GR and AR (Selman, 1996; Cloke, 2008). Structural homology 
also raises the possibility of functional redundancy between these receptors. 
Previous study has shown that this is not the case for PR and AR (Ito, 2002). 
By combining siRNA-mediated knockdown with genome-wide expression 
profiling, it is clear that AR signalling is essential for cytoskeletal organization 
and cell cycle regulation in decidualizing cells. PR knockdown deregulated 
approximately nine times more genes than AR silencing (92 vs. 860 genes, 
respectively). Interestingly, a significant number of PR-regulated genes 
encode for membrane bound receptors and intermediates in various signal 
transduction pathways, suggesting that P4 dependency of the decidual 
phenotype is, at least in part, accounted for by PR-dependent 
reprogramming of pathways activated by growth factors and cytokines 
(Cloke, 2008). A similar approach was adopted to identify MR- and GR-
dependent genes in differentiating HESCs. Instead of using MPA, as it 
introduces a bias in favour of GR responses, P4 in combination with 8-
bromo-cAMP was used and added E as the substrate for 11βHSD1 
conversion. After 4d of treatment, we identified 179 and 107 deregulated 
genes upon GR or MR knockdown, respectively. Like PR (Cloke, 2008), GR 
represses significantly more genes than it induces in decidualizing cells. The 
number of up- and down-regulated genes upon AR knockdown is 
comparable, whereas MR functions primarily to promote the expression of 
certain decidual genes. Cross-referencing of the array data identified only 12 
genes that are regulated by PR or AR as well as GR or MR (Appendix IV, 
Table 6). Mining of the GR-dependent genes yielded some unexpected 
results. For example, GR represses the expression of SPP1 (osteopontin), a 
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major component of the embryo-endometrial interaction (Loke, 1995), 
suggesting that glucocorticoid exposure during the window of implantation 
may interfere with embryo implantation. GR stimulated the induction of 
WNT4, a key component of P4 responses in both the uterus and breast 
(Brisken, 2000; Franco, 2011). Further, GR as well as MR signalling may be 
important for sustained cAMP activity in decidualizing cells by up-regulating 
the α-catalytic subunit of protein kinase A (PRKACA) (Appendix IV, Table 5). 
However, the most striking observation was that GR activity attenuates the 
induction of 18 KRAB-ZNF proteins. With 675 encoding genes, the C2H2 
zinc-finger proteins comprise the largest family of regulatory proteins in 
mammals, and 36% contain a KRAB domain (Frietze, 2010; Rousseau-
Merck, 2002; Vaquerizas, 2009). Over 50% of all human KRAB-ZFP genes 
are located in clusters on chromosome 19, including 15 of the 18 genes 
found to be regulated by GR in this study. The functions of these GR-
repressed KRAB-ZFP genes are unknown with the exception of ZNF420, 
which encodes ATM and p53-associated krüppel type zinc finger protein, a 
negative regulator of p53-mediated apoptosis (Tian, 2009). However, it is 
well established that the KRAB domain confers a potent transcriptional 
repressor function by mediating specific interactions with a co-repressor 
protein, krüppel -associated protein 1 (encoded by TRIM28), which in turn 
serves to recruit chromatin deacetylation machinery (Moosmann, 1996; 
Schultz, 2002; Ayyanathan, 2003), as well as methyltransferase complexes 
(Frietze, 2010). Because KRAB-ZNF transcription factors have been 
implicated in trimethylating H3K9 (Frietze, 2010), the cellular levels of this 
histone mark upon differentiation of HESCs was monitored. Perhaps 
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somewhat fortuitously, this line of inquiry showed that decidualization is 
associated with a decline in global cellular H3K9me3 levels, which is 
disrupted upon GR knockdown. Analysis of genes deregulated upon MR 
knockdown highlighted the dynamic changes in lipid droplet formation and 
retinoid metabolism that occur upon decidual transformation of HESCs. 
Although the MR dependency of these metabolic functions in decidualizing 
HESCs was unanticipated, it is in keeping with the observation that silencing 
of this nuclear receptor in murine adipocytes completely prevents lipid 
accumulation (Hoppmann et al., 2010). In contrast, GR knockout only mildly 
impairs adipogenesis. Aldosterone has been shown to promote adipose 
conversion of 3T3-L1 and 3T3-F442A cells, whereas DEX inhibits terminal 
adipocyte maturation (Caprio, 2007). Further, two MR-dependent genes in 
decidualizing HESCs, RETSAT and DHRS3, are strongly implicated in both 
intracellular lipid accumulation and retinoid metabolism (Deisenroth, 2011; 
Schupp, 2009). 
 
Retinoic acid (RA), the biologically active metabolite of vitamin A (retinol), is 
essential for embryogenesis and maintenance of pregnancy. Both RA 
deficiency and excess causes severe fetal malformation, suggesting that 
retinoid metabolism must be tightly controlled at the fetomaternal interface 
(Niederreither, 2008; Xia, 2010; Han, 2010). RA is derived from oxidation of 
all-trans-retinaldehyde (retinal), an unstable intermediate that fluxes between 
retinol and RA. Because DHRS3 is a retinaldehyde reductase that promotes 
storage of retinol in lipid droplets, its level of expression may be an important 
mechanism to modulate local RA availability (Cerignoli, 2002; Deisenroth, 
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2011). DHRS3 levels are low in undifferentiated HESCs, but expression 
increases markedly upon decidualization, in parallel with the induction of 
11βHSD1. In fact, both enzymes are structurally related members of the 
SDR superfamily that localize to the ER (Maser, 1997). The terminal 
enzymes involved in the synthesis of lipid droplets also localize to the ER 
and often to droplets themselves, as is the case for DHRS3 (Deisenroth, 
2011). Thus, the dynamic changes in the appearance and abundance of lipid 
droplets in decidualizing HESCs may at least partly reflect the changing 
nature of ER-resident enzymes. Lipid droplets are often viewed as mere 
energy storage facilities, containing predominantly neutral lipids and various 
proteins (Goodman, 2008). Based on our observations, it is tempting to 
speculate that the constituents and functions of these lipid droplets also 
change upon decidualization of HESCs, perhaps becoming more akin to the 
retinyl ester storage particles (retinosomes) present in the eye (Orban, 
2011). In summary, the observations suggest that decidualization of the 
endometrium promotes the formation of a corticosteroid gradient at the feto-
maternal interface. Although F is virtually absent in the placenta due to the 
abundant expression of 11βHSD2 (Shams, 1998; McCalla, 1998), its 
production on the maternal side may exert important autocrine as well as 
paracrine functions. For example, local F biosynthesis could constitute a 
major mechanism that protects the fetal allograft against a potential maternal 
immune response. Importantly, the data also suggest that MR is a central 
regulator of the metabolic functions of the maternal decidua. This may be of 
particular importance to human pregnancy, because perfusion of the 
placenta is not established until 10–12 weeks of gestation (Jauniaux, 2000). 
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Consequently, throughout the process of organogenesis (3–8 weeks of 
pregnancy), fetal nutrition depends entirely on secretions produced by 
endometrial glands and decidualizing stroma (Burton, 2011; Spiegler, 2012). 
The role of the endometrial 11βHSD1/GR/MR pathway in reproductive failure 
clearly warrants further investigation. 
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Chapter 4: Elevated                       
peri-implantation uterine natural 
killer cell density in human 
endometrium is associated with 
impaired decidualization stromal 
cells in recurrent miscarriage and 
recurrent implantation failure 
patients 
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4.1 INTRODUCTION 
 
Successful implantation is a subtle dialogue between the maternal 
endometrium and the embryo. A receptive endometrium is a prerequisite 
from the maternal side (Giudice, 1999; Navot, 1991) which lasts for a limited 
period of time. The luminal epithelium undergoes precisely defined 
morphological changes until a receptive endometrium is developed. The 
‘implantation window’ is described as the period in the mid-luteal phase from 
day 19 to day 24, when implantation can take place (Navot, 1991; 
Dominguez, 2003) and is time limited (Wilcox, 1999). This corresponds to the 
time when the embryo hatches, 6 days after LH surge, and consequently 
ready for implantation within the following 24 hours .  Although the luminal 
endometrial epithelium is the primary barrier in the implantation process, the 
progesterone responses in this cellular compartment that underpin the 
receptive phenotype are mediated by signals derived from the underlying 
stromal cells (Simon, 2009), i.e. from decidualization of the stromal 
compartment. 
Decidualization is a progressive process occurring in the late mid secretory 
phase in a temporal and spatial fashion comprising of morphologic, 
biochemical, and vascular modifications initiated by the presence of 
progesterone after oestrogen priming (Ramathal, 2010). The implanting 
blastocyst initially apposes and attaches to the luminal epithelium of the 
endometrial lining about 6–7 days after conception. Soon after the epithelium 
is breached, the interface lies between trophoblast and decidual cells. The 
trophoblast invasion extends beyond the endometrium into the uterine 
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junctional zone, which is the inner third of the myometrium (Brosens, 2010; 
Brosens, 1995). The decidua–trophoblast dialogue orchestrates the 
remarkably dynamic process by which the blastocyst becomes completely 
embedded in the uterine wall within a few days, as early as 10 days after LH 
surge (Norwitz, 2001; de Ziegler, 1998). A defect predisposes to related 
pregnancy complications, including miscarriage, preeclampsia, fetal growth 
restriction, and preterm labour. Inadequate uterine receptivity is thought to be 
responsible for two-thirds of implantation failures (Simón, 1998). 
Uterine natural killer (uNK) cells, an important component of the innate 
immune system, are the most abundant immune cells in the mid-luteal (peri-
implantation) endometrium and in the decidua of early pregnancy (Manaster, 
2008). They represent a unique subset of NK cells; staining brightly for CD56 
(CD56+) but dimly for CD16 (CD16-). uNK cells play a significant role in the 
establishment and maintenance of early pregnancy by promoting decidual 
angiogenesis, spiral arterial remodeling and trophoblast invasion (Hanna, 
2006; Quenby, 2009). In contrast to their circulating (CD56+/CD16+) 
counterparts, there is little evidence for a cytotoxic role of uNK cells at the 
feto-maternal interface. However, uNK express killer-cell immunoglobulin-like 
receptors (KIR) that preferentially bind to human leukocyte antigen (HLA)-C 
molecules expressed on placental cells, suggesting a role in maternal 
allorecognition of fetal trophoblast . They are abundant around the spiral 
arteries, near endometrial glands and adjacent to extravillous trophoblast in 
early pregnancy. Thus, uNK cells are unique in terms of their tissue 
distribution, phenotype and function. Also, resident human endometrial 
stromal cells (HESCs) are thought to serve as gatekeepers for the 
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recruitment and distribution of immune cells in the peri-implantation 
endometrium . For example, decidualizing (differentiating) HESCs secrete 
interleukin 11 (IL-11) and IL-15, two multifaceted cytokines implicated in 
trafficking and differentiation of uNK cells. 
Both the maternal KIR and fetal HLA-C gene systems are highly polymorphic 
and certain genotypic combinations are associated with a modest increase or 
decrease in pregnancy complications, including miscarriage, fetal growth 
restriction and pre-eclampsia.  In addition, several studies reported an 
association between elevated uNK cell levels in mid-luteal endometrium and 
reproductive failure (Chazara, 2011; Quenby, 2009; Clifford, 1999). In 
particular, there is compelling evidence to link increased uNK density to 
recurrent pregnancy loss (RPL), defined here as three or more consecutive 
miscarriages. RPL is a prevalent disorder that affects 1–2% of couples and a 
cause of considerable physical and psychological morbidity (Rai, 2006). 
Furthermore, RPL is associated with increased likelihood of obstetric 
complications and adverse perinatal outcome in a subsequent on going 
pregnancy . Whether mid-luteal uNK cell testing in a non-conception cycle 
predicts subsequent pregnancy complications remains unresolved .   
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4.2  RESULTS 
4.2.1 Elevated uNK cell density in vivo is associated 
with impaired induction of key decidual markers in 
vitro 
 
Previous studies have shown that an aberrant decidual response, associated 
with reproductive disorders such as endometriosis and recurrent pregnancy 
loss (RPL), is maintained in culture (Klemmt, 2006; Salker, 2012). This 
prompted further investigation into the possibility of uNK cell density in vivo 
reflecting the induction of 11βHSD1 in response to decidual cues. For this, 
timed endometrial biopsies 21were divided and processed as follows: one 
part for CD56 immunostaining and the other for primary HESCs. These 
cultures were passaged once, grown to confluency, and treated with 8-
bromo-cAMP, P4 and E for either 4 or 8 days. As shown in Figure 4.1, there 
was a striking inverse correlation between uNK cell density in vivo and the 
responsiveness of paired primary cultures to differentiation stimuli. This 
inverse correlation was noted for PRL and IGFBP1, two ‘classical’ decidual 
marker genes (Fig. 4.1A & 4.1B).  
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4.2.1  Cytokines IL-11 and IL-15 
 
Upon examining whether this association extended to IL-11 and IL-15, 
cytokines implicated in regulating uNK cells (Ain, 2004; Ashkar, 2003; Ain, 
2004; Ashkar, 2003; Godbole, 2010). Rather surprisingly, there was a trend 
towards higher levels of induction of IL-11 and IL-15 transcripts in 
decidualizing HESC cultures obtained from biopsies with normal uNK cell 
densities (Fig. 4.2A & 4.3B), although this did not reach statistical 
significance (P > 0.05).  
 
 
Figure 4.2:   Induction of IL11 and IL15 mRNA in decidualizing HESCs in culture does not 
correlate to uNK cell densities in vivo. A & B, the uNK cell densities in 21 biopsies were 
correlated to the induction of IL11 and IL15 transcripts, respectively, in corresponding 
primary HESCs decidualized either for 4 days (left panel) or 8 days (middle panel). The right 
panel shows the mean (± SEM) induction in biopsies deemed to have normal or elevated 
uNK cell counts. 
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4.3   DISCUSSION 
 
Increased uNK cell density in mid-luteal endometrium has been associated 
with reproductive failure, especially RPL (Chazara, 2011; Quenby, 2009; 
Clifford, 1999). However, the mechanisms that account for cyclic recruitment 
of uNK cell precursors and subsequent proliferation and differentiation within 
the peri-implantation environment are not well understood. In addition to IL-
11 and IL-15, several other endometrial factors may be implicated in this 
process, including chemokine (C-X-C) motif ligand 14, IL-12 and IL-33 
(Salker, 2012; Karsten, 2009; Mokhtar, 2010). Notably, the decidual process 
in the human endometrium is under tight spatiotemporal control (Gellersen, 
2007). It is initiated in the mid-luteal phase of the cycle first in stromal cells 
surrounding the terminal spiral arteries and underlying the luminal epithelium. 
Thus, rather than the total number of uNK cells, it is possible that excessive 
migration of uNK cells from their usual position in the basal and peri-vascular 
regions of the endometrium to the sub-luminal region is the hallmark of an 
abnormal decidual response that predisposes for early pregnancy loss. 
Finally, there is increasing evidence that the responsiveness of endometrial 
cells to differentiation signals is subjected to epigenetic programming 
(Grimaldi, 2011),  which explains how an aberrant decidual response in vivo 
is maintained, at least partly, upon differentiation of purified HESCs in vitro 
(Klemmt, 2006; Salker, 2012; Aghajanova, 2010; Salker, 2011). In 
agreement, high uNK cell density in vivo is associated with blunted induction 
decidual marker genes, such as PRL and IGFBP1, in primary cultures. 
Somewhat paradoxically, induction of IL-11 and IL-15 also tended to be 
lower in decidualizing cells established from biopsies with elevated uNK cell 
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levels, although this trend was not significant. This observation does not 
exclude the possibility that expression levels of these cytokines in situ 
correlate with uNK cell levels as reported for IL-15 in a recent study . 
Human uNK cells have been described as immature and inactive before 
pregnancy (Manaster, 2008). It is unclear as to how high uNK cell densities 
prior to conception predisposes to subsequent pregnancy failure. Ablation of 
these cells in mice has been shown to compromise spiral arteriole 
remodelling and maintenance of decidual integrity seen after mid-pregnancy. 
Yet uNK cell deficient Il15-/- mice are fertile, have normal gestation lengths 
and litter sizes comparable to wild-type mice . Similarly, human uNK cells are 
implicated in spiral artery remodelling. They are a rich source of angiogenic 
growth factors, although paradoxically the endometrium of RPL patients is 
characterized by reduced expression of several key factors, including PDGF-
BB, Ang-2, VEGF-A and VEGF-C .  
It seems likely that complex and dynamic gradients of chemoattractants and 
chemorepellents control the spatiotemporal distribution of uNK cells in the 
peri-implantation endometrium. The above data suggest that excessive uNK 
cells in the subluminal stroma compartment prior to conception may serve as 
a potential biomarker for a suboptimal decidual response in pregnancy.  
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Chapter 5: Elevated                  
peri-implantation uterine natural 
killer cell density in human 
endometrium is associated with 
impaired corticosteroid 
signalling in decidualizing 
stromal cells 
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5.1 INTRODUCTION 
 
Uterine NK (uNK) cells express the glucocorticoid receptor (GR) but lack 
progesterone receptor (PR), rendering them directly responsive to cortisol 
but not progesterone (Henderson, 2003; Guo, 2012). Consistent with this 
notion, pre-conceptual glucocorticoid (prednisolone) treatment significantly 
reduces uNK cell density in RPL subjects as well as endometrial 
angiogenesis . Progesterone massively enhances the expression and activity 
of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) in decidualizing 
HESCs as shown in Chapter 3, , suggesting that local cortisol biosynthesis 
plays an integral role in the preparation of the endometrium for implantation. 
Decidualization is further associated with a decline in GR expression and 
reciprocal induction of the mineralocorticoid receptor (MR), which in turn 
drives the expression of several key enzymes involved in lipid and retinoid 
metabolism, including retinol saturase (RETSAT), various short-chain 
dehydrogenases/reductases (SDRs; such as DHRS3, DHRS4 and 
DHRS4L2), and StAR-related lipid transfer protein 5 .  
Emerging evidence suggests that aberrant differentiation of resident HESCs 
into specialist decidual cells is the hallmark of RPL. Taken together, these 
observations raises the possibility that excessive uNK cell levels in mid-luteal 
endometrial samples may reflect relative local corticosteroid deficiency, 
caused by inadequate induction of decidual 11βHSD1 and resulting in 
impaired local metabolic function.  
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5.2 RESULTS 
5.2.1 Mid-luteal uNK cell density correlates inversely         
with endometrial 11βHSD1 expression  
 
Routinely uNK cell densities are assessed by CD56 immunostaining of timed 
(days LH+7 to LH+10) endometrial biopsies from women suffering 
reproductive failure. Based on previous studies, normal uNK cell density is 
defined as 5% CD56+ cells in the stroma underlying the luminal epithelium. 
Hence, apparent excess of uNK cells in the peri-implantation endometrium 
may reflect impaired 11βHSD1 expression and relative cortisol deficiency. To 
test this hypothesis, a TMA was constructed using biopsies with normal 
(n=18) as well as elevated (n=18) uNK cell levels. Consecutive tissue 
sections were stained with anti-CD56 and anti-11βHSD1 antibodies, 
respectively. As shown in Figure 5.1A, a strong inverse correlation was 
observed between uNK cell density and 11βHSD1 immunoreactivity. In fact, 
this negative correlation was apparent at low magnification (Fig. 5.1B) and 
confirmed by semi-quantitative image analysis (Fig. 5.1C). 
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Previous studies have shown that an aberrant decidual response associated 
with reproductive disorders such as endometriosis and recurrent pregnancy 
loss (RPL), is maintained in culture. This prompted us to investigate if uNK 
cell density in vivo could reflect the induction of 11βHSD1 in response to 
decidual cues. To this end, we divided timed endometrial biopsies 21and 
processed one part for CD56 immunostaining and the other for primary 
HESCs. These cultures were passaged once, grown to confluency, and 
treated with 8-bromo-cAMP, P4 and E for either 4 or 8 days. As shown in 
Figure 5.2, there was a striking inverse correlation between uNK cell density 
in vivo and the responsiveness of paired primary cultures to differentiation 
stimuli. This inverse correlation was not only apparent for the induction of 
HSD11B1, the gene that encodes 11βHSD1 (Fig. 5.2A), but also for PRL and 
IGFBP1, two ‘classical’ decidual marker genes (Fig. 5.2B & 2C) as already 
seen earlier. 
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5.2.1 Elevated uNK cell density in vivo is associated 
with impaired expression of MR- dependent 
metabolic enzymes 
 
The TMA was examined for the expression of the cortisol-responsive 
receptors; GR and MR. As reported by others , MR and GR are both 
expressed in the endometrial stroma (Fig. 5.3A). Semi-quantitative analysis 
of the TMA showed no difference in stromal GR immunoreactivity in biopsies 
characterized elevated versus normal uNK cell levels. In contrast, increased 
% CD56+ cell density was associated with significant lower MR expression 
levels (P < 0.05; Fig. 5.3B). 
Previous knockdown experiments (as described in chapter 3) have shown 
that the 11βHSD1/MR axis in decidualizing HESCs regulates the expression 
of several enzymes involved in lipid metabolism and retinoid acid 
biosynthesis and storage (293). The expression levels of two target genes, 
DHRS3 and RETSAT, to monitor the MR activity in decidualizing primary 
HESC cultures established from biopsies with normal or elevated uNK cell 
levels were measured. Both genes were moderately induced upon treatment 
with 8-bromo-cAMP/P4/E in a time-dependent manner when the primary 
HESCs cultures were established from samples with 5% CD56+ cells in the 
subepithelial stroma (Fig. 5.4). By contrast, this induction was negligible or 
absent in cultures established from high uNK cell samples. To validate these 
findings, we performed Western blot analysis of primary HESCs decidualized 
with 8-bromo-cAMP/P4/E for either 4 or 8 days. As shown in Figure 5.5, 
DHRS3 was strongly expressed in primary cultures decidualized for 4 and 8 
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days and noticeably much more so in cultures established from samples with 
normal uNK cell density. By contrast, RETSAT was barely detectable after 4 
days of differentiation in both sample sets, although by 8 days, expression 
appeared stronger in cultures derived from samples with 5% CD56+ cell 
densities. The overall pattern of DHRS3 and RETSAT expression in these 
time-course cultures correlated well with the expression of 11βHSD1 (Fig. 
5.5).  
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Figure 5.3: Immunohistochemistry - GR and MR staining of undifferentiated HESCs.  A. GR staining 
(brown stain) noted in the nucleus and cytoplasm of endometrial glandular cells as well as in the 
glandular lumen. Semi-quantitative analysis shown in the right did not show statistical significance 
between the low and high uNK cell groups. B. MR staining (brown stain) is seen in the nucleus and 
cytoplasm of endometrial stromal cells as well as in the glandular lumen. Semi-quantitative analysis 
shows higher concentration in the low uNK cell group, *, P < 0.05 
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Figure 5.5:   11βHSD1, DHRS3 and RETSAT protein expression in decidualizing endometrial 
cells depending on uNK cell count. This is composite figure showing 11βHSD1, DHRS3 and 
RETSAT protein expression in decidualizing endometrial cells on western blot analysis, and 
the correlation between the high and low uNK cell groups. β-Actin served as a loading 
controls 
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From the experiments detailed in chapter 3; we know that decidualizing 
stromal cells show significant increase in the expression of the enzyme 11β 
HSD1 (as opposed to 11βHSD2) which is primarily involved in the 
conversion of inactive glucocorticoid to the active form of glucocorticoid i.e. 
cortisol. Concurrently there is a shift from glucocorticoid dominance to 
mineralocorticoid dominance upon stromal cell decidualization. The 
experiments in chapter 4 draw us to the fact that high uNK cell density in the 
sub epithelial region of the endometrium is associated with impaired 
decidualization. The current chapter marries the above together with the 
finding that high uNK cell density down regulates 11βHSD1 expression. The 
expression of glucocorticoid receptors does not show much correlation with 
the uNK cell density; however, the mineralocorticoid receptors are down 
regulated in the endometrium with high uNK cell density. The association of 
high uNK cell density with defective decidualization and glucocorticoid 
Signalling was further supported by the finding of impaired induction of 
DHRS3 and RETSAT transcripts in decidualizing cultures established from 
high uNK cell biopsies. These enzymes are involved in lipid metabolism and 
retinoid acid (RA) biosynthesis and storage. Both shortage and excess of RA 
contribute to fetal malformation, suggesting that retinoid metabolism must be 
regulated at the feto-maternal interface (Han et al., 2010). Alcohol 
dehydrogenase and NADP(H)-dependent SDR, including DHRS3, oxidize 
retinal to retinol and promote its storage as retinyl esters. Similarly, RETSAT 
is involved in regulation of retinoid storage as lipid droplets (Schupp et al., 
2009). Interestingly, RA inhibits decidualization of HESCs and excess levels 
of RA or retinal are cytotoxic (Brar et al., 1996). Thus, high uNK cell density 
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in the peri-implantation endometrium may be associated with perturbations in 
the retinoid metabolism pathway in the stromal compartment, which in turn 
predispose for an impaired decidual response and compromise histiotrophic 
support of the early conceptus. 
Thus, endometrium with high uNK cell density as seen in women with 
recurrent miscarriage and recurrent implantation failure show aberrant 
decidualization with impaired induction of the 11βHSD1 which is the key 
enzyme in the local corticosteroid metabolism with a more significant impact 
on the mineralocorticoid dependant retinoid metabolism in these cells. 
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LIMITATIONS OF THE STUDY: 
 
The hypotheses of this study were derived from different strands of clinical 
evidence showing association between recurrent miscarriage and high 
uterine NK cell density in their endometrium. The uterine biopsies taken in 
the luteal phase of the menstrual cycle were analysed for the uterine NK cell 
density between days 7-10 after LH surge. Ideally, all biopsies should be 
timed on the same day i.e. LH + 7 days as previously published. However 
this was not possible due to logistic reasons due to biopsies falling over 
weekend. This has an impact on the uNK cell density as their numbers 
increase through the decidual phase from days 7 to 10 post LH surge. 
The uNK cell density was analysed in the sub epithelial region of the 
endometrium at 40X magnification. Along the strip of endometrium stained 
for CD56; five high power fields are chosen and the uterine NK cell density 
counted and expressed as the percentage amongst stromal cells. There is a 
natural tendency to be drawn towards highly stained area of the sub 
epithelial region. This gives rise to the question whether this type of selection 
creates subjective bias. One could argue that it is in fact more pertinent that 
nests of high density stained areas are analysed which might be relevant in 
causing endometrial aberration in women with recurrent miscarriage or 
recurrent implantation failure. The depth to which these CD56 stained cells 
are analysed for quantification is yet to be determined. In order to minimise 
variations; in this study 40X magnification used with endometrial endothelium 
in view with minimal vacant spaces as possible. However, in this study, the 
same observer did the quantitative assessment and used the same standard 
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for all the samples. Due to this, the results are unlikely to change in their 
interpretation. 
Secondly, the cut off taken to quantify the uNK cell density of 5% as high is 
based on some previous observational studies. One can notice in the 
experiments that this cut off is in fact difficult to confirm as there appears to 
be a few samples which lie between 5 and 10%. These samples do not quite 
show the marked differences in the induction of the key enzymes and target 
genes studied. This is more apparent when logarithmic scale is used to 
correlate the findings. The cut-off needs to be determined based on a larger 
population study. Again, in this study, the same observer did the 
quantification and used the same cut-off for all samples. 
The cell culture studies undertaken are in vitro, hence not an exact 
replication of the in vivo state. In the molecular primary cell culture studies, 
the expression of 11βHSD1 was assessed by challenging it with the inactive 
cortisone as substrate for its activity. The significant induction of the 
expression of 11βHSD1 was good enough to imply that the 11βHSD1 
produces the critical ligand(s) that controls GR- and MR-dependent gene 
expression in in differentiating HESCs. Hence experiments to silence 
11βHSD1 via siRNA administration and then assessing the impact of the loss 
of function on GR- and MR-dependent gene expression during 
decidualization were not done. This would have further helped bolster the 
hypothesis that ligands produced by 11βHSD1 indeed control the pathways 
regulated by GR and MR in human endometrium. 
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Time permitting, one could have further studied and determined that the 
downstream genes of GR or MR such as ZNF486 or GR1A1are indeed the 
primary target of these receptors. This would involve bioinformatics analyses 
of selected genes to examine whether they harbour the genes in their 
promoter/enhancer regions. Also chromatin immunoprecipitation could be 
done to verify whether these genes are direct targets of GR or MR. 
We also recognise the microarray analyses which yielded a number of genes 
coding for GR and MR are downstream genes and may not necessarily be 
the primary targets of these receptors. 
Despite some of the limitations enumerated; this study gives a strong 
molecular basis to the clinical studies in women with recurrent miscarriage 
and recurrent implantation failure that: 
 High uNK cell density is indeed associated with aberrant endometrial 
decidualization process in such women 
 The possible role of progesterone supplement during the window of 
implantation and in the early implantation phase 
 Role of corticosteroid as a possible immune modulatory treatment  
These need to be validated in a larger randomised controlled trial. The 
proposed design for this trial is that of a prospective multi-centre randomised 
controlled trial where prednisolone versus placebo is used in the luteal and 
early implantation phase of women with recurrent miscarriage and high uNk 
cell counts. 
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Chapter 6: Conclusion 
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Human reproduction is a relatively inefficient process with a probability of 
conception of 25–30% per cycle and only 50% of these conceptions advance 
beyond 20 weeks of gestation. Of the pregnancies that are lost, 75% 
represent a failure of implantation and are therefore not clinically recognized 
as pregnancies (Norwitz et al., 2001). Recurrent Pregnancy Loss (RPL) is 
defined as the loss of three or more consecutive pregnancies, affects 1% of 
couples trying to conceive (Stirrat, 1990) It has been estimated that 1–2% of 
second-trimester pregnancies miscarry before 24 weeks of gestation(Wyatt 
et al., 2005). RPL is a prevalent disorder that affects 1%–2% of couples and 
a cause of considerable physical and psychological morbidity (Rai & Regan, 
2006). Early pregnancy loss is a frustrating and heart-wrenching experience 
for both the patient and the physician and poses a challenge to the clinicians 
and immunologists. Treatment of proven efficacy is available for only 15% of 
women with RM, e.g., those with antiphospholipid syndrome (Quenby et al., 
2005b). Several studies have tried to understand the aetiology of this 
distressing condition. Of these, reproductive immunology is a fast emerging 
concept especially in women with recurrent miscarriages allowing 
immunomodulation as treatment prospect. Uterine natural killer (NK) cells 
are the most studied in this field. 
Human uterine endometrial natural killer (uNK) cells are the unique subset of 
peripheral NK cells, being positive for CD56+ and CD16-.  They are unique in 
their location, function and phenotype. This subset of NK cells in the uterine 
endometrium is the example for regulatory function of NK cells as opposed to 
the cytotoxic function of the CD56 dim CD16 positive NK cell subset in the 
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peripheral blood. Ablation of these cells in mice has been shown to 
compromise spiral arteriole remodelling and maintenance of decidual 
integrity seen after mid-pregnancy (Croy et al., 2003).  Yet uNK cell deficient   
IL15-/- mice are fertile, have normal gestation lengths and litter sizes 
comparable to wild-type mice (Barber & Pollard, 2003).  Many roles have 
been implicated to the uNK cells including spiral artery remodelling, decidual 
angiogenesis and maternal allorecognition. They are a rich source of 
angiogenic growth factors. However, it is interesting to note that the 
endometrium of RPL patients is characterized by reduced expression of 
several key factors, including PDGF-BB, Ang-2, VEGF-A and VEGF-C (Lash 
et al., 2012). Hence the function and mechanism of the roles of uNK cells still 
remain unclear. 
Increased uNK cell density in mid-luteal endometrium has been associated 
with reproductive failure, especially RPL (Chazara et al., 2011; Quenby et al., 
2009; Clifford et al., 1999). However, the mechanisms that account for cyclic 
recruitment of uNK cell precursors and subsequent proliferation and 
differentiation within the peri-implantation environment are not well 
understood. In addition to IL-11 and IL-15, several other endometrial factors 
may be implicated in this process, including chemokine (C-X-C) motif ligand 
14, IL-12 and IL-33 (Karsten et al., 2009; Mokhtar et al., 2010; Salker et al., 
2012). Human uNK cells have been described as immature and inactive 
before pregnancy (Manaster et al., 2008). It is unclear as to how high uNK 
cell densities prior to conception predisposes for subsequent pregnancy 
failure.  
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Studies have shown that preconceptual prednisolone treatment markedly 
reduces uNK cell density in RPL patients (Quenby et al., 2005a) and uterine 
NK cells express GR but not progesterone receptors (Guo et al., 
2012).These suggest that glucocorticoids are likely to act directly on these 
cells. We have seen that 11βHSD1 expression and enzyme activity is 
significantly up regulated in decidualizing HESCs and this is driven by cAMP 
and P4 signalling (Kuroda et al., 2012). Further, inhibition of 11βHSD1 
activity with either carbenoxolone disodium salt or PF 915275 virtually 
abolishes the induction of 11βHSD1, indicating that local cortisol signalling 
reinforces the expression of this enzyme in decidualizing cells (Kuroda et al., 
2012). Upon decidualization, there is a shift from glucocorticoid to 
mineralocorticoid dominance. The expression of MR related genes are up 
regulated upon decidualization. There appears to be an induction of cortisol 
gradient upon decidualization of HESCs. The experiments show a strong 
negative correlation between uNK cell densities and expression of 11βHSD1 
in differentiating stromal cells in vivo. High uNK cell density in vivo is 
associated with blunted induction of 11βHSD1 as well as decidual marker 
genes, such as PRL and IGFBP1, in primary cultures. Upon studying the 
cytokines which are thought to have regulatory function on uNK cells, the 
induction of IL-11 and IL-15 also tended to be lower in decidualizing cells 
established from biopsies with elevated uNK cell levels, although this trend 
was not significant. The decidual process in the human endometrium is 
under tight spatiotemporal control (Gellersen et al., 2007). It is initiated in the 
mid-luteal phase of the cycle first in stromal cells surrounding the terminal 
spiral arteries and underlying the luminal epithelium. Thus, rather than the 
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total number of uNK cells, it is possible that excessive migration of uNK cells 
from their usual position in the basal and peri-vascular regions of the 
endometrium to the sub-luminal region is the hallmark of an abnormal 
decidual response that predisposes for early pregnancy loss. Thus, 
increased density of CD56+ cells in the subluminal endometrial stromal 
compartment may be an indirect marker of local corticosteroid deficiency. We 
have seen that there is blunted induction of 11βHSD1, MR and MR related 
genes DHRS3 and RETSAT transcripts in decidualizing cultures established 
from high uNK cell biopsies. These enzymes are involved in lipid metabolism 
and retinoid acid (RA) biosynthesis and storage. Both shortage and excess 
of RA contribute to foetal malformation, suggesting that retinoid metabolism 
must be regulated at the feto-maternal interface (Han et al., 2010). RA 
inhibits decidualization of HESCs and excess levels of RA or retinal are 
cytotoxic (Brar et al., 1996). Thus, high uNK cell density in the peri-
implantation endometrium may be associated with perturbations in the 
retinoid metabolism pathway in the stromal compartment, which in turn 
predisposes for an impaired decidual response and compromise histiotrophic 
support of the early conceptus.  
Thus, the spatiotemporal distribution of uNK cells is a complex and dynamic 
process and this is closely knitted with the human endometrial stromal cells. 
Besides glands and other immune cells, decidualizing stromal cells play a 
major role in governing this process, at least partially by inducing a cortisol 
gradient that establishes a nutritive environment essential for post-
implantation embryo development and foetal growth. Thus excessive uNK 
cells in the subluminal stroma compartment prior to conception may serve as 
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a potential biomarker for a suboptimal decidual response in pregnancy. A 
recent pilot randomised, double-blind controlled clinical trial suggested an 
improvement in live birth rate with prednisolone in women with RPL and high 
mid-luteal uNK cell density (Tang et al., 2011). Future study needs validating 
these results in a larger trial.  
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Appendix I 
 
 
Division of Obstetrics and Gynaecology 
Information for Women 
Title of Project: Research into the womb lining and fertility. 
You are being invited ti take part in a research study. Before you decide whether 
you wish to participate or not, it is important for you to understand why the research 
is being done and what it will involve. Please read the following information carefully 
and discuss it with relatives, friends and your GP, if you wish. If there is anything 
that is not clear, or if you have any further questions, please do not hesitate to ask. 
Take time to decide whether you would like to take part or not. You should not take 
part in this study if you do not wish to. If you decide not to take part, your treatment 
will not be affected by your decision. If you decide to participate, please let us know 
beforehand if you are currently involved in another study. You are free to withdraw 
at any time without explanation and any subsequent treatment will not be affected. 
The womb lining sheds and regenerates once every month, when you have a period 
it is this lining coming away. The womb lining is the site where the embryo attaches 
and commences growing to become a pregnancy. We are doing research looking 
for reasons why the womb lining in some diseases may be less receptive to an 
embryo. This research involves testing for products 9such as proteins) in the womb 
lining, which may be important for the embryo to attach. 
You have been asked to take part in this study because you will be having an 
operation in a few days’ time. The doctor’s looking after you will be removing part of 
your womb lining as part of your treatment. A small part of the womb lining is 
removed from your womb while you are under anaesthetic. This does not cause you 
extra pain, discomfort or inconvenience. Normally, unless you request otherwise, 
your excess womb lining is disposed of once sufficient sample has been sent for 
diagnosis. However, if you agree to take part in the study, the doctor looking after 
you will ensure that the spare womb lining is passed to us for study in laboratory. 
Extra tissue will not be taken for the purposes of the research. There is no risk to 
you from donating some of your womb lining above that of the surgical procedure 
which you will soon undertake. It will leave no long term effects because your womb 
lining regenerates every month. 
After you have donated the tissue, the researchers will not need to see you again 
and there is no need for you to visit the GP. Although there is no immediate medical 
benefit to you from taking part, the information that we get from this study may help 
us to treat women in the future who experience problems with infertility.  
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Women who are pregnant cannot take part in this study and those at risk of a 
pregnancy will have a pregnancy test performed to exclude the possibility of 
pregnancy. 
The researchers working on these samples will not know which samples belong to 
which women, as they will have been coded (given a reference number) and there 
will be no way of tracing the samples back to individual donors. It is possible that the 
results from the research study could be published in a medical or scientific journal. 
However, please be reassured that you will not be identified in any such publication. 
Confidentiality of data is therefore assured. 
If you do suffer any adverse effects because of your participation in this study, you 
will be compensated through the University Hospitals of Coventry and 
Warwickshire, “No Fault” Compensation Scheme. 
For further information, please contact: 
Professor Jan Brosens on 0247696 8704 (email: J.J.Brosens@warwick.ac.uk) 
Thank you for taking part in this study. You will be given a copy of the information 
sheet to keep. 
(Version 00.2:18/11/2009) 
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Sample Collection, Contact & Clinical Details 
 
SAMPLE COLLECTION: 
 Obtain endometrial sample by pipelle or curette (more= better) 
 Put sample in sterilin with normal saline or culture medium 
 Organize transport to lab. 
 
CONTACT DETAILS: 
Prof Jan Brosens:  0247696 8704 
Lab Number:   0247696 8612 
PATIENT DETAILS (Please complete) 
Age:……………………………………………………………… 
Recurrent miscarriage: Y/N 
Time-to-pregnancy: <3months, <6months, >6months (please circle) 
Infertility: Y/N 
Endometriosis/tubal/male factor/unexplained/PCOS (please circle) 
Other:…………………………………………………………….. 
LMP:………………………………………………………………. 
Parity:……………………………………………………………… 
Current treatment:………………………………………………... 
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Participant Consent Form 
Title of project: 
 
 
 
The participant should complete the whole of this sheet him or herself. 
(Please tick each statement if it applies to you) 
I have read the Information sheet for Patients and Healthy Volunteers.   
I have been given the opportunity to ask questions and discuss this study . 
I have received satisfactory answers to all my questions.     
I have received enough information about the study.  
 
The study has been explained to me by: 
Prof/Dr/Mr/Mrs/Ms……………………………………………………………………………
…… 
I understand that I am free to withdraw from the study  
at any time, without having to give a reason for  
withdrawing and without affecting my future medical care. 
 
I agree to take part in this study.  
 
 
 
 
Signed…………………………………………………………………Date…………………
………. 
 
Name in Block 
Capitals.…………………………………………………………………………….. 
 
 
 
Investigator’s 
signature……………………………………………...Date………………………. 
 
Name in Block Capitals……………………………………………………………. 
 
 
Establishment of primary cell cultures using biopsy samples of human 
endometrium as a model to investigate decidualization and implantation. 
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Appendix II 
RTQ-PCR primer pairs 
Gene Forward Primer Reverse Primer 
L19 GCG GAA GGG TAC AGC CAA  GCA GCC GGC GCA AA 
11 βHSD 1 AGC AAG TTT GCT TTG GAT GG AGA GCT CCC CCT TTG ATG AT 
GR CCC TAC CCT GGT GTC ACT GT GGT CAT TTG GTC ATC CAG GT 
MR GGC ACT CGC TGG CCT GGA TG GTC TCC ATC GCT GCC TCG GC 
PRL AAG CTG TAG AGA TTG AGG AGC 
AAA C 
TCA GGA TGA ACC TGG CTG ACT A 
IGFBP1 CGAAGG CTC TCC ATG TCA CCA TGT CTC CTG TGC CTT GGC TAA AC 
WNT 4 TCA GCC CAC AGG GCT TCC AGT CGG CTC GCC AGC ACG TCT 
DHRS3 AGC GCG GCG CCA GAA AGA TT TCA CCC ACC TTC TCC CGG ACG 
FBXO32 GCG GCA GTT TCG TGA GCG AC GGG TGC AAT ATC CAT GGC 
GCT CTT 
GRIA1 AAG GGG TCT GCC CTG AGA AAT CCA ACG CCT GCC ACA TTG CTG AGG 
ZNF486 ACA CAC AAC TGG 
GGG TTT GGC AAT 
ACA CAC AAC TGG 
GGG TTT GGC AAT 
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Appendix III 
 
  
                     Gene Lists 
 
 
Table 1: 
 
 
Gene symbol Gene name Fold change 
SNORD41 Small nucleolar RNA, C/D box 41 -2.73 
SNORD57 Small nucleolar RNA, C/D box 57 -2.71 
A2M Alpha-2-macroglobulin -2.56 
STARD5 StAR-related lipid transfer (START) domain containing 5 -2.46 
SNORD75 Small nucleolar RNA, C/D box 75 -2.45 
SMAP2 Small ArfGAP2 -2.43 
SNORD15A Small nucleolar RNA, C/D box 15A -2.12 
DHDDS Dehydrodolichyl diphosphate synthase -2.10 
SERPINA3 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), 
member 3 
-2.00 
EIF5AL1 Eukaryotic translation initiation factor 5A-like 1 -1.92 
BCAS3 Breast carcinoma amplified sequence 3 -1.86 
AIG1 Androgen-induced 1 -1.82 
SNORD116-6 Small nucleolar RNA, C/D box 116-6 -1.80 
FECH Ferrochelatase -1.79 
FAM86B1 Family with sequence similarity 86, member B1 -1.79 
C9orf116 Chromosome 9 open reading frame 116 -1.79 
DPCD Deleted in primary ciliary dyskinesia homolog -1.77 
STARD9 StAR-related lipid transfer (START) domain containing 9 -1.76 
LRCH1 Leucine-rich repeats and calponin homology (CH) domain -1.74 
ELOVL1 Elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 
1 
-1.74 
HIST2H2AB Histone cluster 2, H2ab -1.73 
HDAC3 Histone deacetylase 3 -1.71 
SNX12 Sorting nexin 12 -1.71 
ARHGAP1 Rho GTPase activating protein 1 -1.69 
ENTPD3 Ectonucleoside triphosphate diphosphohydrolase 3 -1.69 
MLXIP MLX interacting protein -1.69 
FBXO32 F-box protein 32 -1.68 
MAK16 MAK16 homolog -1.68 
MFSD8 Major facilitator superfamily domain containing 8 -1.67 
ZNF528 Zinc finger protein 528 -1.67 
ACSS3 Acyl-CoA synthetase short-chain family member 3 -1.64 
LONP1 Lon peptidase 1, mitochondrial -1.64 
WDR31 WD repeat domain 31 -1.63 
NAT10 N-acetyltransferase 10 -1.63 
KRT23 Keratin 23 (histone deacetylase inducible) -1.63 
DHRS4 Dehydrogenase/reductase (SDR family) member 4 -1.62 
LIMK1 LIM domain kinase 1 -1.61 
C1QTNF1 C1q and tumor necrosis factor related protein 1 -1.60 
MIPEP Mitochondrial intermediate peptidase -1.60 
DONSON Downstream neighbor of SON -1.59 
GNAL Guanine nucleotide binding protein (G protein), alpha activating activity 
polypeptide, olfactory type 
-1.59 
ADCY2 Adenylate cyclase 2 -1.59 
TEX261 Testis expressed 261 -1.58 
C1QTNF9 C1q and tumor necrosis factor related protein 9 -1.58 
GYPE Glycophorin E -1.58 
MRPL40 Mitochondrial ribosomal protein L40 -1.57 
ATF1 Activating transcription factor 1 -1.56 
RETSAT Retinol saturase (all-trans-retinol 13,14-reductase) -1.54 
STK16 Serine/threonine kinase 16 -1.53 
DHRS3 Dehydrogenase/reductase (SDR family) member 3 -1.51 
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 Table 2. Genes up-regulated upon MR knockdown  
 
Gene symbol 
 
Gene name 
 
Fold change 
LRRFIP1 Leucine rich repeat (in FLII) interacting protein 1 2.49 
LRRC37B Leucine rich repeat containing 37B 2.07 
NUFIP1 Nuclear fragile X mental retardation protein interacting protein 1 2.06 
C7orf13 Chromosome 7 open reading frame 13 2.04 
MAP3K1 Mitogen-activated protein kinase kinase kinase 1 1.97 
RTP4 Receptor (chemosensory) transporter protein 4 1.93 
NAG18 NAG18 Mrna 1.77 
LOC100128364 Hypothetical protein LOC100128364 1.77 
MURC Muscle-related coiled-coil protein 1.75 
WDSUB1 WD repeat, sterile alpha motif and U-box domain containing 1 1.75 
FAM19A2 Family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 1.72 
GCNT4 Glucosaminyl (N-acetyl) transferase 4, core 2 1.71 
SYDE2 Synapse defective 1, Rho GTPase, homolog 2 1.70 
FAM99A Family with sequence similarity 99, member A 1.69 
TRMU tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase  1.67 
ENTPD1 Ectonucleoside triphosphate diphosphohydrolase 1 1.66 
ZNF223 Zinc finger protein 223 1.65 
ZCCHC14 Zinc finger, CCHC domain containing 14 1.65 
SNORD45B Small nucleolar RNA, C/D box 45B 1.63 
CCRL1 Chemokine (C-C motif) receptor-like 1 1.61 
FAM106A Family with sequence similarity 106, member A 1.60 
DPH3B DPH3B, KTI11 homolog B 1.59 
LOC220594 TL132 protein 1.58 
ZNF181 Zinc finger protein 181 1.58 
LCN8 Lipocalin 8 1.58 
SGK3 Serum/glucocorticoid regulated kinase family, member 3 1.56 
SLITRK6 SLIT and NTRK-like family, member 6 1.56 
CLN8 Ceroid-lipofuscinosis, neuronal 8 1.55 
ID2 Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 1.54 
LOC100129455 Hypothetical protein LOC100129455 1.54 
MMD Monocyte to macrophage differentiation-associated 1.53 
C20orf177 Chromosome 20 open reading frame 177 1.52 
SLC25A2 Solute carrier family 25 1.51 
HDX Highly divergent homeobox 1.51 
UPRT Uracil phosphoribosyltransferase (FUR1) homolog 1.51 
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Table 3. Top 50 down-regulated genes upon GR knockdown  
 
Gene symbol 
 
Gene name 
 
Fold change 
SNORD74 Small nucleolar RNA, C/D box 74 -3.36 
C13orf29 Chromosome 13 open reading frame 29 -2.33 
ADAMTS2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 -2.25 
STIM1 Stromal interaction molecule 1 -1.90 
ADCY9 Adenylate cyclase 9 -1.83 
NRSN2 Neurensin 2 -1.83 
SLC25A20 Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20  -1.83 
ACSS2 Acyl-CoA synthetase short-chain family member 2 -1.81 
TIMM22 Translocase of inner mitochondrial membrane 22 homolog -1.76 
SRGAP2 SLIT-ROBO Rho GTPase activating protein 2 -1.73 
EIF3B Eukaryotic translation initiation factor 3, subunit B -1.71 
ACSL1 Acyl-CoA synthetase long-chain family member 1 -1.71 
FAM48B2 Family with sequence similarity 48, member B2 -1.71 
PMM1 Phosphomannomutase 1 -1.70 
ACACA Acetyl-CoA carboxylase alpha -1.68 
FAM164C Family with sequence similarity 164, member C -1.65 
TANC2 Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 -1.64 
NSMCE1 Non-SMC element 1 homolog -1.64 
RHOC Ras homolog gene family, member C -1.64 
P4HA3 Prolyl 4-hydroxylase, alpha polypeptide III -1.63 
AMFR Autocrine motility factor receptor -1.63 
TSPAN5 Tetraspanin 5 -1.63 
FAM50A Family with sequence similarity 50, member A -1.63 
AIFM2 Apoptosis-inducing factor, mitochondrion-associated, 2 -1.62 
GNA11 Guanine nucleotide binding protein (G protein), alpha 11 -1.62 
SURF4 surfeit 4 -1.62 
LRPAP1 low density lipoprotein receptor-related protein associated protein 1 -1.62 
TLN1 Talin 1 -1.61 
DEPDC6 DEP domain containing 6 -1.61 
SNF8 SNF8, ESCRT-II complex subunit, homolog -1.61 
VAV2 Vav 2 guanine nucleotide exchange factor -1.60 
SNX17 Sorting nexin 17 -1.60 
ANPEP Alanyl (membrane) aminopeptidase -1.60 
YRDC YrdC domain containing -1.59 
ACTC1 Actin, alpha, cardiac muscle 1 -1.59 
MMAB Methylmalonic aciduria (cobalamin deficiency) cblB type -1.59 
LMNA Lamin A/C -1.59 
TBC1D2B TBC1 domain family, member 2B -1.59 
EYS Eyes shut homolog -1.58 
SDCCAG1 Serologically defined colon cancer antigen 1 -1.58 
RABAC1 Rab acceptor 1 (prenylated) -1.58 
NDUFV1 NADH dehydrogenase (ubiquinone) flavoprotein 1 -1.58 
FTSJD2 FtsJ methyltransferase domain containing 2 -1.58 
WNT4 Wingless-type MMTV integration site family, member 4 -1.57 
OGDH Oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) -1.57 
R3HCC1 R3H domain and coiled-coil containing 1 -1.57 
APEH N-acylaminoacyl-peptide hydrolase -1.56 
RASA3 RAS p21 protein activator 3 -1.56 
PLOD1 Procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 -1.56 
ABR Active BCR-related gene -1.56 
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Table 4. Top 50 up-regulated genes upon GR knockdown 
 
Gene symbol 
 
Gene name 
 
Fold change 
SNORD13P2 Small nucleolar RNA, C/D box 13 pseudogene 2 3.60 
LOC100130876 Hypothetical protein LOC100130876 3.26 
ZNF486 Zinc finger protein 486 2.49 
GPAM Glycerol-3-phosphate acyltransferase, mitochondrial 2.45 
TUBD1 Tubulin, delta 1 2.37 
HAS2 Hyaluronan synthase 2 2.35 
HMGN5 High-mobility group nucleosome binding domain 5 2.19 
MCM9 Minichromosome maintenance complex component 9 2.18 
SPP1 Secreted phosphoprotein 1 (Osteopontin) 2.14 
ZNF791 Zinc finger protein 791 2.13 
RRP7B Ribosomal RNA processing 7 homolog B 2.07 
RGS4 Regulator of G-protein Signalling 4 2.06 
SNORA75 Small nucleolar RNA, H/ACA box 75 2.05 
UPF3B UPF3 regulator of nonsense transcripts homolog B 2.00 
NAALAD2 N-acetylated alpha-linked acidic dipeptidase 2 1.99 
PMS1 PMS1 postmeiotic segregation increased 1 1.95 
C14orf106 Chromosome 14 open reading frame 106 1.92 
RWDD4A RWD domain containing 4A 1.91 
ZNF738 Zinc finger protein 738 1.90 
ZNF253 Zinc finger protein 253 1.88 
CFI Complement factor I 1.86 
CASP1 Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) 1.84 
ATXN3 Ataxin 3 1.83 
ING2 Inhibitor of growth family, member 2 1.82 
ZNF613 Zinc finger protein 613 1.80 
COX7B Cytochrome c oxidase subunit VIIb 1.79 
EIF1B Eukaryotic translation initiation factor 1B 1.78 
ZNF626 Zinc finger protein 626 1.78 
NCRNA00204 Non-protein coding RNA 204 1.76 
ZNF311 Zinc finger protein 311 1.74 
CCDC28A Coiled-coil domain containing 28A 1.73 
LYRM1 LYR motif containing 1 1.72 
ARID4B AT rich interactive domain 4B (RBP1-like) 1.72 
RAC1 Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding 
protein Rac1) 
1.72 
NKAP NFKB activating protein 1.71 
ZNF91 Zinc finger protein 91 1.71 
SEPP1 Selenoprotein P, plasma, 1 1.71 
PALMD Palmdelphin 1.70 
ZNF624 Zinc finger protein 624 1.70 
GCC2 GRIP and coiled-coil domain containing 2 1.70 
RBAK RB-associated KRAB zinc finger 1.70 
PPIL4 Peptidylprolyl isomerase (cyclophilin)-like 4 1.69 
SET SET nuclear oncogene 1.69 
RIPK2 Receptor-interacting serine-threonine kinase 2 1.67 
MTF2 Metal response element binding transcription factor 2 1.67 
ZNF420 Zinc finger protein 420 1.66 
NCRNA00219 Non-protein coding RNA 219 1.66 
RFC1 Replication factor C (activator 1) 1 1.65 
EXTL2 Exostoses (multiple)-like 2 1.65 
NMI N-myc (and STAT) interactor 1.65 
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Table 5. Genes regulated by MR and GR   
 
Gene symbol 
 
Gene name 
MR siRNA fold 
change 
GR siRNA fold 
change 
C15orf51 Dynamin 1 pseudogene -5.82 -3.24 
LOC100289668 Similar to dynamin 1 -4.72 -3.21 
SNORD14E Small nucleolar RNA, C/D box 14E -4.71 -3.10 
SNORD4B Small nucleolar RNA, C/D box 4B -3.52 -3.05 
SNORA73A Small nucleolar RNA, H/ACA box 73A -3.19 -1.79 
MIR29C MicroRNA 29c -2.26 -1.93 
SNORD82 Small nucleolar RNA, C/D box 82 -2.20 -2.04 
SNORD38B Small nucleolar RNA, C/D box 38B -2.17 -2.15 
TMEM194B Transmembrane protein 194B -2.14 -1.83 
SCARNA17 Small Cajal body-specific RNA 17 -2.02 -1.87 
MGC16384 Hypothetical protein LOC114130 -1.95 -2.23 
HFE Hemochromatosis -1.94 -1.75 
NOP56 NOP56 ribonucleoprotein homolog -1.93 -1.51 
LARGE Like-glycosyltransferase -1.86 -2.02 
ENO1 Enolase 1, (alpha) -1.84 -1.63 
SRGAP2 SLIT-ROBO Rho GTPase activating protein 2 -1.79 -1.66 
PARP3 Poly (ADP-ribose) polymerase family, member 3 -1.77 -1.64 
DHCR7 7-dehydrocholesterol reductase -1.74 -1.60 
NUDT8 Nudix (nucleoside diphosphate linked moiety X)-
type motif 8 
-1.74 -1.53 
IFI35 Interferon-induced protein 35 -1.72 -1.70 
RCAN3 RCAN family member 3 -1.70 -1.54 
CCDC88C Coiled-coil domain containing 88C -1.68 -1.65 
ATPAF2 ATP synthase mitochondrial F1 complex assembly 
factor 2 
-1.67 -1.52 
LSAMP Limbic system-associated membrane protein -1.67 -1.76 
MPPE1 Metallophosphoesterase 1 -1.67 -1.72 
LOC100132356 Hypothetical protein LOC100132356 -1.63 -1.51 
ALKBH2 alkB, alkylation repair homolog 2 -1.62 -1.74 
CD81 CD81 molecule -1.62 -1.51 
DHRS4L2 Dehydrogenase/reductase (SDR family) member 4 
like 2 
-1.61 -1.51 
SNORA70G Small nucleolar RNA, H/ACA box 70G 
(retrotransposed) 
-1.59 -1.59 
CD151 CD151 molecule (Raph blood group) -1.59 -1.56 
YIF1A Yip1 interacting factor homolog A -1.58 -1.54 
STX17 Syntaxin 17 -1.57 -1.56 
CCDC149 Coiled-coil domain containing 149 -1.56 -1.66 
ANXA6 Annexin A6 -1.55 -1.78 
DNM2 Dynamin 2 -1.55 -1.57 
GRIA1 Glutamate receptor, ionotropic, AMPA 1 -1.54 1.77 
KRT19 Keratin 19 -1.54 -1.65 
KDM4C Lysine (K)-specific demethylase 4C -1.53 -1.69 
LITAF Lipopolysaccharide-induced TNF factor -1.51 -1.58 
MYO1C Myosin IC -1.51 -1.62 
PRKACA Protein kinase, cAMP-dependent, catalytic, alpha -1.51 -1.50 
ZNF254 Zinc finger protein 254 1.50 1.57 
TFPI Tissue factor pathway inhibitor (lipoprotein-
associated coagulation inhibitor) 
1.50 1.57 
YEATS4 YEATS domain containing 4 1.51 1.56 
HDGFRP3 Hepatoma-derived growth factor, related protein 3 1.57 1.55 
IKZF5 IKAROS family zinc finger 5 1.58 1.57 
PCDHB16 Protocadherin beta 16 1.58 1.50 
CCDC14 Coiled-coil domain containing 14 1.58 1.64 
ZNF625 Zinc finger protein 625 1.60 1.55 
TAF1A TATA box binding protein (TBP)-associated factor, 
RNA polymerase I, A 
1.62 1.51 
C17orf51 Chromosome 17 open reading frame 51 1.71 1.74 
ZNF669 Zinc finger protein 669 1.76 1.78 
SNORD73A Small nucleolar RNA, C/D box 73A 1.76 2.17 
AMZ2P1 Archaelysin family metallopeptidase 2 pseudogene 
1 
1.79 1.82 
SASS6 Spindle assembly 6 homolog 1.83 2.05 
ARL15 ADP-ribosylation factor-like 15 1.96 1.98 
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LOC100130713 Hypothetical protein LOC100130713 2.25 1.79 
FBXO9 F-box protein 9 2.42 3.15 
LOC729595 Similar to high mobility group box 3 3.01 4.64 
 
 
Table 6. MR / GR genes also regulated by AR or PR 
Gene symbol  Gene name MR GR AR PR 
      
WDSUB1  WD repeat, sterile alpha motif and U-box domain containing 1 ↑ − ↓ − 
HDGFRP3  Hepatoma-derived growth factor, related protein 3 ↑ ↑ − ↑ 
LARGE Like-glycosyltransferase ↓ ↓ − ↓ 
MPPE1 Metallophosphoesterase 1 ↓ ↓ − ↓ 
NUDT8 Nudix (nucleoside diphosphate linked moiety X)-type motif 8 ↓ ↓ − ↓ 
ACSL1  Acyl-CoA synthetase long-chain family member 1 − ↓ ↑ ↓ 
SDCCAG1  Serologically defined colon cancer antigen 1 − ↓ ↓ − 
WNT4  Wingless-type MMTV integration site family, member 4 − ↓ ↓ ↓ 
ANPEP Alanyl (membrane) aminopeptidase  − ↓ − ↓ 
DEPDC6 DEP domain containing 6 − ↓ − ↓ 
ZBTB1   Zinc finger and BTB domain containing 1 − ↑ ↓ − 
UPF3B  UPF3 regulator of nonsense transcripts homolog B − ↑ − ↑ 
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Background:Decidualizing human endometrial stromal cells (HESCs) profoundly up-regulate 11-
hydroxysteroid dehydrogenase type 1 (11HSD1), the enzyme that converts inert cortisone to
active cortisol.We postulated that the induction of a cortisol gradient upon decidualization of the
periimplantation endometriummay impact on the uterine natural killer (uNK) cell population and
on local expression of corticosteroid-dependent target genes.
Methods:Midluteal endometrial biopsies (n 55) were processed for uNK cell (CD56) analysis and
primaryHESC cultures. The cultures remainedeitheruntreatedorweredecidualized for 4or 8days.
A tissue microarray was constructed from endometria with normal (n 18) and elevated uNK cell
(n  18) scores. An abnormal uNK cell test was defined as greater than 5% CD56 cells in the
subluminal stroma.
Results: Increased uNK cell density was associated with lower endometrial expression of 11HSD1
and mineralocorticoid receptor (MR) but not glucocorticoid receptor in vivo. Elevated uNK cell
density also corresponded to impaired induction of key decidualmarkers (11HSD1, prolactin, and
insulin-like growth factor binding protein-1) andMR-dependent enzymes (dehydrogenase/reduc-
tase member 3 and retinol saturase) in differentiating HESC cultures. Increased uNK cell density in
vivo was not associated with increased in vitro expression of either IL-15 or IL-11, two cytokines
implicated in uNK cell regulation.
Conclusions: Elevated levels of uNK cells in the stroma underlying the surface epithelium are
associated with inadequate cortisol biosynthesis by resident decidualizing cells and suboptimal
induction of key MR-dependent enzymes involved in lipid biogenesis and the retinoid transport
pathway. Our observations suggest that uNK cell testing identifies those women at risk of repro-
ductive failure due to relative uterine cortisol deficiency. (J Clin Endocrinol Metab 98: 4429–4437,
2013)
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Uterine natural killer (uNK) cells, an important com-ponent of the innate immune system, are the most
abundant immune cells in midluteal (periimplantation)
endometrium and in the decidua of early pregnancy (1).
They represent aunique subset of natural killer cells, stain-
ing intensely for CD56 but not for CD16 antigens. uNK
cells play a significant role in the establishment and main-
tenance of early pregnancy by promoting decidual angio-
genesis, spiral artery remodeling, and trophoblast inva-
sion (2, 3). In contrast to their circulating (CD56/
CD16) counterparts, there is little evidence for a
cytotoxic role of uNK cells at the fetomaternal interface.
However, uNK cells express killer cell immunoglobulin-
like receptors that preferentially bind to human leukocyte
antigen-Cmolecules expressed on placental cells, suggest-
ing a role in maternal allorecognition of fetal trophoblast
(4). They are abundant around the spiral arteries, near
endometrial glands, and adjacent to extravillous tropho-
blast in early pregnancy. Thus, uNK cells are unique in
termsof their tissuedistribution, phenotype, and function.
Both the maternal killer cell immunoglobulin-like re-
ceptor and fetal human leukocyte antigen-C gene systems
are highly polymorphic and certain genotypic combina-
tions are associated with a modest increase or decrease in
pregnancy complications, including miscarriage, fetal
growth restriction, and preeclampsia (4). In addition, sev-
eral studies reported an associationbetween elevateduNK
cell levels inmidluteal endometriumand reproductive fail-
ure (4–6). In particular, there is compelling evidence to
link increased uNK density to recurrent pregnancy loss
(RPL), defined here as three or more consecutive miscar-
riages. RPL is a prevalent disorder that affects 1%–2% of
couples and a cause of considerable physical and psycho-
logicalmorbidity (7). Furthermore,RPL is associatedwith
an increased likelihood of obstetric complications and
adverse perinatal outcome in a subsequent ongoing preg-
nancy (8). Whether midluteal uNK cell testing in a non-
conception cycle predicts subsequent pregnancy compli-
cations remains unresolved (9).
Resident human endometrial stromal cells (HESCs) are
thought to serve as gatekeepers for the recruitment and
distribution of immune cells in the periimplantation en-
dometrium (10). For example, decidualizing (differenti-
ating) HESCs secrete IL-11 and IL-15, two multifaceted
cytokines implicated in trafficking and differentiation of
uNK cells (11–13). uNK cells express the glucocorticoid
receptor (GR) but lack progesterone receptor, rendering
them directly responsive to cortisol but not progesterone
(14, 15). Consistent with this notion, preconceptual glu-
cocorticoid (prednisolone) treatment significantly reduces
uNK cell density in RPL subjects as well as inhibiting en-
dometrial angiogenesis (16, 17). We recently demon-
strated that progesterone massively enhances the expres-
sion and activity of 11-hydroxysteroid dehydrogenase
type 1 (11HSD1) in decidualizing HESCs (18), suggest-
ing that local cortisol biosynthesis plays an integral role in
the preparation of the endometrium for implantation. De-
cidualization is further associated with a decline in GR
expression and reciprocal induction of the mineralocor-
ticoid receptor (MR), which in turn drives the expression
of several key enzymes involved in lipid and retinoid me-
tabolism, including retinol saturase (RETSAT), various
short-chain dehydrogenases/reductases (such as dehydro-
genase/reductase (DHRS) member 3, DHRS4, and
DHRS4L2), and steroidogenic acute regulatory protein-
related lipid transfer protein 5 (18).
Emerging evidence suggests that aberrant differentia-
tion of residentHESCs into specialized decidual cells is the
hallmark of RPL (19, 20). Taken together, these observa-
tions raise the possibility that excessive uNK cell levels in
midluteal endometrial samples reflect relative local corti-
costeroid deficiency, caused by inadequate induction of
decidual 11HSD1 and result in impaired local metabolic
function.
Materials and Methods
Patient selection and endometrial sampling
The studywas approved by the local ethics committee (1997/
5065). Subjects were recruited in the Implantation Clinic, a ded-
icated research clinic at UniversityHospitals Coventry andWar-
wickshire National Health Service Trust for patients suffering
RPL or recurrent in vitro fertilization treatment failure. Written
informed consent was obtained prior to tissue collection. Endo-
metrial biopsies were timed between 7 and 10 days after the
preovulatory LH surge. Samples were obtained using aWallach
Endocell sampler (Wallach) under ultrasound guidance, starting
from the uterine fundus and moving downward to the internal
cervical ostium. Each biopsy was divided, with one part fixed in
formalin for immunohistochemistry and the other processed for
primary cell culture. The demographic details of participating
subjects are summarized in Supplemental Tables 1 and 2, pub-
lished on The Endocrine Society’s Journals Online web site at
http://jcem.endojournals.org.
Primary cell culture
HESCs were isolated, cultured, and maintained as de-
scribed (20). Primary cultures were passaged once, allowed to
grow to confluency, and then decidualized with 0.5 mM
8-bromoadenosine cAMP (8-bromo-cAMP; Sigma), 1 M
progesterone (P4; Sigma), and 0.1 M cortisone (E; Sigma).
Cortisone, which is inactive, was added to decidualizing
HESC cultures as the substrate for endogenous conversion by
11HSD11 to cortisol (18).
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Immunohistochemistry
Five-micrometer-thick formalin-fixed, paraffin-embedded
tissue sections were labeled with antibody to CD56 (NCL-
CD56-1B6; Novacastra) using standard methods and detection
systems (3). The uNK cell density was determined as the per-
centage of uNK cells within the stromal cell population. Because
uNK cell density varies with endometrial depth, counting of
CD56 cells was confined to the stroma underlying the luminal
epithelium. Five randomly selected high-power magnification
fields per biopsy were assessed using ImageJ software (Rasband,
W. S., ImageJ, National Institutes of Health) to minimize inter-
observer variability (21, 22). Normal uNK cell density was de-
fined as 5% or less CD56 cells in the stroma underlying the
luminal epithelium (17, 23). A Mirax Midi slide scanner was
used to scan bright-field sections with a 20 objective with a
resolution of 0.23 m/pixel. This produces images that can be
dynamically manipulated within the viewer software, allowing
optical magnifications up to 20 and digital magnification to
200.
Tissue microarray (TMA)
Areas of interest, ie, subepithelial regions, were spotted and
tissue microarrays comprising duplicate 0.6-mm cores from 18
cases in each group were constructed using Alphelys TMA De-
signer R 2 version 1.0.0.8. Sections (3 m) were cut from com-
pleted array blocks and transferred to silanized glass slides.
Sections from these arrays were then stained for CD56, 1:200
(NCL-CD56-1B6; Novocastra); 11HSD1, 1:300 (AB83522;
Abcam);MR, 1:400 (H-300: SC-11412; Santa Cruz Biotechnol-
ogy); and GR, 1:200 (E-20: SC-1003; Santa Cruz Biotechnol-
ogy). Semiquantative analysis was performed using a Panoramic
viewer to capture images. High-power (400) images were an-
alyzed with Image J (http://rsbweb.nih.gov/ij/) using the color
deconvolution plugin and thresholding to assess the percentage
of strongly immunopositive endometrial cells. The observers
were blind as to the origin of the samples.
Real-time quantitative PCR
Total RNAwas extracted with RNA STAT-60 from primary
HESCcultures.After treatmentwith amplification-grade deoxy-
ribonuclease I (Invitrogen Ltd), cDNA was generated using the
SuperScript II first-strand synthesis system for RT-PCR kit (In-
vitrogen). Template quantification was performed with an ABI
StepOne system (Applied Biosystems) using Power SYBRGreen
PCR master mix (Applied Biosystems). RNA input variances
werenormalized against the levels of theL19housekeeping gene,
which encodes a ribosomal protein. All measurements were per-
formed in duplicate. Specific primer pairs were designed using
Primer3 software (http://frodo.wi.mit.edu): L19 sense, 5-GCG
GAA GGG TAC AGC CAA T-3, L19-R antisense, 5-GCA
GCC GGC GCA AA-3; 11HSD1 sense, 5-AGC AAG TTT
GCTTTGGATGG-3, 11HSD1antisense, 5-AGAGCTCCC
CCT TTG ATGAT-3; decidual prolactin (PRL) sense, 5-AAG
CTG TAG AGA TTG AGG AGC AAA C-3, decidual PRL an-
tisense, 5-TCA GGA TGA ACC TGG CTG ACT A-3; IGF-
binding protein-1 (IGFBP1) sense, 5-CGA AGG CTC TCC
ATG TCA CCA-3, IGFBP1 antisense, 5-TGT CTC CTG TGC
CTT GGC TAA AC-3; IL-11 sense, 5-CTC GAG TTT CCC
CAG ACC CTC GG-3, IL-11 antisense, 5-TGT CAG CAC
ACCTGGGAGCTGTAG-3; IL-15 sense, 5-TGGCTGCTG
GAA ACC CCT TGC-3, IL-15 antisense, 5-CCC TGC ACT
GAAACAGCCCAAAA-3;DHRS3 sense, 5-AGCGCGGCG
CCA GAA AGA TT-3, DHRS3 antisense, 5-TCA CCC ACC
TTC TCC CGG ACG-3; and RETSAT sense, 5-CGC TGC
CTG CCA GGT GTG AAG-3, RETSAT antisense, 5-AGA
CGT AGC GCT CCA TCG CC-3.
Western blot analysis
Whole-cell protein extracts were obtained by direct lysis in
Laemmli buffer heated to 100°C. Proteins resolved by SDS-
PAGEwere transferred to a polyvinyl difluoride membrane (GE
Healthcare) and probed with antibodies raised against 11HSD1,
1:1000 (AB83522; Abcam); DHRS3, 1:1000 (15393-1-AP; Pro-
teinTech Group); RETSAT, 1:1000 (SAB1407586; Sigma); and
-actin, 1:100 000 (A1978; Sigma). After incubation with horse-
radish peroxidase-conjugated secondary antibodies diluted 1:2000
(DAKO), immunoreactivity was visualized using the ECL che-
moluminescent detection kit (Amersham).
Statistical analysis
Data were analyzed with the statistical package GraphPad
Prism (GraphPad Software Inc). A Student’s t test and aMann-
Whitney U test were used when appropriate. Logarithmic
transformations were used when data were not normally dis-
tributed. Pearson’s correlation coefficient (r) was used to as-
sess the correlation between uNK cell densities in vivo and the
induction of various genes upon decidualization of corre-
sponding primary HESC cultures. Statistical significance was
assumed when P  .05.
Results
Midluteal uNK cell density correlates inversely
with endometrial 11HSD1 expression
We routinely assess uNK cell densities by CD56 immu-
nostaining of timed (d LH7 to LH10) endometrial bi-
opsies from women suffering reproductive failure. Based
on previous studies, normal uNK cell density is defined as
5% or less CD56 cells in the stroma underlying the lu-
minal epithelium (17, 23).We speculated that an apparent
excess of uNK cells in the periimplantation endometrium
may reflect impaired 11HSD1 expression and relative
cortisol deficiency. To test this hypothesis, a TMA was
constructed using biopsies with normal (n 18) aswell as
elevated (n  18) uNK cell levels. The TMA was stained
with anti-CD56 and anti-11HSD1 antibodies. As shown
in Figure 1A, a strong inverse correlation was observed
between uNK cell density and 11HSD1 immunoreactiv-
ity. This negative correlationwas confirmed by semiquan-
titative image analysis (Figure 1B).
Elevated uNK cell density in vivo is associated
with impaired induction of key decidual markers
in vitro
Previous studies have shown that an aberrant decidual
response, associated with reproductive disorders such as
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endometriosis and RPL, is maintained in culture (24, 25).
This prompted us to investigate whether uNK cell density
in vivo could reflect the inductionof11HSD1 in response
to decidual cues. To this end, we divided timed endome-
trial biopsies and processed one part for CD56 immuno-
staining and the other part for primaryHESCs. These cul-
tures were passaged once, grown to confluency, and
treated with 8-bromo-cAMP, P4, and E for either 4 or 8
days. As shown in Figure 2, there was a striking inverse
correlation between uNK cell density in vivo and the re-
sponsiveness of paired primary cultures to differentiation
stimuli (Supplemental Table 1). This inverse correlation
was apparent for the induction of not onlyHSD11B1, the
gene that encodes 11HSD1 (Figure 2A) but also for PRL
and IGFBP1, two classical decidual marker genes (Figure
2, B and C).
We also examinedwhether this association extended to
IL-11 and IL-15, cytokines implicated in regulating uNK
cells (11–13). Rather surprisingly, there was a significant
trend toward higher levels of induction IL-15, but not
IL-11, transcripts in decidualizing HESC cultures ob-
tained from biopsies with normal uNK cell densities (Fig-
ure 3, A and B).
Elevated uNK cell density in vivo is associated
with impaired expression of MR-dependent
metabolic enzymes
Next, we used the TMA to examine the expression of
the cortisol-responsive receptors, GR and MR. As re-
ported by others (26), GR and MR are both expressed in
the endometrial stroma (Figure 4A). Semiquantitative
analysis of the TMA showed no difference in stromal GR
immunoreactivity in biopsies characterized by elevated vs
normal uNK cell levels. In contrast, an increased percent-
age of CD56 cell density was associated with signifi-
cantly lower MR expression levels (P  .05; Figure 4B).
Previous knockdown experiments in decidualizing
HESCs have shown that the 11HSD1/MR axis regulates
the expression of several enzymes involved in lipid me-
tabolism and retinoid acid biosynthesis and storage (18).
We measured the expression levels of two target genes,
DHRS3 and RETSAT, to monitor the MR activity in de-
cidualizing primary HESC cultures established from bi-
opsies with normal or elevated uNK cell levels. Both genes
were moderately induced upon treatment with 8-bromo-
cAMP/P4/E in a time-dependent manner when the pri-
mary HESC cultures were established from samples with
5%or lessCD56 cells in the subepithelial stroma (Figure
5). By contrast, this induction was significantly impaired
in cultures established from high uNK cell samples.
To validate these findings, we performed Western
blot analysis of primary HESCs decidualized with
8-bromo-cAMP/P4/E for 4 days. As shown in Figure 6A,
11HSD1 and DHRS3 were abundantly expressed in
primary cultures decidualized for 4 days. Induction of
RETSAT, however, requires prolonged decidualiza-
tion. This enzyme was barely detectable after 4 days of
differentiation and only in primary cultures established
from samples with 5% or less CD56 cells in the sub-
epithelial stroma. Semiquantitative analysis of the blots
showed that elevated uNK cell density in vivo is asso-
ciated with significantly lower 11HSD1 expression in
corresponding decidualizing primary HESC cultures
and a trend toward lower DHRS3 levels (P  .03 and
P  .07, respectively; Figure 6B).
Discussion
Increased uNK cell density in midluteal endometrium has
been associated with reproductive failure, especially RPL
(4–6) However, the mechanisms that account for cyclic
Figure 1. Inverse correlation between uNK cell density in the subluminal epithelium and expression of 11HSD1. A, Representative CD56 and
11HSD1 immunostaining in midluteal endometrial biopsies deemed to have normal or elevated uNK cell count (5% or 5% CD56 cells in the
stroma, respectively). Original magnification, 20. B, Relative 11HSD1 immunostaining after image analysis of a TMA containing biopsies with
normal (5%; n  18) or increased (5%, n  18) uNK cell density in the subluminal stroma. ***, P  .001.
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recruitment of uNK cell precursors and subsequent pro-
liferation and differentiation within the periimplantation
environment are notwell understood. In addition to IL-11
and IL-15, several other endometrial factors may be im-
plicated in this process, including chemokine motif ligand
14, IL-12, and IL-33 (25, 27, 28). Different strands of
evidence suggest that induction of a cortisol gradient upon
decidualization of HESCs is also a key regulator of uNK
cells in periimplantation endometrium. First, preconcep-
tual prednisolone treatment markedly reduces uNK cell
density inRPLpatients (17). uNKcells expressGRbut not
progesterone receptors (15), the inference being that glu-
cocorticoids are likely toact directlyon these cells. Second,
we found a strong negative correlation between uNK cell
densities and expression of 11HSD1 in differentiating
stromal cells in vivo. We have shown previously that
11HSD1expressionandenzymeactivity indecidualizing
HESCs is driven by cAMP and P4 signaling (18). Further-
more, inhibition of 11HSD1 activity with either carben-
oxolone disodium salt or PF 915275 virtually abolishes
the induction of HSD11B1, indicating that local cortisol
signaling reinforces the expression of this enzyme in de-
cidualizing cells through an autocrinemechanism (18). By
contrast, the expression of the type 2 isoform (11HSD2),
the dehydrogenase that converts cortisol into inactive cor-
tisone, is low in both undifferentiated and decidualizing
HESCs (18). Notably, the decidual process in the human
endometrium is under tight spatiotemporal control (29). It
is initiated in the midluteal phase of the cycle first in stro-
mal cells surrounding the terminal spiral arteries and un-
derlying the luminal epithelium. Thus, rather than the to-
tal tissue concentration of uNK cells, it is possible that
excessivemigration of uNK cells from their usual position
in the basal and perivascular regions of the endometrium
Figure 2. Inverse correlation between uNK cell densities in vivo and the induction of decidual markers in vitro. A, The uNK cell densities in
midluteal biopsies correlated inversely to the induction of 11HSD1 transcripts in primary HESCs decidualized for 4 days (left panel) or 8 days
(middle panel). Note the logarithmic Y-axis. The right panel shows the mean (SEM) induction of 11HSD1 transcripts in biopsies deemed to have
normal or elevated uNK cell counts. B, The uNK cell densities in midluteal biopsies correlated inversely to the induction of PRL transcripts in primary
HESCs decidualized for 4 days (left panel) or 8 days (middle panel). The right panel shows the mean (SEM) induction of PRL transcripts in biopsies
deemed to have normal or elevated uNK cell counts. Note the logarithmic Y-axis. C, The uNK cell densities in midluteal biopsies correlated inversely
to the induction of IGFBP1 transcripts in primary HESCs decidualized for 4 days (left panel) or 8 days (middle panel). The right panel shows the
mean (SEM) induction of PRL transcripts in biopsies deemed to have normal or elevated uNK cell counts. Note the logarithmic Y-axis. *, P  .05;
**, P  .01.
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to the subluminal region is the hallmark of an abnormal
decidual response that predisposes for early pregnancy
loss. Finally, there is increasing evidence that the respon-
siveness of endometrial cells to differentiation signals is
subject to epigenetic programming (30), which explains
how an aberrant decidual response in vivo is maintained,
at least partly, upon differentiation of purified HESCs in
vitro (24, 25, 31). In agreement, we found that high uNK
cell density in vivo is associated with blunted induction of
HSD11B1 as well as decidual marker genes, such as PRL
and IGFBP1, in primary cultures. This strong inverse cor-
relation suggests that the5%thresholdofuNKcell density
is somewhat arbitrary. Whether increased uNK cells den-
sities correlate to increased risk of pregnancy failure war-
rants further investigation.
In addition to decidual marker genes, induction of
IL-11 and IL-15 also tended to be lower in decidualizing
cells established from biopsies with elevated uNK cell lev-
els. This observation does not exclude that expression lev-
els of these cytokines in situ correlate with uNK cell levels
as reported for IL-15 in a recent study (32).
HumanuNKcells havebeendescribedas immature and
inactive before pregnancy (1).Howelevated levels of uNK
cells prior to conception predispose to subsequent preg-
nancy failure is unclear. Ablation of these cells in mice has
been shown to compromise spiral arteriole remodeling
andmaintenance of decidual integrity seen after midpreg-
nancy (3, 33). Yet uNK cell-deficient IL-15/ mice are
fertile and have normal gestation lengths and litter sizes
comparable with wild-type mice (34). Similarly, human
uNK cells are implicated in spiral artery remodeling. They
are a rich source of angiogenic growth factors, although
paradoxically the endometrium of RPL patients is char-
acterized by reduced expression of several key factors, in-
Figure 3. Induction of IL11 and IL15 mRNA in decidualizing HESCs in culture and uNK cell densities in vivo. A and B, The uNK cell densities in
midluteal biopsies were correlated to the induction of IL11 and IL15 transcripts, respectively, in corresponding primary HESCs decidualized for
either 4 days (left panel) or 8 days (middle panel). The right panel shows the mean (SEM) induction in biopsies deemed to have normal or
elevated uNK cell counts.
Figure 4. Increased uNK cell levels are associated with impaired MR
expression. A and B, The expression of GR and MR, respectively, in the
subluminal stroma was assessed by immunostaining of a TMA
containing biopsies with normal (5%; n  18) or increased (5%,
n  18) uNK cell density in the subluminal stroma. The left panel
shows representative immunostaining (original magnification, 40),
whereas the right panel depicts semiquantitative image analysis of the
immune staining. ***, P  .001.
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cluding platelet-derived growth factor-BB, angiotensin-2,
vascular endothelial growth factor-A, and vascular endo-
thelial growth factor-C (35). Our data suggest that in-
creased density of CD56 cells in the subluminal endo-
metrial stromal compartment may be an indirect marker
of local corticosteroid deficiency. Furthermore, our data
indicate that the 11HSD1/MR axis in target cells may be
particularly affected as exemplified by the impaired in-
duction of DHRS3 and RETSAT transcripts in decidual-
izing cultures established from high uNK cell biopsies.
These enzymes are involved in lipid metabolism and ret-
inoid acid (RA) biosynthesis and storage. Both shortage
and excess of RA contribute to fetal malformation, sug-
gesting that retinoidmetabolismmust be regulated closely
at the fetomaternal interface (36). Alcohol dehydrogenase
and nicotinamide adenine dinucleotide phosphate oxi-
dase-dependent short-chain dehydrogenases/reductases,
including DHRS3, oxidize retinal to retinol and promote
its storage as retinyl esters. Likewise, RETSAT is involved
in the regulation of retinoid storage as lipid droplets (37).
Interestingly, RA inhibits decidualization of HESCs, and
excess levels ofRAor retinal are cytotoxic (38). Thus, high
uNK cell density in the periimplantation endometrium
may be associated with perturbations in the retinoid me-
tabolism pathway in the stromal compartment, which in
turn predisposes for an impaired decidual response and
compromise histiotrophic support of the early conceptus.
Thus, it seems likely that complex and dynamic gradi-
ents of chemoattractants and chemorepellents control the
spatiotemporal distribution of uNK cells in the periim-
Figure 5. Elevated uNK cell density is associated with blunted expression of the MR-dependent genes in decidualizing HESCs. A, The uNK cell
densities in 21 biopsies correlated inversely to the induction of DHRS3 transcripts in primary HESCs decidualized for 4 days (left panel) or 8 days
(middle panel). The right panel shows the mean (SEM) induction of DHRS3 transcripts in biopsies deemed to have normal or elevated uNK cell
counts. B, The uNK cell densities in 21 biopsies correlated inversely to the induction of RETSAT transcripts in primary HESCs decidualized for 4 days
(left panel) or 8 days (middle panel). The right panel shows the mean (SEM) induction of RETSAT transcripts in biopsies deemed to have normal
or elevated uNK cell counts. *, P  .05; **, P  .01.
Figure 6. A, Composite figure showing 11HSD1, DHRS3, and RETSAT protein expression in primary HESC cultures decidualized for 4 days. A
total of eight primary cultures were established from biopsies with normal or elevated uNK cell densities. -Actin served as a loading control. B,
Semiquantitative analysis of 11HSD1 and DHRS3 expression relative to -actin. Because of the low level of expression, RETSAT expression was
not quantified. *, P  .05.
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plantation endometrium. In addition to glands and other
immune cells, decidualizing stromal cells play amajor role
in governing this process, at least partially, by inducing a
cortisol gradient that establishes a nutritive environment
essential for postimplantation embryo development and
fetal growth. Our data suggest that excessive uNK cells in
the subluminal stromal compartment prior to conception
may serve as a potential biomarker for a suboptimal de-
cidual response in pregnancy. A recent pilot randomized,
double-blind controlled clinical trial suggested an im-
provement in live birth rate with prednisolone in women
with RPL and high midluteal uNK cell density (23), al-
though this finding needs validating in a larger trial. In
addition, assessment of uNK cell density varies greatly
from laboratory to laboratory and intercycle variation has
been reported (22). To be clinically useful, international
standardizationofuNKcell assessment isurgentlyneeded.
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Induction of 11-HSD 1 and Activation of Distinct
Mineralocorticoid Receptor- and Glucocorticoid
Receptor-Dependent Gene Networks in Decidualizing
Human Endometrial Stromal Cells
Keiji Kuroda, Radha Venkatakrishnan, Madhuri S. Salker, Emma S. Lucas,
Fozia Shaheen, Masako Kuroda, Andrew Blanks, Mark Christian,
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The actions of glucocorticoids at the feto-maternal interface are not well understood. Here, we
show that decidualization of human endometrial stromal cells (HESCs) in response to progester-
one and cAMP signaling is associated with a strong induction of 11-hydroxysteroid dehydroge-
nase type 1 (11HSD1) expression and enzyme activity. Decidualization also triggered a gradual
decrease in glucocorticoid receptor (GR) expression and reciprocal increase in mineralocorticoid
receptor (MR) levels. Gene expression profiling of differentiating HESCs after small interfering
RNA (siRNA)-mediated knockdown of either GR or MR identified 239 and 167 significantly regu-
lated genes, respectively. Interestingly, GR-repressed genes were enriched for Krüppel-associated
box domain containing zinc-finger proteins, transcriptional repressors involved in heterochroma-
tin formation. In agreement, GR knockdown was sufficient to enhance trimethylated H3K9 levels
in decidualizing cells. Conversely, we identified several MR-dependent genes implicated in lipid
droplet biogenesis and retinoid metabolism. For example, the induction in differentiating HESCs
ofDHRS3, encoding a highly conserved enzyme that catalyzes the oxidation/reduction of retinoids
and steroids, was enhanced by aldosterone, attenuated in response to MR knockdown, and
abolished upon treatment with the MR antagonist RU26752. Furthermore, we demonstrate that
decidualization is associated with dynamic changes in the abundance and distribution of cyto-
plasmic lipid droplets, the formation ofwhichwas blocked by RU26752. In summary, progesterone
drives local cortisol biosynthesis by decidual cells through induction of 11-hydroxysteroid dehy-
drogenase type 1 (11HSD1), leading to transcriptional regulation of distinct GR and MR gene
networks involved in epigenetic programming and lipid and retinoid metabolism, respectively.
(Molecular Endocrinology 27: 192–202, 2013)
Glucocorticoids have been implicated in many pro-cesses that underpin successful embryo implanta-
tion, placentation, and the growth and development of
the fetus (1). Consequently, modulation of glucocorticoid
action represents a potential strategy for the treatment or
prevention of a variety of pregnancy-related disorders.
For example, glucocorticoid treatment has been advo-
cated for the prevention of early pregnancy loss based on
its ability to reduce the abundance of uterine natural killer
cells during the periimplantationwindow (2), to stimulate
human chorionic gonadotropin secretion by cultured hu-
man cytotrophoblasts (3), and to accelerate trophoblast
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growth and invasion (4). However, implantation is an
inflammatory process that depends on local release of
proinflammatory cytokines and prostaglandins (5–8). By
disabling the cytokine-prostaglandin signaling cascade,
glucocorticoids potentially could impact adversely on
early pregnancy events. Furthermore, compelling evi-
dence suggests that prolonged exposure to high levels of
glucocorticoids in pregnancy is detrimental for both pla-
cental and fetal development (9–11).
Tissue levels of active endogenous glucocorticoids de-
pend on the expression of 11-hydroxysteroid dehydro-
genase (11HSD) enzymes. Although the 11HSD1 iso-
form is a bidirectional enzyme, it predominantly catalyzes
the conversion of inert cortisone (E) to active cortisol (F),
thus increasing tissue levels of active glucocorticoids (12).
The reduced nicotinamide adenine dinucleotide [NAD(H)]-
dependent type 2 isoform (11HSD2) acts as a dehydro-
genase, converting F to E (13). The main cellular targets
for F are glucocorticoid receptor (GR) and mineralocor-
ticoid receptor (MR). However, GR normally colocalizes
with 11HSD1 in vivo, whereas 11HSD2 is commonly
found in MR-expressing tissues. Nevertheless, hypercor-
tisolism can result in apparent mineralocorticoid excess
as in Cushing syndrome (14). Further, some cell types like
adipocytes do not significantly express 11HSD2, thus
enabling F to act through MR (15, 16).
Both 11HSD isoforms as well as GR and MR are
expressed in human endometrium (17). Interestingly, GR
expression is confined to stromal cells, whereas MR is
reportedly present in both stromal and glandular com-
partments. Further, 11HSD1, but not 11HSD2, is
highly up-regulated upon differentiation of primary hu-
man endometrial stromal cells (HESCs) into specialist de-
cidual cells in vitro (18). This progesterone (P4)-driven
differentiation process bestows unique functions on the
endometrium that are essential for pregnancy, including
the ability to regulate trophoblast invasion, to modulate
local angiogenesis, to recruit specialized uterine natural
killer cells and macrophages, and to resist environmental
and oxidative stress (19, 20). Based on these observations,
we speculated that induction of 11HSD1 would lead to
increased F bioavailability, which in turn regulates the
expression of distinct GR- and MR-dependent gene net-
works in decidualizing HESCs.
Materials and Methods
Patient selection
This study was approved by the Hammersmith and Queen
Charlotte’s and Chelsea Research Ethics Committee (1997/
5065). Written informed consent was obtained from all partic-
ipating subjects before tissue collection. Endometrial biopsies
were timed between 7 and 11 d after the preovulatory LH surge.
Primary cell culture
Endometrial samples were obtained from premenopausal
women without uterine pathology, and HESCs were isolated,
cultured, and maintained as described previously (16). Samples
were collected in Earle’s buffered saline containing 100 U/ml
penicillin and 100 g/ml streptomycin. The tissues were washed
twice in a 1:1 mixture of DMEM and Ham’s F12 (DMEM/F12)
(Sigma, Poole, UK), finely minced, and enzymatically digested
with collagenase (134 U/ml) and deoxyribonuclease type I (156
U/ml) (Sigma) for 1 h at 37C. After centrifugation at 400 g for
4 min, the pellet was resuspended in maintenance medium of
DMEM/F12 containing 10% dextran-coated charcoal-treated
fetal bovine serum (DCC-FBS), 1% L-glutamine, and 1% anti-
biotic-antimycotic solution. Proliferating HESCs were cultured
in maintenance medium until confluence. In decidualization ex-
periments, confluent monolayers were maintained in DMEM/
F12 now containing 2% DCC-FBS and treated with 0.5 mM
8-bromoadenosine cAMP (8-bromo-cAMP) (Sigma, St. Louis,
MO) alone or in combination with 1 M medroxyprogesterone
acetate (MPA) (Sigma), 1 M P4 (Sigma), 0.1 M dexametha-
sone (DEX) (Sigma), 0.1 M E (Sigma), 1 M aldosterone
(Sigma), 10 M RU26752 (Sigma), 0.1 M carbenoxolone diso-
dium salt (CBX) (Sigma), or 0.1 M PF 915275 (PF) (Tocris
Bioscience, Abingdon, UK).
Transient transfection
Primary HESCs, cultured in 12-well plates until confluency,
were transfected using the ProFection mammalian transfection
kit (Promega, Madison, WI), with 100 nM per well of the fol-
lowing small interfering RNA (siRNA) reagents (Dharmacon,
Lafayette, CO): siCONTROL nontargeting (NT) siRNA pool,
GR siGENOME SMARTpool siRNA, or MR siGENOME
SMARTpool siRNA.
Western blot analysis
Whole-cell protein extracts were obtained by direct lysis in
Laemmli buffer heated to 100 C. Proteins resolved by SDS-
PAGEwere transferred to a polyvinyl difluoride membrane (GE
Healthcare, Uppsala, Sweden) and probed with antibodies
raised against GR, 1:1000 (E-20: SC-1003; Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA); MR, 1:1000 (H-300: SC-11412;
Santa Cruz Biotechnology, Inc.); 11HSD1, 1:1000 (ab83522;
Abcam, Cambridge, UK); 11HSD2, 1:2000 (ab80317; Ab-
cam); P4 receptor (PR), 1:1000 (NCL-L-PGR-312; Leica Bio-
systems, Newcastle, UK); histone 3 lysine 9 (H3K9) trimethyla-
tion (H3K9me3), 1:1000 (49-1008; Invitrogen Ltd., Paisley,
UK); dehydrogenase/reductase superfamily (DHRS)3, 1:1000
(15393-1-AP; Proteintech Group, Manchester, UK); and -ac-
tin, 1:100,000 (A1978; Sigma). After incubation with horserad-
ish peroxidase-conjugated secondary antibodies, 1:2500,
(Roche Diagnostics, Mannheim, Germany), chemiluminescence
receptor; GRIA1, glutamate receptor, ionotropic, 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-
yl)propanoic acid; HESC, humanendometrial stromal cell; H3K9, histone3 lysine 9;H3K9me3,
H3K9 trimethylation; 11HSD, 11-hydroxysteroid dehydrogenase; IGFBP1, IGF-binding pro-
tein 1; KRAB-ZNF, Krüppel-associated box domain containing ZNF; MPA, medroxyprogester-
one acetate; MR, mineralocorticoid receptor; NT, nontargeting; P4, progesterone; PF, PF
915275; PR, P4 receptor; PRL, prolactin; RA, retinoic acid; RTQ, real-time quantitative; siRNA,
small interfering RNA; WINT4, wingless-type MMTV integration site family, member 4; ZNF,
zinc-finger.
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was visualized using the ECL chemiluminescence detection kit
(Amersham, Little Chalfont, UK).
Real-time quantitative (RTQ)-PCR
Total RNA was extracted from primary HESC cultures. Af-
ter treatment with amplification grade deoxyribonuclease I (In-
vitrogen Ltd.), cDNAwas generated using the SuperScript First-
Strand Synthesis System for RT-PCR kit (Invitrogen Ltd.).
Template quantification was performed with an ABI Step One
System (Applied Biosystems, Foster City, CA) using Power
SYBRGreen PCRMasterMix (Applied Biosystems) as dye layer
and the relative standard curve calculation method. RNA input
variances were normalized against the levels of the L19 house-
keeping gene, which encodes a ribosomal protein. All measure-
ments were performed in duplicate. Specific primer pairs were
designed using Primer3 software (http://frodo.wi.mit.edu): L19
sense, 5-GCG GAA GGG TAC AGC CAA T-3 and L19-R
antisense, 5-GCA GCC GGC GCA AA-3; 11HSD1 sense,
5-AGC AAG TTT GCT TTG GAT GG-3 and 11HSD1 an-
tisense, 5-AGA GCT CCC CCT TTG ATG AT-3; GR sense,
5-CCC TAC CCT GGT GTC ACT GT-3 and GR antisense,
5-GGT CAT TTG GTC ATC CAG GT-3; MR sense, 5-GGC
ACT CGC TGG CCT GGA TG-3 and MR antisense, 5-GTC
TCC ATC GCT GCC TCG GC-3; decidual prolactin (PRL)
sense, 5-AAG CTG TAGAGA TTG AGGAGCAAA C-3 and
decidual PRL antisense, 5-TCA GGA TGA ACC TGG CTG
ACTA-3; IGF-binding protein 1 (IGFBP1) sense, 5-CGAAGG
CTC TCC ATG TCA CCA-3 and IGFBP1 antisense, 5-TGT
CTC CTG TGC CTT GGC TAA AC-3; wingless-type MMTV
integration site family, member 4 (WNT4) sense, 5-TCA GCC
CAC AGG GCT TCC AGT-3 and WNT4 antisense, 5-CGG
CTC GCC AGC ACG TCT TT-3; F-box only protein 32
(FBXO32) sense, 5-GCG GCA GTT TCG TGA GCG AC-3
and FBXO32 antisense, 5-GGG TGC AAT ATC CAT GGC
GCTCTT-3; glutamate receptor, ionotropic, 2-amino-3-(3-hy-
droxy-5-methyl-isoxazol-4-yl)propanoic acid (GRIA1) sense,
5-AAG GGG TCT GCC CTG AGA AAT CCA-3 and GRIA1
antisense, 5-ACG CCT GCC ACA TTG CTG AGG-3; zinc-
finger (ZNF)486 sense, 5-CTG GAG GAG TGG CAT TGC
CTG G-3 and ZNF486 antisense, 5-ACA CAC AAC TGG
GGG TTT GGC AAT-3; and DHRS3 sense, 5-AGC GCG
GCG CCA GAA AGA TT-3 and DHRS3 antisense, 5-TCA
CCC ACC TTC TCC CGG ACG-3.
Radio-thin layer chromatography
The activity of 11HSD1 in HESCs was analyzed essentially
as described in literature (21, 22). Briefly, the microsome-con-
taining fraction of undifferentiated and decidualized HESCs
was incubated with reduced nicotinamide adenine dinucleotide
phosphate (NADPH) (1 mM) and [3H] E. [14C] F (3 103 dpm)
was added to monitor procedural losses together with 50 g of
unlabeled F. The assay was performed under initial rate condi-
tions, and less than 12% of the substrate was converted to
product. Precursor and product steroids were separated by thin
layer chromatography using chloroform: methanol (9:1, vol/
vol). Retention factor values for F and E were 0.5 and 0.8,
respectively. The amount of radioactivity was measured by scin-
tillation spectrometry. Enzyme activity was determined as the
amount of product formed per milligram of protein per hour
after correction for procedural losses.
Microarray analysis
Genome-wide microarray analysis was performed on pri-
mary cultures established from four different patients. Each cul-
ture was first transfected either with NT-siRNA or siRNA oli-
gos against MR or GR. The cells were then decidualized for 4 d
with 8-bromo-cAMP, P4, and E. Total RNA was extracted us-
ing STAT-60 reagent (AMS Biotechnology, Abingdon, UK).
RTQ-PCR was performed after first-strand cDNA synthesis to
determine the level of GR and MR knockdown. RNA quality
was analyzed on an Agilent 2100 bioanalyzer (Agilent Technol-
ogies, Waldbronn, Germany). Microarray analysis on total
RNA samples was performed by UCL Genomics using Biocon-
ductor version 2.0 and R version 2.9.0. The robust multiarray
analysis algorithmwas used to obtain normalized data and gene
signals. This method performs within-chip and between-chip
normalizations in a single step. Gene summaries are generated
using the Affymetrix Expression Console software. The criteria
used to generate lists of differentially expressed genes are based
on standard filtering by fold change (50%change) and include
false discovery rate filter (P 0.05). Gene ontology annotation
was performed using the Database for Annotation, Visualiza-
tion, and Integrated Discovery Bioinformatics Resources 6.7
(SAIC-Frederick, Inc., Frederick, MD). Microarray data have
been deposited in GEO, accession number GSE42538.
Confocal microscopy and lipid droplets staining
Primary HESCs cultured on glass slides were fixed with 4%
paraformaldehyde (Sigma) and permeabilized by 0.1% Triton
X-100 (BDH Chemicals, London, UK). BODIPY 493/503 (In-
vitrogen Ltd.) was applied at 1 g/ml in PBS. BODIPY-stained
samples had to be washed with PBS before imaging. 4,6-Di-
amidino-2-phenylindole was used to identify nuclei. We exam-
ined samples under epifluorescent optics, and digital images
were obtained with a Zeiss 510 confocal laser scanning micro-
scope (Zeiss, Oberkochen, Germany).
Statistical analysis
Data presented in this study are representative of four or
more biological replicates (i.e. primary cultures established from
different biopsies). Statistical analysis was performed using a
Student’s t test after normalization of the data. The level of
significance was defined as P  0.05.
Results
Expression of 11HSDs, GR, and MR in
undifferentiated and decidualized HESCs
To examine whether corticosteroid signaling plays a
role in decidualization, we first examined the expression
levels of 11HSD1, 11HSD2, GR, and MR in undiffer-
entiated HESCs and cells differentiated with 8-bromo-
cAMP and MPA for 2, 4, 6, or 8 d. As shown in Fig. 1A,
decidualization of HESCs was associated with a remark-
able induction of 11HSD1 in a time-dependent manner.
This was paralleled by a strong increase in 11HSD1
enzyme activity in decidualizing cells (Fig. 1B). In con-
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trast, 11HSD2 expression was low in HESCs, and in the
absence of treatment with 8-bromo-cAMP and MPA, ex-
pression further declined in response to low-serum (2%
DCC-FBS) culture conditions. UndifferentiatedHESCs also
abundantly express GR. However, treatment with 8-bro-
mo-cAMP and MPA down-regulated this nuclear receptor
(Fig. 1A). MR followed a reversed pattern with expression
gradually rising in differentiating HESCs. Notably, cultur-
ing HESCs in low-serum conditions for several days was
sufficient to alter MR and GR expression in opposite direc-
tions, although the effect wasmuchmore pronounced upon
8-bromo-cAMP and MPA treatment (Fig. 1A).
We next examined the regulation of 11HSD1mRNA
in response to differentiation signals in 10 independent
primary cultures. As shown in Fig. 1C, 11HSD1 tran-
script levels invariably increased by several orders ofmag-
nitude in response to 8-bromo-cAMP and MPA treat-
ment. Furthermore, the down-regulation of GR and
reciprocal induction of MR at protein level in decidualiz-
ing cells were reflected at transcript level (Fig. 1, D and E).
P4 drives the expression of 11HSD1 in
decidualizing HESCs
MPA is a progestin with significant glucocorticoid ac-
tions.We therefore used P4 andDEX to examine whether
either PR or GR drives the induction of 11HSD1 in
differentiating HESCs. Time-course analysis demon-
strated that, in contrast to P4, DEX had little or no effect
on the induction of 11HSD1 transcripts in 8-bromo-
cAMP-treated cells (Fig. 2A). Compared with treatment
with 8-bromo-cAMP alone, addition of DEX did up-reg-
ulate 11HSD1 protein levels, although this response was
much more pronounced with 8-bromo-cAMP and P4
(Fig. 2B). Western blot analysis also revealed that cAMP
signaling drives the down-regulation of GR and recipro-
cal induction of MR in decidualizing cells (Fig. 2B). As
previously reported (23), 8-bromo-cAMP reduces cellular
levels of PR isoforms (PR-A and PR-B). Although cotreat-
ment with P4 induces a mobility shift in PR migration on
SDS-PAGE, reflecting ligand-dependent receptor phos-
phorylation, DEX had no effect (Fig. 2B). We also com-
FIG. 1. Expression of 11HSD enzymes, GR, and MR in decidualizing HESCs. A, Primary HESCs were treated with 8-bromo-cAMP and MPA in
time-course experiments lasting 8 d. Total protein lysates were harvested at the indicated time points and subjected to Western blot analysis for
11HSD1, 11HSD2, GR, and MR. -Actin served as a loading control. B, 11HSD1 activity was measured using radio-thin layer chromatography
in HESCs treated with 8-bromo-cAMP and MPA for the indicated time points. C, Induction of 11HSD1 mRNA in 10 independent primary cultures
treated with 8-bromo-cAMP and MPA for either 4 or 8 d. The data show fold change in expression relative to levels in undifferentiated HESCs
(dotted line). Note the logarithmic y-axis. The horizontal bar indicates median. *, P  0.05; **, P  0.001. D and E, The same sample set was
analyzed for GR and MR, respectively.
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pared the induction of two decidual markers, PRL and
IGFBP1, in primary cultures with 8-bromo-cAMP and
either P4 or DEX. Unlike P4, DEX had no effect on
cAMP-dependent induction of PRL transcripts in HESCs
(Fig. 2C). However, DEX was more potent than P4 in
enhancing IGFBP1 expression in cultures stimulated with
8-bromo-cAMP, especially during the early stages of the
decidual process (Fig. 2D).
To test whether 11HSD1-dependent F biosynthesis
modulates the expression of decidual marker genes, we
decidualized primary HESCs with 8-bromo-cAMP and
P4 in the presence or absence of E. Addition of E has no
effect on the induction of PRL. However, it strongly en-
hanced the expression of IGFBP1 and, albeit less pro-
nounced, 11HSD1 transcripts (Supplemental Fig. 1,
published on The Endocrine Society’s Journals Online
web site at http://mend.endojournals.org). Conversely,
treatment of primary cultures with an 11HSD1inhibitor
(CBX or PF) attenuated the induction of IGFBP1 and
HSD11B1 but not PRL (Supplemental Fig. 2). These ob-
servations underscore that 11HSD1-dependent F bio-
synthesis impacts selectively on the expression of decidual
marker genes.
Identification of GR- and MR-dependent genes in
decidualizing HESCs
Next, we set out to identify GR- and MR-dependent
genes responsive to endogenous F biosynthesis in differ-
entiating HESCs. To do this, four individual primary cul-
tures were first transfected with NT-, GR-, orMR-siRNA
and then treated with 8-bromo-cAMP, P4, and E for 4 d.
Total mRNA and protein lysates were extracted from
parallel cultures. Western blot analysis was used to con-
firm GR and MR knockdown (Fig. 3A). GR knockdown
had no impact on MR, 11HSD1, or PR levels. In con-
trast, MR silencing seemed to hinder the induction of
11HSD1 and modestly up-regulated GR levels.
Total RNA extracted from decidualizing cultures
transfected with NT-, GR-, or MR-siRNA was processed
for whole genome microarray analysis. Using a cut-off of
more than or equal to 1.5-fold change, 179 and 107 GR-
andMR-selective genes, respectively, were identified (P
0.05) (Fig. 3B). Interestingly, GR knockdown resulted in
significantly more up- than down-regulated genes (106
vs. 73, respectively; 2 test, P  0.001), whereas MR
knockdown had the opposite effect (up- and down-regu-
lated genes: 35 vs. 72, respectively; 2 test, P  0.001).
Supplemental Tables 1–4 list the genes induced or re-
FIG. 2. Glucocorticoids selectively modulate the expression of decidual marker genes. A, RTQ-PCR analysis of 11HSD1 transcript levels in HESCs
treated with 8-bromo-cAMP with or without P4 or DEX for 2, 4, and 8 d. The results show the fold change (mean  SEM) in 11HSD1 transcript
levels relative to vehicle control of four independent primary cultures. B, Western blot analysis of GR, MR, 11HSD1, and PR proteins in whole-cell
lysates obtained from primary HESCs treated with a combination of 8-bromo-cAMP with or without P4 or DEX for 4 d. -Actin served as a loading
control. C and D, Fold change (mean  SEM) in PRL and IGFBP1 mRNA levels, respectively, relative to vehicle control of four independent primary
cultures. Different letters above the error bars indicate that those groups are significantly different from each other at P  0.05.
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pressed byGR andMR.We also identified 60 genes under
control of both nuclear receptors in decidualizing HESCs
with only a single gene,GRIA1, regulated in an opposing
manner (Supplemental Table 5).We choseGRIA1 as well
as WNT4 and FBXO32 (putative GR- and MR-depen-
dent genes, respectively) for initial validation of the array
findings. Using independent cultures, we first monitored
the expression of these genes in response to treatment
with 8-bromo-cAMP, P4, and E for 4 or 8 d and then
examined the impact of either GR or MR knockdown.
GRIA1, which encodes for one of the four ionotropic
2-amino-3-(3-hydroxyl-5-methyl-isoxazol-4-yl)propanoic
acid receptor subunits (24), is profoundly repressed in dif-
ferentiating cells with transcript levels declining more than
90% after 4 d of treatment (Fig. 4A). This repression was
partially relieved upon GR knockdown but enhanced in re-
sponse to MR silencing (Fig. 4B).WNT4 and FBXO32 are
both induced upon decidualization predominantly in a GR-
and MR-dependent manner, respectively (Fig. 4). Interest-
ingly, FBXO32, which encodes the E3 ubiquitin ligases
Atrogin-1, was recently shown to be an 11HSD1-depen-
dent gene in skeletal muscle cells (25). In agreement, treat-
ment of primary cultures with either CBX or PF inhibited
FBXO32 andGRIA1 expression in decidualizing cells PRL
(Supplemental Fig. 2). In case of GRIA1, this suggests that
MR-dependent inductionmaybedominantoverGR-depen-
dent inhibition. However, 11HSD1 inhibition had no sig-
nificant effect on the induction of WNT4 in decidualizing
cells. Thus, like other steroid hormone receptors, GR and
MRmodify decidual gene expression in a ligand-dependent
and ligand-independent manner.
GR limits the expression Krüppel-associated box
domain containing ZNF (KRAB-ZNF) transcriptional
repressors
After correction for multiple testing (Benjamini and
Hochberg false discovery rate), gene ontology annotation
revealed that the genes repressed by GR were strongly
enriched for KRAB-ZNF proteins (P  0.0001). In fact, 18
members of this family of transcriptional repressors were up-
regulated upon GR knockdown: ZNF91, ZNF92, ZNF100,
ZNF253, ZNF254, ZNF311, ZNF420, ZNF484, ZNF486,
ZNF585A,ZNF586,ZNF613,ZNF624,ZNF625,ZNF626,
ZNF669, ZNF738, and ZNF791. Notably, the expression of
five (ZNF181, ZNF223, ZNF254, ZNF625, and ZNF669)
also increased uponMR knockdown (Supplemental Tables 4
and 5). Validation analyses demonstrated that the expression
of ZNF486 transcripts declines modestly upon treatment of
HESCswith8-bromo-cAMP,P4, andE (Fig. 5A, left panel). In
agreement with the array findings, GR knockdown selective
up-regulated ZNF486mRNA levels in differentiating HESCs
by approximately 2-fold (Fig. 5A, right panel).
KRAB-ZNF proteins block transcriptional initiation
by recruiting a variety of chromatin modifiers to promot-
ers of target genes, resulting in an increase in H3K9me3
(26, 27). We therefore decided to monitor this repressive
chromatin mark to determine whether GR plays a role in
chromatin remodeling that underpins the decidual phe-
notype (28). Western blot analysis revealed a gradual de-
cline in global H3K9me3 levels in response to differenti-
ation cues (Fig. 5B, left panel). Knockdown of GR, and
perhaps to a lesser extent of MR, was sufficient to reverse
this response (Fig. 5B, right panel).
MR is essential for retinoid metabolism and lipid
droplet biogenesis
In contrast to GR, MR acts primarily as a transcrip-
tional activator in decidualizing HESCs (Supplemental
Tables 1 and 5). Perhaps the most striking observation is
that several MR-induced genes encode for key enzymes
involved in retinoid metabolism and cholesterol homeo-
stasis, including retinol saturase, members of the short-
chain DHRS (DHRS3, DHRS4, and DHRS4L2), the dehy-
drocholesterol reductase DHCR7, and the steroidogenic
acute regulatory protein-related lipid transfer protein do-
main containing protein STARD5. To validate the array
findings, we focused on DHRS3 (also known as retinal
short-chain dehydrogenase/reductase 1). This enzyme was
FIG. 3. Identification of GR- and MR-regulated genes in decidualizing
HESCs. A, Western blot analysis of GR, MR, 11HSD1, and PR
expression in protein lysates extracted from primary cultures first
transfected with NT-, GR-, or MR-siRNA and then treated with 8-
bromo-cAMP, P4, and E for 4 d. -Actin served as a loading control. C,
Venn diagram showing the number of differentially expressed genes in
decidualizing cells treated with 8-bromo-cAMP, P4, and E for 4 d in
response to GR or MR knockdown.
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highly induced at both mRNA and protein level in a time-
dependent manner upon treatment of primary HESCs with
8-bromo-cAMP, P4, and E (Fig. 6A). MR knockdown at-
tenuated the induction ofDHRS3 transcripts in decidualiz-
ing cells (Fig. 6B, right panel). To further explore MR de-
pendency of DHRS3 expression in decidualizing cells,
primary cultureswere treatedwith 8-bromo-cAMP, P4, and
either aldosterone or RU26752, a MR antagonist (29, 30).
Although addition of aldosterone potentiated the induction
DHRS3 in cells differentiated with 8-bromo-cAMP and P4,
RU26752 completely abolished this response (Fig. 6B, right
panel).
DHRS3 has recently been implicated in endoplasmic
reticulum (ER)-derived lipid droplet formation (31).
Loading of primary HESCs with a cell-permeable lipo-
philic fluorescence dye, BODIPY 493/503, followed by
confocal microscopy demonstrated that decidualization
is associated with highly dynamic changes in the appear-
ance of these cytoplasmic lipid droplets. Undifferentiated
HESCs contain numerous small droplets. Unexpectedly,
these lipid droplets were consistently less abundant after
4 d of differentiation (Fig. 6C). By d 8, the droplets had
reaccumulated especially near the periphery of the cells.
Four days later, fewer but larger and more centrally lo-
calized lipid droplets were present in decidualizing
HESCs (Fig. 6C). Next, we treated pri-
mary cultures with 8-bromo-cAMP,
P4, and either aldosterone or RU26752
for 8 d. Interestingly, although addi-
tion of aldosterone favored the forma-
tion of larger droplets, RU26752 virtu-
ally abolished their presence all
together (Fig. 6D).
Discussion
Elevated circulating P4 levels maintain
thematernal decidual response in preg-
nancy and are therefore indispensable
for survival of the fetus. However, cir-
culating levels of androgens, aldoste-
rone, and F also increase in early preg-
nancy (10, 32–34). Furthermore, the
endometrium expresses the full com-
plement of cognate receptors as well as
a host of steroidogenic enzymes that
will determine the local bioavailability
of different ligands. For example, in-
creased expression accounts for the
higher conversion of testosterone to di-
hydrotestosterone in secretory com-
pared with proliferative endometrium
(35, 36). We now show that P4 drives by 11HSD1 ex-
pression, which is further reinforced by F production and
signaling. This positive feedback mechanism renders
HSD11B1 one of the most highly induced genes upon
HESC differentiation (18). We further show that decidu-
alization is also associated with a rebalancing of cortico-
steroid receptors in favor of MR.
MR and GR show significant amino acid homology in
their ligand- and DNA-binding domains with PR and an-
drogen receptor (AR) (37). Together, these four receptors
constitute the 3-ketosteroid receptor subfamily of nuclear
receptors. The structural homology between these recep-
tors implies that a degree of promiscuity may exist in the
binding of various natural or synthetic ligands. This is
indeed the case. For example, P4 binds MR, although the
physiological consequences of this interaction, if any, are
still unknown (38). Similarly,MPA, which unlike P4 does
not have the propensity to partition onto glass and plastic
in culture, is widely used to study PR responses in vitro,
yet it is also a potent activator of GR and AR (35, 39).
Structural homology also raises the possibility of func-
tional redundancy between these receptors. In a previous
study, we showed that this is not the case for PR and AR
(35). By combining siRNA-mediated knockdownwith ge-
FIG. 4. Expression and validation of putative GR- and MR-dependent genes in decidualizing
HESCs. A, Expression of the putative GR- and MR-dependent genes in primary cultures
treated 8-bromo-cAMP, P4, and E for the indicated time points. The results show mean fold
change (SEM) relative to levels in undifferentiated cells (dotted lines). B, Independent primary
cultures (n  3) not used in the array analysis were first transfected with NT-, GR-, or MR-
siRNA and subsequently treated with 8-bromo-cAMP, P4, and E for 4 d. Transcript levels were
measured by RTQ-PCR and expressed as fold-induction (SEM) relative to expression levels in
transfected HESCs with NT-siRNA before differentiation (dotted lines). *, P  0.05.
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nome-wide expression profiling, we showed that AR signal-
ing is essential for cytoskeletal organization and cell cycle
regulation in decidualizing cells. PR knockdown deregu-
lated approximately nine times more genes than AR silenc-
ing (92 vs. 860 genes, respectively). Interestingly, a signifi-
cant number of PR-regulated genes encode for membrane-
bound receptors and intermediates in various signal
transduction pathways, suggesting that P4 dependency of
the decidual phenotype is, at least in part, accounted for by
PR-dependent reprogramming of pathways activated by
growth factors and cytokines (35).
We adopted a similar approach to identify MR- and
GR-dependent genes in differentiating HESCs. However,
we decided against using MPA, because it introduces a
bias in favor of GR responses. Instead, we combined
8-bromo-cAMP with P4 and added E as the substrate for
11HSD1 conversion. After 4 d of treatment, we identi-
fied 179 and 107 deregulated genes upon GR or MR
knockdown, respectively. Like PR (35), GR represses sig-
nificantly more genes than it induces in decidualizing
cells. The number of up- and down-regulated genes upon
AR knockdown is comparable, whereas MR functions
primarily to promote the expression of certain decidual
genes. Cross-referencing of the array data identified only
12 genes that are regulated by PR or AR as well as GR or
MR (Supplemental Table 6).
Mining of the GR-dependent genes yielded some un-
expected results. For example, GR represses the expres-
sion of SPP1 (osteopontin), a major component of the
embryo-endometrial interactome (40), suggesting that
glucocorticoid exposure during the window of implanta-
tion may interfere with embryo implantation. GR stimu-
lated the induction of WNT4, a key component of P4
responses in both the uterus and breast (41, 42). Further,
GR as well as MR signaling may be important for sus-
tained cAMP activity in decidualizing cells by up-regulat-
ing the -catalytic subunit of protein kinase A (PRKACA)
(Supplemental Table 5).
However, the most striking observation was that GR
activity attenuates the induction of 18 KRAB-ZNF pro-
teins.With 675 encoding genes, the C2H2 zinc-finger pro-
teins comprise the largest family of regulatory proteins in
mammals, and 36% contain a KRAB domain (27, 43,
44). Over 50%of all humanKRAB-ZFP genes are located
in clusters on chromosome 19, including 15 of the 18
genes found to be regulated by GR in this study. The
functions of these GR-repressed KRAB-ZFP genes are un-
known with the exception of ZNF420, which encodes
ATM and p53-associated krüppel type zinc finger pro-
tein, a negative regulator of p53-mediated apoptosis (45).
However, it is well established that the KRAB domain
confers a potent transcriptional repressor function byme-
diating specific interactions with a corepressor protein,
kru¨ppel-associated protein 1 (encoded by TRIM28),
which in turn serves to recruit chromatin deacetylation
machinery (46–48), as well as methyltransferase com-
plexes (27). Because KRAB-ZNF transcription factors
have been implicated in trimethylating H3K9 (27), we
decided to monitor the cellular levels of this histone mark
upon differentiation of HESCs. Perhaps somewhat fortu-
itously, this line of inquiry showed that decidualization is
associated with a decline in global cellular H3K9me3 lev-
els, which is disrupted upon GR knockdown.
Analysis of genes deregulated upon MR knockdown
highlighted the dynamic changes in lipid droplet forma-
tion and retinoid metabolism that occur upon decidual
transformation of HESCs. Although the MR dependency
of these metabolic functions in decidualizing HESCs was
unanticipated, it is in keeping with the observation that
silencing of this nuclear receptor in murine adipocytes
completely prevents lipid accumulation (49). In contrast,
GR knockout only mildly impairs adipogenesis. Aldoste-
rone has been shown to promote adipose conversion of
3T3-L1 and 3T3-F442A cells, whereas DEX inhibits ter-
minal adipocyte maturation (50). Further, two MR-de-
pendent genes in decidualizing HESCs, RETSAT and
DHRS3, are strongly implicated in both intracellular lipid
accumulation and retinoid metabolism (31, 51).
FIG. 5. GR signaling plays a role in chromatin remodeling in
decidualizing HESCs. A, ZNF486 transcript levels were measured in
four primary cultures treated 8-bromo-cAMP, P4, and E for the
indicated time points (left panel) as well as in cultures decidualized for
4 d after GR or MR knockdown (right panel). The results show mean
fold change (SEM) relative to levels in undifferentiated cells (dotted
lines). *, P  0.05. B, Western blot analysis of H3K9me3 expression in
total protein lysates from primary cultures treated 8-bromo-cAMP, P4,
and E for the indicated time points (left panel) as well as from cultures
decidualized for 4 d upon GR or MR knockdown (right panel). -Actin
served as a loading control.
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Retinoic acid (RA), the biologically active metabolite
of vitamin A (retinol), is essential for embryogenesis and
maintenance of pregnancy. Both RA deficiency and ex-
cess cause severe fetal malformation, suggesting that ret-
inoid metabolism must be tightly controlled at the feto-
maternal interface (52–54). RA is derived from oxidation
of all-trans-retinaldehyde (retinal), an unstable interme-
diate that fluxes between retinol andRA. BecauseDHRS3
is a retinaldehyde reductase that promotes storage of ret-
inol in lipid droplets, its level of expression may be an
important mechanism to modulate local RA availability
(31, 55). We now show that DHRS3 levels are low in
undifferentiated HESCs, but expression increases mark-
edly upon decidualization, in parallel with the induction
of 11HSD1. In fact, both enzymes are structurally re-
lated members of the SDR superfamily
that localize to the ER (56). The termi-
nal enzymes involved in the synthesis
of lipid droplets also localize to the ER
and often to droplets themselves, as is
the case for DHRS3 (31). Thus, the dy-
namic changes in the appearance and
abundance of lipid droplets in decidu-
alizing HESCs may at least partly re-
flect the changing nature of ER-resi-
dent enzymes. Lipid droplets are often
viewed as mere energy storage facili-
ties, containing predominantly neutral
lipids and various proteins (57). Based
on our observations, it is tempting to
speculate that the constituents and
functions of these lipid droplets also
change upon decidualization of
HESCs, perhaps becoming more akin
to the retinyl ester storage particles
(retinosomes) present in the eye (58).
In summary, our observations sug-
gest that decidualization of the endo-
metrium promotes the formation of a
corticosteroid gradient at the feto-ma-
ternal interface. Although F is virtually
absent in the placenta due to the abun-
dant expression of 11HSD2 (59, 60),
its production on the maternal side
may exert important autocrine as well
as paracrine functions. For example,
local F biosynthesis could constitute a
major mechanism that protects the fe-
tal allograft against a potential mater-
nal immune response. Importantly, our
data also suggest that MR is a central
regulator of the metabolic functions of
the maternal decidua. This may be of particular impor-
tance to human pregnancy, because perfusion of the pla-
centa is not established before 10–12 wk of gestation
(61). Consequently, throughout the process of organo-
genesis (3–8 wk of pregnancy), fetal nutrition depends
entirely on secretions produced by endometrial glands
and decidualizing stroma (62, 63). The role of the endo-
metrial 11HSD1/GR/MR pathway in reproductive fail-
ure clearly warrants further investigation.
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